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Genetic and pharmacological investigation of α4-containing GABAA receptors in 
conditioned behaviours influenced by cocaine 
 
α4-subunit containing GABAA receptors (α4-GABAARs) are often found co-assembled 
with δ-subunits in extrasynaptic locations on nucleus accumbens (NAc) medium spiny 
neurons (MSNs), were they mediate a tonic form of inhibition thought to control the 
excitability of the neuron. This thesis combines genetic and pharmacological techniques 
to explore the role of α4-GABAARs in locomotor and reward-conditioned behaviours. 
 
Activation of α4-GABAARs by systemic or intra-accumbal administration of THIP, a 
GABAAR agonist with a preference for δ-subunits, was able to reduce cocaine-
potentiated locomotor activity in wildtype but not GABAAR α4-subunit knockout mice. 
Similarly, the ability of repeated cocaine to induce behavioural sensitisation was 
unaffected in GABAAR α4-subunit knockout mice, but systemic THIP was able to 
reduce the sensitised increase in locomotor activity in wildtype but not knockout mice. 
α4-GABAARs are also able to modulate behavioural responses to reward-conditioned 
stimuli and their enhancement by cocaine. Deletion of GABAAR α4-subunits from 
dopamine D1-expressing neurons facilitated cocaine-CPP, and activation of α4-
GABAARs on NAc D1-MSNs was able to attenuate cocaine-enhancement of cocaine 
CPP. Conversely, deletion of GABAAR α4-subunits from dopamine D2-expressing 
neurons increased CRf responding, and activation of α4-GABAARs on NAc D2-MSNs 
was able to attenuate cocaine-potentiation of CRf responding. These data also indicate 
that there is a dissociation in the NAc MSNs mediating cocaine-CPP and CRf 
responding. This may be explained by the different glutamatergic inputs needed to 
provide information about conditioned cues important for these behaviours.  
 
The data presented within this thesis indicate that α4-GABAAR-mediated inhibition of 
D1- and D2-expressing neurons plays an important physiological role in controlling 
behavioural responses to conditioned cues. Furthermore, NAc α4βδ GABAARs may 
provide a potential therapeutic target by which to limit the enhancement of locomotor 
and conditioned-behaviours by cocaine. 	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Chapter 1 
 
Introduction 
 
1.1. The nature of drug abuse and addiction 
 
Recent world health organisation (WHO) statistics estimate that between 3.4-6.6% of 
the global adult population used an illicit drug in the five years leading up to, and 
including 2010 (World Health Organization, 2012). Within the UK alone approximately 
5.6 million adults (8.9% of the national population) used an illicit drug in 2012 (UK 
Home Office, 2012). Of these users, some 10-13% continue to be problem users with 
drug dependence and/or use disorders (British Medical Association, 2012). While the 
use of many illicit drugs has fallen in recent years, global cocaine use has remained 
stable, with between 13.2-19.5 million users worldwide (World Health Organization, 
2012), Indeed, within the UK, approximately 2.2% of adults (1.4 million people) are 
reported to have used cocaine within 2012 (UK Home Office, 2012). With the cost of 
Class A drug-related crime estimated to be approximately £100billion since 1998, with 
an extra £10billion in health costs, it is clear that substance abuse and addiction to drugs 
of abuse, including cocaine, are considerable economic and social problems (British 
Medical Association, 2012). Thus there is an explicit need for comprehensive research 
into the cellular, molecular, genetic and behavioural etiology of addiction to drugs of 
abuse, in order to provide efficacious treatments. 
 
1.2. Why study GABAA receptors in the context of addiction? 
 
γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter within the 
mammalian central nervous system and thus is critically involved in the regulation of 
neuronal excitability. GABAA receptors (GABAARs) are widely distributed throughout 
the brain and are extremely heterogeneous, with individual subunit compositions 
conferring a broad range of physiological properties and functional roles. It is now clear 
that GABAARs may play an important role in mediating the rewarding and motivational 
properties of addictive drugs. Indeed, GABAARs are reported to influence the effects of 
many abused drugs, including; psychostimulants, alcohol, benzodiazepines and 
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barbiturates. Consequently, compounds altering the activity of specific GABAAR 
subtypes may also prove efficacious in the treatment of addiction to drugs of abuse. 
 
This thesis will explore the role of α4-containing GABAARs (α4-GABAARs) in 
behaviours associated with addiction to drugs of abuse. Furthermore, the role of α4-
GABAARs in controlling cocaine influences on addiction-related behaviours will also 
be explored. This introduction will begin by describing reward-associated neuronal 
circuitry and properties of GABAARs. Finally, GABAAR-associated control of 
addiction-related behaviours will be discussed.  
 
1.3. Reward circuitry and GABAergic components 
 
1.3.1. The Basal Ganglia 
 
The basal ganglia (BG) are a collection of interconnected subcortical nuclei, including 
the striatum, globus pallidus externa (GPe) and interna (GPi), substantia nigra pars 
compacta (SNc) and pars reticulata (SNr), and subthalamic nucleus (STN). Regions 
within the BG are anatomically linked to the cerebral cortex and thalamo-cortical motor 
system via a series of parallel, but largely structurally and functionally distinct cortico-
subcortical circuits (Alexander and Crutcher, 1990; Haber, 2003). This topology is 
proposed to dynamically and adaptively mediate the flow of information from the 
frontal cortex to the motor system, resulting in facilitation or inhibition of competing 
actions (Mink, 1996; Nicola, 2006). Thus, the BG are critical for the coordination of 
cognitive, motor and emotional functions, and their dysfunction underlies a multitude of 
neuropathologies (Alexander and Crutcher, 1990; Haber, 2003; Cohen and Frank, 
2009).  
1.3.1.1. Basic circuit anatomy of the Basal Ganglia 
 
Classically, BG loops are identified according to the presumed role of the main cortical 
projection areas, and have been subdivided as; motor, oculomotor, limbic, associative, 
and orbitofrontal circuits (Alexander et al., 1986; Alexander and Crutcher, 1990; 
DeLong and Wichmann, 2007). Alternatively, these circuits have also been functionally 
categorized into the; motor, visual, executive, and motivational loops (Seger, 2008; 
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Seger and Spiering, 2011). Each of these loops share certain topological features 
common to all cortico-subcortical circuits. Specific regions of the cortex send excitatory 
glutamatergic projections to the input structures of the BG, including the striatum and 
STN (Alexander and Crutcher, 1990). From here, the BG ouput nuclei, including the 
GPi, SNr and ventral pallidum exert a tonic GABA-mediated inhibitory control over 
their target nuclei in the thalamus. Finally, the thalamus then sends excitatory 
glutamatergic projections back to the cortex, thus completing the ‘loop’.  
1.3.1.2. Basal Ganglia Pathways 
Within each circuit, the influence of neuronal afferents coding for specific actions or 
tasks are modulated with the support of three different pathways, passing from the 
cortex to the thalamus, known as the ‘direct’, ‘indirect’ and ‘hyperdirect’ pathways.  
The direct pathway, often referred to as the “Go” pathway, originates in dopamine D1-
receptor expressing striatonigral neurons co-expressing the peptides substance-P and 
dynorphin (Vincent et al., 1982; Christensson-Nylander et al., 1986). Neurons in the 
direct pathway form monosynaptic inhibitory connections with SNr/GPi neurons, 
suppressing inhibition of the thalamus, and ultimately disinhibiting selected behaviours 
(Chevalier et al., 1985; Chevalier and Deniau, 1990). Contrary to the direct pathway, 
the indirect pathway, termed the “NoGo” pathway, originates in dopamine D2-receptor 
expressing striatopallidal neurons co-expressing enkephalin (Beckstead and Kersey, 
1985; Gerfen et al., 1990). Neurons within the indirect pathway project to the GPe and 
onto the SNr/GPi complex via a polysynaptic disinhibitory connection, and an indirect 
GPe-STN-GPi connection, ultimately inhibiting the thalamus and suppressing selected 
behaviours (Albin et al., 1995; Cohen and Frank, 2009).  
More recently the importance of the STN has been highlighted, with the discovery of 
the cortico-subthalamo-pallidal “hyperdirect” pathway, in which cortical afferents 
bypasses the striatum altogether, projecting directly to the STN (Nambu et al., 2002). 
This pathway has been termed the “Global NoGo” pathway as the STN sends diffuse 
excitatory projections to many GPi neurons, producing a global rather than selective 
suppression of responses (Frank, 2006; Cohen and Frank, 2009). It has been proposed 
that this pathway is especially important for premature response inhibition, and 
termination of initiated behaviours (Aron and Poldrack, 2006; Frank, 2006). 
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Figure 1.1. 
          
Fig.1.1. A simplified model of striatal direct, indirect and hyperdirect pathways. 
Striatonigral D1 direct pathway neurons inhibit the GPi/SNr and release inhibition of 
thalamic activity, promoting behaviour. Whereas, striatonigral D2 indirect pathway 
neurons inhibit the GPe, disinhibiting the STN and exciting the GPi/SNr, which 
ultimately inhibits the thalamus and thus suppresses behaviour. The cortico-
subthalamo-pallidal hyperdirect pathway also suppresses behaviour by exciting the 
STN, which then excites the GPi/SNr resulting in an inhibition of the thalamus. The 
balance between these opposing projections is likely to be regulated by both 
dopaminergic and GABAergic signaling within the striatum. mPFC, medial prefrontal 
cortex; NAc, nucleus accumbens; VTA, ventral tegmental area; SNc, substantia nigra 
pars compacta; SNr, substantia nigra pars reticulata; GPe, external globus pallidus; 
GPi, internal globus pallidus; STN, subthalamic nucleus. 
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1.3.1.3. The Striatum 
Effective BG action selection is contingent upon the precise modulation of neuronal 
excitability within each of the BG nuclei, a role thought to be principally mediated by 
neurons within the largest component and primary afferent structure of the BG, the 
striatum.  
1.3.1.3.1. Striatal Medium Spiny Neurons (MSNs) 
The vast majority of neurons within the striatum are GABAergic projection medium 
spiny neurons (MSNs), accounting for approximately 95% of the total neuronal 
population (Wilson, 1993). MSNs are the target of glutamatergic inputs from the cortex, 
ventral hippocampus, amygdala and thalamus synapsing at the spines, as well as 
midbrain dopaminergic projections received at the dendrites and spine necks (Smith et 
al., 1994). Striatopallidal MSNs are a major target for topographical sensorimotor 
corticostriatal projections, afferents from neighbouring regions of the cortex projecting 
to neighbouring regions of the striatum (Berretta et al., 1997; Wright et al., 1999). 
Classically, MSNs have been characterised electrophysiologically by their 
hyperpolarized resting membrane potential and low input resistance (Kita et al., 1984). 
More recently the development of bacterial artificial chromosome (BAC) transgenic 
mice expressing enhanced green fluorescent protein (eGFP) under the control of 
promoters for D1 and D2 receptors has allowed for the investigation of distinct 
physiological differences between striatonigral and striatopallidal MSNs. Whole-cell 
patch-clamp recordings revealed D2-expressing indirect-pathway MSNs to exhibit larger 
EPSPs and greater repetitive spiking than D1-expressing direct-pathway MSNs (Kreitzer 
and Malenka, 2007). This physiological dichotomy may in part be explained by 
anatomical differences between D1- and D2 MSNs; D1 MSNs have a considerably 
greater dendritic surface area than that of D2 MSNs (Gertler et al., 2008). However this 
difference was not attributable to greater branching or length of dendrites, but to a 
greater total number of primary dendrites on D1 MSNs. 
Early in vivo recordings also revealed striatal MSNs to demonstrate irregular burst 
firing, accompanied by a shift between two preferred subthreshold membrane potential 
states (Wilson and Kawaguchi, 1996). Membrane potentials alternate between a resting 
hyperpolarized ‘down’ state (-90 to -70 mV), and a less hyperpolarized ‘up’ state (-60 to 
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-40 mV). Irregular spike discharge and spontaneous burst firing are observed only 
during the up state during which MSNs are only a few millivolts (3-5 mV) below spike 
threshold (Wilson and Groves, 1981). Thus the transition from the down state to the up 
state is proposed to be critical for spike firing in MSNs.  
The two-state behaviour of MSNs arises from both their intrinsic membrane properties, 
and phasic changes in the excitatory inputs they receive (Wilson and Kawaguchi, 1996). 
During the down state the input resistance of MSNs is low (10-30 MOhms), creating a 
stable membrane potential that is relatively insensitive to small synaptic inputs. This 
inward rectification is created by the high expression of hyperpolarization-activated 
KIR2 potassium channels, which move the membrane potential closer to the potassium 
reversal potential and therefore limit membrane depolarization (Nisenbaum and Wilson, 
1995). However, in the presence of a sufficiently strong synchronous depolarizing input, 
MSNs can shift to an outwardly rectifying up state (Blackwell et al., 2003). This up 
state is dependent upon sustained excitatory input and is modulated by the influence of 
depolarization-activated potassium channels, largely in the Kv1 family, which maintain 
the membrane potential within a relatively narrow range marginally below the spike 
threshold (Shen et al., 2004). Given the action of these intrinsically rectifying ion 
channels it has been questioned what kind of synaptic input can trigger spiking in the up 
state? One possibility is that brief depolarisations following rapidly changing synaptic 
currents provide a window during which large sudden inputs can trigger a spike before 
voltage-sensitive channels are recruited to oppose their action (Wilson, 1995). Another 
possibility is that GABAergic activity may synchronise with large excitatory inputs to 
enable spikes to be triggered. 
GABAergic activity has been revealed to be involved in the generation of the up state in 
striatal MSNs (Kita, 1996). Although GABAergic inputs to MSNs have classically been 
considered inhibitory, activation of GABAARs has been demonstrated to produce 
excitatory effects under certain physiological conditions (Cherubini et al., 1991; 
Gulledge and Stuart, 2003). The reversal potential of GABAA-mediated synaptic 
responses in MSNs lies within the range for activation by outwardly rectifying up state 
currents (Misgeld et al., 1982). It has been shown that when the up state in MSNs is 
below the reversal potential of GABAA inputs, inhibition from fast-spiking interneurons 
results in depolarisation of MSNs (Plenz and Kitai, 1998), further adding to the 
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excitatory cortical inputs directly onto the MSNs. 
1.3.1.3.2.  Striatal Interneurons 
The remaining 5% of striatal neurons consist of aspiny interneurons and can be 
characterised anatomically and histochemically as large cholinergic interneurons, and 
medium-sized GABAergic interneurons, divided into (a) parvalbumin-, (b) 
somatostatin-, neuropeptide Y- and nitric oxide synthase-, and (c) calretinin-expressing 
interneurons (Kawaguchi et al., 1995). In comparison with MSNs, receptor phenotype 
and functional role of these striatal interneurons remain relatively unclear. 
The best best-explored interneurons, cholinergic interneurons, are characterised 
morphologically by their large (20-50um diameter) cell body and widespread dendritic 
and axonal fields (Wilson et al., 1990; Kawaguchi et al., 1995). Electrophysiologically, 
in vivo recordings reveal cholinergic interneurons to exhibit slow irregular but tonic 
spontaneous activity (2-10Hz), a depolarised resting potential and long-duration action 
potentials (Wilson et al., 1990; Bennett et al., 2000). In addition to excitatory 
innervation from the thalamus and cortex, cholinergic interneurons receive inhibitory 
GABAergic inputs from MSNs (Bolam et al., 1986; Chang, 1988; Brown et al., 2012). 
Although few in number (1-2% of striatal cells), these interneurons exert a powerful 
influence over the striatum, integrating synaptic inputs over an extensive area, and 
projecting to multiple MSNs, and to a lesser extent, fast-spiking parvalbumin-
expressing interneurons (Bolam et al., 1984; Chang and Kita, 1992). More recently it 
has been argued that cholinergic interneurons are heavily involved in reward-based 
learning and act as key mediators of dopamine-dependent striatal plasticity (Wang et al., 
2006). Midbrain dopamine neurons and tonically active striatal cholinergic interneurons 
are known to act cooperatively, dynamically modifying their activity to signal reward-
related events (Cragg, 2006). A pause in the tonic activity of cholinergic interneurons in 
response to salient cues is proposed to serve as a ‘temporal window’, allowing phasic 
dopaminergic activity to be distinguished from previously gated tonic dopamine states 
(Morris et al., 2004). This complex partnership makes it is possible for dopamine to 
signal what to learn, and cholinergic interneurons to signal when to learn. This is further 
supported by recent evidence that GABA projection neurons from the ventral tegmental 
area (VTA) synapse almost exclusively on NAc cholinergic interneurons, inhibiting 
their activity to promote stimulus-outcome learning (Brown et al., 2012).  
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GABAergic interneurons have also been shown to express distinct physiological 
properties. A population of roughly 1% of all striatal neurons are distinguished 
histochemically by the selective expression of the calcium-binding protein parvalbumin 
(Berke, 2011). Electrophysiologically, these interneurons express fast-firing and short 
duration action potentials with a short-spike after-hyperpolarization, and thus have been 
termed fast-spiking (FS) interneurons (Kawaguchi et al., 1995). FS interneurons receive 
excitatory inputs from the cortex and thalamus, and inhibitory inputs from other 
interneurons and a subpopulation of neurons within the globus pallidus (Chang and 
Kita, 1992; Bevan et al., 1998; Sidibé and Smith, 1999; Ramanathan et al., 2002). 
Unlike MSNs, which receive very few synapses from many different afferents, FS 
interneurons receive multiple inputs from individual afferent fibres (Bennett and Bolam, 
1994). FS interneurons are functionally coupled via both chemical synapses and gap 
junctions on their dendrites (Kita et al., 1990). The resulting matrix is predicted to 
synchronize FS interneuron activity and coordinate inhibitory projections onto MSNs 
(Fukuda, 2009). The presence of GABAA-mediated synaptic contacts onto numerous 
MSN somata and dendrites allows FS interneurons to inhibit the generation of action 
potentials (Bennett and Bolam, 1994; Kubota and Kawaguchi, 2000). Each FS 
interneuron projects to as many as 135-541 MSNs, with each MSN receiving input from 
approximately 4-27 FS interneurons (Koós and Tepper, 1999). The complete role of 
these interneurons is not yet clear, although given their rich inhibitory connectivity with 
MSNs it is proposed that parvalbumin-containing FS interneurons contribute 
significantly to regulation of MSN activity (Berke, 2011).  
The second group of GABAergic interneuron are those expressing somatostatin, 
neuropeptide Y, and nitric oxide synthase (Kawaguchi et al., 1995). These interneurons 
exhibit unique electrophysiological properties, demonstrating low-threshold and 
persistent plateau depolarizations, high input resistance, and relatively depolarized 
resting potentials, and thus have been termed low-threshold spiking (LTS) interneurons 
(Kawaguchi, 1993). Morphologically these LTS interneurons are characterized by fewer 
dendritic branches and less dense, more extensive axonal arborisation in comparison to 
FS and cholinergic interneurons (Kawaguchi, 1993). Similar to FS interneurons, LTS 
interneurons receive innervation from both the cortex and the thalamus, and project to 
MSNs (Vuillet et al., 1989). However, LTS interneurons have also been shown to 
receive synaptic inputs from nigrostiatal dopaminergic afferents (Kubota et al., 1988). 
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Interestingly a third population of striatal GABAergic interneurons has been revealed to 
express similar morphological and electrophysiological properties to those expressing 
somatostatin, neuropeptide Y, and nitric oxide synthase, and thus are thought to be a 
subtype of LTS interneurons. These interneurons express calretinin, a calcium binding 
protein, and are found predominantly within the rostral-medial region of the caudate 
putamen, where they are proposed to act as calcium buffers (Baimbridge et al., 1992; 
Résibois and Rogers, 1992). Although exhibiting inputs from cortical afferents similar 
to those of other LTS interneurons, calretinin-expressing interneurons do not receive 
any innervation from the thalamus (Sidibé and Smith, 1999). Although it is likely that 
LTS neurons also act to dynamically modulate the activity of the MSNs to which they 
project, their physiological role is largely yet to be elucidated. 
1.3.1.3.3.  Striatal Architecture  
Classically, the striatum has been divided into two subregions, dorsal and ventral, on the 
basis of specific cortical, thalamic and dopaminergic afferents (Heimer and Wilson, 
1975; McGeorge and Faull, 1989). Broadly, the dorsal striatum comprises the caudate 
nucleus and putamen, whereas the ventral striatum incorporates the nucleus accumbens 
(NAc) core and shell, olfactory tubercle, and the ventromedial portions of the caudate 
and putamen. However, it is difficult to clearly define anatomical boundaries between 
these subregions, and an alternative ventromedial-dorsolateral functional zonation has 
also been proposed (O'Doherty et al., 2004; Voorn et al., 2004; Atallah et al., 2007).  
In accordance with a functional delineation, cortical, thalamic and amygdaloid inputs 
into the striatum are primarily arranged in a dorsolateral-to-ventromedial fashion. 
Premotor and motor cortical areas, the mediodorsal, ventroanterior and ventrolateral 
thalamus, and the central nucleus of the amygdala (CeA), largely project to the caudate 
nucleus and putamen, supporting the involvement of the dorsal striatum in sensorimotor 
control and motor planning (Kemp and Powell, 1970; Aldridge et al., 1980; McFarland 
and Haber, 2000). Conversely, axon collaterals from the orbital and medial prefrontal 
cortex, midline and medial intralaminar nuclei, and basolateral amygdala (BLA), are 
received within the ventral striatum, notably the NAc, and are thought to be critical in 
the development of reward-based learning and goal-directed behaviours (Kunishio and 
Haber, 1994; Everitt et al., 1999; Haber, 2003). A further input is from ventral 
hippocampus, which may play an important role in context (Crombag et al., 2008). 
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Thus, although cytoarchitecturally overlapping, the substantial convergence of afferents 
into distinct domains, has lead to the dorsal and ventral striatum being widely 
functionally distinguished within the literature as the caudate-putamen complex and 
NAc, respectively (McFarland and Haber, 2000; Haber, 2003). 
1.3.1.3.4. The Nucleus Accumbens (NAc) 
The NAc, comprising the subregions core and shell, is known to be a critical structure 
for mediating the rewarding and motivational properties of addictive drugs (Wise, 1998; 
Everitt et al., 2001). Inputs from the VTA, prefrontal cortex (PFC) and BLA converge 
within the NAc, where goal-seeking actions are selected in response to reward-
predictive stimuli (Wise, 1998; Hikosaka et al., 2006; Nicola, 2006). A common facet of 
many drugs of abuse is their ability to increase dopamine release within the NAc, 
especially within the shell subregion (Wise, 1987; Di Chiara and Imperato, 1988; Wise, 
1988; Pettit and Justice, 1989). Electrophysiological evidence has revealed NAc 
neurons to increase in sensitivity to dopamine following repeated cocaine exposure 
(Henry and White, 1991). This neural sensitisation of the NAc and other mesolimbic 
dopamine systems is known to be extremely robust, with behavioural effects of 
sensitisation, including potentiated locomotor activity following amphetamine, 
persisting undiminished for over a year, and possibly longer (Robinson and Berridge, 
1993). Moreover it has been argued that repeated drug exposure also leads to 
sensitisation to the incentive motivational properties of drugs (Robinson and Berridge, 
1993). In keeping with these ideas, pre-sensitisation with amphetamine, cocaine, 
morphine or ethanol has been shown to facilitate the later acquisition of self-
administration or conditioned place preference (CPP) produced by the same, or a 
different drug (Lett, 1989; Horger et al., 1990; Piazza et al., 1990; Mendrek et al., 1998; 
Hoshaw and Lewis, 2001; Camarini and Hodge, 2004). 
The incentive-sensitisation theory proposed by Robinson and Berridge (1993), suggests 
that the neural substrates mediating ‘wanting’, the attribution of incentive salience, and 
‘liking’, the hedonic experience, of a drug are dissociable. Following repeated exposure 
to the drug, ‘wanting’ but not ‘liking’ becomes sensitized (Berridge and Robinson, 
1995). Through associative learning, drug-associated stimuli gain incentive salience and 
can in themselves trigger ‘wanting’, even in the face of reduced ‘liking’. This notion of 
a dissociation between ‘wanting’ and ‘liking’ is supported by an anatomical separation 
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between the reinforcing effects of drugs, and more general aspects of natural reward. 
Lesions of the NAc shell were sufficient to block cocaine- and amphetamine-CPP 
(Sellings and Clarke, 2003; Sellings et al., 2006), and accordingly, intra-NAc shell 
administration of cocaine facilitated CPP, with core infusions having no effect (Liao et 
al., 2000). Similarly, intra-NAc shell infusions of amphetamine facilitated the ability of 
a Pavlovian reward cue to trigger increased instrumental responding for a sucrose 
reward, without increasing the positive hedonic reaction to the sucrose (Wyvell and 
Berridge, 2000). Interestingly, lesions of the NAc shell attenuated of the induction of, 
but not expression of behavioural sensitisation to cocaine (Todtenkopf et al., 2002a; 
2002b), and intra-NAc shell but not core infusions of cocaine or amphetamine were 
sufficient to induce sensitisation (Pierce and Kalivas, 1995; Filip and Siwanowicz, 
2001). More recently, it has been revealed that this functional delineation may not be as 
simple as first appeared, with the both the NAc shell and core being implicated in drug-
seeking, however the former controlling behaviour by spatial/contextual information, 
and the later controlling behaviour by discrete cues (Bossert et al., 2007; Ito et al., 2008; 
Ito and Hayen, 2011). The intricacies of these processes and the influence of 
information from hippocampal and amygdala projections to the core and shell have yet 
to be elucidated. 
The neural mechanisms of action selection within the NAc are still largely unclear, but a 
recent hypothesis posits that neuronal ensembles within the NAc may represent 
different stimulus-action associations, which when activated by conditioned stimuli 
compete with each other for control of behaviour (Nicola, 2006). This is supported by 
histochemical evidence that following repeated exposure to cocaine in a specific 
environmental context, a small population of sparsely distributed accumbal neurons are 
selectively activated by cocaine only when in the conditioned environment (Crombag et 
al., 2002; Mattson et al., 2008). Selective inactivation of these neurons with the 
‘Duan02 inactivation method’ was demonstrated to attenuate cocaine-induced 
locomotor sensitisation in animals receiving cocaine in the drug-paired but not non-
paired environment (Koya et al., 2009). Under this model, drug-induced dopamine 
release in the NAc acts to increase the firing of neurons representing stimulus-action 
associations likely to lead to maximal reward (Nicola, 2006). Although still unclear, it 
has been suggested that GABAARs within the NAc may also facilitate action selection 
and discriminative amplification via their ability to mediate lateral inhibition between 
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NAc MSNs, thus suppressing competing interactions between single projection neurons 
(Taverna et al., 2004; 2005). 
Indeed, a role for NAc GABAARs in mediating the rewarding and motivational 
properties of drugs, and addiction-related behaviours, has begun to be revealed. 
Microinjections of GABAA receptor agonists directly into the NAc shell have been 
demonstrated to increase consumption of sucrose, with no difference in water 
consumption (Basso and Kelley, 1999). Moreover, GABAergic transmission within 
local microcircuits of the NAc shell have been shown to mediate motivated behaviours, 
with rostral shell infusions of the GABAA agonist muscimol inducing CPP, and caudal 
shell infusions inducing conditioned place aversion (Reynolds and Berridge, 2001; 
2002). 
1.3.1.4. The Ventral Tegmental Area (VTA) 
The VTA is the origin of the dopaminergic cell bodies of the mesolimbic dopamine 
system, and projects to the striatum, in particular the NAc, as well as limbic-related 
areas, including the amygdala, hippocampus and prefrontal cortex (Swanson, 1982; 
Albanese and Minciacchi, 1983; Ikemoto, 2007). Rodents have been shown to readily 
self-administer cocaine, morphine, nicotine or ethanol directly into the VTA (Bozarth 
and Wise, 1981; Corrigall et al., 1994; David et al., 2004; Rodd et al., 2004; 2005), and 
accordingly, lesions of the VTA disrupted self-administration of cocaine and heroin 
(Roberts and Koob, 1982; Bozarth and Wise, 1986). Furthermore, it has been proposed 
that neuroadaptations of the VTA play an important role in the initiation of behavioural 
sensitisation, while the NAc is involved in the expression of sensitisation (Kalivas and 
Stewart, 1991; Pierce and Kalivas, 1997; White and Kalivas, 1998). This is supported 
by evidence that repeated administration of cocaine, amphetamine or dopamine re-
uptake inhibitors into the VTA resulted in initiation of behavioural sensitisation 
(Vezina, 1996; Cornish and Kalivas, 2001). 
Finally, the dopaminergic projection from the VTA to the NAc has been demonstrated 
to be crucial for behavioural and NAc neuronal firing responses to incentive cues (Yun 
et al., 2004). VTA neurons are known to increase their firing rate in response to a 
conditioned stimulus previously paired with primary rewards (Schultz, 1997; Fiorillo et 
al., 2003). Inactivation of the VTA by the GABAA agonist muscimol abolished the 
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ability of conditioned cues to increase instrumental responding in a test of Pavlovian to 
instrumental transfer (PIT), as well as decreasing cocaine-seeking maintained by 
conditioned reinforcers (Di Ciano and Everitt, 2004; Murschall and Hauber, 2006).  
1.3.1.5. The Ventral Pallidum (VP) 
Dopaminergic afferents from the VTA and GABAergic projections from the NAc 
converge within the VP, which in turn projects back to reward-associated structures of 
the mesolimbic dopamine system and output nuclei, mediating reciprocal information 
exchange as well as motor output for limbic motivation signals (Mogenson et al., 1980; 
Mogenson and Yang, 1991; Groenewegen et al., 1993; Churchill and Kalivas, 1994). It 
is thought that release of VP neurons from the tonic GABAergic inhibitory inputs of the 
NAc is a key ‘downstream’ mechanism by which hyperpolarization of the NAc 
stimulates reward and motivation (Smith et al., 2009). Lesions of the VP, as well as 
muscimol microinjection-induced VP inactivation, decrease voluntary food and drink 
consumption, replacing positive hedonic taste reactions with aversive reactions 
(Cromwell and Berridge, 1993; Shimura et al., 2006). VP lesion or inactivation has 
further been shown to attenuate Pavlovian incentive learning, reducing instrumental 
responding for alcohol or cocaine, as well as blocking acquisition and expression of 
sucrose, amphetamine or morphine CPP (Robledo and Koob, 1993; Harvey et al., 2002; 
June et al., 2003). VP neurons demonstrate phasic burst firing in response to sucrose 
rewards, as well as anticipatory firing in response to conditioned cues predicting sucrose 
reward (Tindell et al., 2004). Recent evidence suggests that VP neurons encode 
incentive sensitisation, and use separate population- and firing rate activity-patterns to 
distinguish ‘liking’ from ‘wanting’ enhancements by amphetamine and opiates (Smith 
et al., 2009). 
1.3.2. The Prefrontal Cortex (PFC) 
Neuroimaging studies reveal the orbitofrontal cortex of addicted subjects to be activated 
during intoxication, craving, and bingeing, and deactivated during withdrawal 
(Goldstein and Volkow, 2002). The prefrontal cortex (PFC) provides excitatory 
glutamatergic projections to multiple sites within the mesolimbic dopamine system, 
including the VTA and NAc, inducing burst firing of DA neurons (Sesack et al., 1989; 
Chergui et al., 1993; Carr and Sesack, 2000). Although PFC GABA neurons do not 
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directly project to reward-associated circuitry in the basal ganglia, they can indirectly 
modulate NAc and VTA activity by inhibition of PFC glutamatergic afferents to various 
BG nuclei (Christie et al., 1987; Matsumura et al., 1992). 
 
Intra-PFC microinjections of the GABAA receptor antagonist bicuculline in primates 
have been shown to increase impulsivity, associated with addiction (Sawaguchi et al., 
1988; 1989). More recently, direct administration of the GABAA receptor agonist 
muscimol into the ventral medial PFC potentiated morphine-induced conditioned place 
preference (CPP), while picrotoxin, a GABAA receptor antagonist (channel blocker), 
had the inverse effect (Rozeske et al., 2009). Similarly, the ventral medial PFC 
projection onto GABAergic MSNs expressing D1-receptors within the NAc shell has 
been implicated in mediating relapse vulnerability to drugs of abuse (Fuchs et al., 2004; 
Bossert et al., 2012).  
 
1.3.3. The Amygdala 
 
The amygdala has classically been associated with the modulation of memory 
consolidation and emotional learning, including appetitive and fear conditioning 
(Gallagher et al., 1990; Everitt et al., 2000; Wilensky et al., 2000; McGaugh, 2002; 
Paré, 2003). In particular, the BLA, which projects heavily to the NAc as well as the 
medial PFC (mPFC) and hippocampus, is proposed to play an important role in 
mediating affective motivational behaviour (Everitt et al., 2000; Balleine et al., 2003; 
Cardinal et al., 2003; Balleine and Killcross, 2006). 
  
The BLA sends monosynaptic excitatory glutamate projections to both principle 
pyramidal and parvalbumin-expressing GABAergic interneurons within the mPFC, 
inducing either excitatory responses or feed-forward inhibition of mPFC neurons 
(Pérez-Jaranay and Vives, 1991; Gabbott et al., 2006). In turn, the mPFC projects back 
to the BLA forming a neural loop proposed to be important for integrating affective 
information with information of stimulus properties, thus forming stimulus-outcome 
associations (Quirk et al., 2003). From here, the BLA also sends glutamatergic 
projections to GABAergic NAc MSNs, critically involved in the modulation of 
incentive motivational properties of reward-associated stimuli, and the central nucleus 
of the amygdala (CeN). The CeN is the main source of amygdala output to the 
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brainstem, hypothalamus and basal forebrain, known to be involved in the mediation of 
fear and anxiety responses (Davis, 1992; Quirk et al., 2003; Kalin et al., 2004; Stuber et 
al., 2011), as well as positive incentives (Everitt et al., 1999; 2003; Balleine and 
Killcross, 2006). 
 
BLA neurons have been demonstrated to phasically fire in response to reward-
predictive cues, with synaptic strength of BLA neurons directly correlated to the success 
of reward-learning (Uwano et al., 1995; Tye and Janak, 2007; Tye et al., 2008). 
Accordingly, lesions of the BLA attenuate sucrose, cocaine or morphine CPP, as well as 
reducing cue-induced reinstatement of cocaine self-administration (Everitt et al., 1991; 
Fuchs et al., 2002; Yun and Fields, 2003; Milekic et al., 2006). Interestingly, rats with 
BLA lesions are still able to acquire normal conditioned responding to a stimulus paired 
with a food reward, but fail to adjust their responding to the conditioned stimuli 
accordingly when the reward is devalued (Hatfield et al., 1996; Balleine et al., 2003). 
This suggests that the BLA is necessary for encoding or retrieval of the absolute value 
of an unconditioned stimulus associated with a learnt conditioned stimulus, information 
needed to guide effective reward-seeking behavioural responses (Cardinal et al., 2003; 
Everitt et al., 2003). 
 
It also appears that the dopamine transmission within the BLA may modulate stimulus-
reward learning. Increased extracellular dopamine is observed in the BLA of rats 
during, and following performance under a discriminative operant task, as well as in 
response to cocaine-paired cues (Hori et al., 1993; Weiss et al., 2000). Intra-BLA 
administration of amphetamine or the dopamine agonist 7-OH-DPAT, have also been 
shown to enhance appetitive Pavlovian conditioning in a discriminative approach task, 
and intra-BLA dopamine antagonism is sufficient to attenuate conditioned reinstatement 
of drug-seeking (Hitchcott et al., 1997a; 1997b; See et al., 2001). More recently, 
evidence suggests a switch occurs in BLA dopamine receptor control of reward 
memory, with blockade of BLA D1, but not D2 receptor transmission blocking 
morphine CPP in drug-naïve rats, and the reverse demonstrated in drug-dependent and 
animals in drug withdrawal (Lintas et al., 2011). 
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1.3.4. The Hippocampus 
 
The hippocampus formation underlies the learning of associations between 
environmental contexts and unconditioned stimuli, known to be a powerful 
determinants of drug-seeking behaviour and relapse (Selden et al., 1991; Kim and 
Fanselow, 1992; Shalev et al., 2000; Robbins, 2002). Stimulation of the ventral 
subiculum of the hippocampus has been demonstrated to induce enduring dopamine 
(DA) release within the NAc through increased firing of VTA dopaminergic projection 
neurons (Brudzynski and Gibson, 1997; Legault et al., 2000). Theta-burst hippocampal 
stimulation also resulted in reinstatement of drug-taking behaviour by contextual cues 
following extinction of cocaine-self administration in rats, an effect subsequently 
blocked by pharmacological inactivation of the hippocampus (Vorel et al., 2001; Luo et 
al., 2011). Similarly, bilateral lesions or pharmacological inactivation of the 
hippocampus have also been revealed to block both the acquisition and expression of 
cocaine or morphine CPP (Meyers et al., 2003; 2006; Milekic et al., 2006), abolish the 
potentiating effect of intra-NAc amphetamine on locomotor activity and responding 
with conditioned reinforcement (Burns et al., 1993), and impair acquisition of cocaine 
self-administration (Caine et al., 2001).  
 
Behavioural evidence, gene expression and anatomical projection patterns suggest that 
the hippocampus can be divided into separate structures (see (Fanselow and Dong, 
2010) for review). The dorsal hippocampus is implicated primarily in the cognitive 
process of learning and memory associated with navigation, exploration, and 
locomotion (Jung et al., 1994; Moser et al., 1995; Zhang et al., 2004), whereas the 
ventral hippocampus is the part of the temporal lobe associated with motivational and 
emotional behavior (Henke, 1990; Ferbinteanu and McDonald, 2001; Kjelstrup et al., 
2002). 
1.3.5. Summary 
The NAc is the main input structure of the basal ganglia and is thought to be a critical 
structure for action selection and decision-making. Glutamatergic projections from 
regions including the amygdala, hippocampus and PFC are thought to compete within 
the NAc for control over behavioural responses to salient stimuli, which are 
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communicated to basal ganglia output structures by direct or indirect pathways. 
Dopamine and GABA are thought to act within the NAc to modulate the influence of 
reward-related glutamatergic projections. A detailed anatomical model of connectivity 
between structures involved in the mediation of reward is provided bellow (Fig. 1.2.).  
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Figure 1.2. 
 
Fig. 1.2. An updated model of reward circuitry. Recent investigations have revealed a 
rather more complex organization of cortical and subcortical anatomy, complicating the 
investigation of neuronal pathways involved in mediating reward. mPFC, medial 
prefrontal cortex; ACh, Acetylcholine; AMG, amygdala; HIP, hippocampus; NAc, 
nucleus accumbens; VTA, ventral tegmental area; SNc, substantia nigra pars compacta; 
SNr, substantia nigra pars reticulata; GPe, external globus pallidus; GPi, internal globus 
pallidus; STN, subthalamic nucleus. 
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1.4. Structure of GABAARs and molecular basis of GABAAR signalling.  
 
1.4.1. GABAA receptors 
 
GABAARs are heteropentameric chloride channels belonging to a large super-family of 
cys-loop ligand-gated ion channels, also including nicotinic acetylcholine receptors, 
glycine receptors, and the 5-HT3 receptor (Goetz et al., 2007; Connolly, 2008). 
GABAAR subunits consist of four hydrophobic transmembrane domains (TM1–4) of 
about 20 amino acids, with TM2 believed to line the pore of the channel (Jacob et al., 
2008; Macdonald and Botzolakis, 2009). The large extracellular amino terminus is the 
site of GABA binding (between the alpha and beta subunits), and also contains binding 
sites for psychoactive drugs, such as benzodiazepines (Bz) (between alpha and gamma) 
and barbiturates (Ba) (between the alpha and beta) (Johnston, 2005). Each receptor 
subunit also contains a large intracellular domain between TM3 and TM4 that is the site 
for various protein interactions and post-translational modifications that modulate 
receptor activity (Macdonald and Botzolakis, 2009). There are currently known to be 18 
GABAAR subunits, which can be divided by sequence homology into seven subunit 
categories: α (1–6), β (1–3), γ (1–3), δ, ε, θ, π and ρ (1-3) (Jacob et al., 2008). However 
despite the potential for vast numbers of individual receptor isoforms, mammalian CNS 
GABAAR stoichiometry typically consists of two α subunits, two β subunits and one γ 
(or one δ) subunit (Whiting et al., 1995; Sieghart, 2006). Selective assembly of 
GABAAR isoforms occurs within the endoplasmic reticulum. This allows GABAARs of 
different composition to be selectively expressed and targeted to specific subcellular 
localities, where receptors of different composition reveal functional differences in their 
physiological and pharmacological properties.  
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Figure 1.3. 
                         
Fig 1.3. Heteropentameric composition of a GABAA receptor including binding sites for 
GABA (G), benzodiazepines (Bz), barbituates (Ba), neurosteroids (N), and a disputed 
binding site for ethanol (E).  GABAA receptors typically consist of two α-subunits (α1-
6), two β-subunits (β1-3) and either a γ- or δ-subunit, around a central chloride (Cl-) 
channel. 	  
 
 
1.4.2. Synaptic vs Perisynaptic/Extrasynaptic GABAA receptors  
 
Classically, GABAA receptors have been reported to mediate inhibition in the adult 
mammalian CNS via fast ‘phasic’ transmission of activity occurring within the synapse. 
However, within the last two decades a growing body of evidence has identified 
GABAA receptors located extrasynaptically, either perisynaptically or distant from 
synapses. These extrasynaptic GABAARs respond to low levels of ambient or spillover 
GABA to generate a ‘tonic’ form of inhibition (Wei et al., 2003; Farrant and Nusser, 
2005; Brickley and Mody, 2012). Typically, synaptic phasic GABAARs comprise α1, 
α2, α3 or α5, with β2/3 and γ2 subunits, whereas tonic extrasynaptic GABAARs have 
largely been found to be comprised of α4 or α6, coupled with β2/3 and δ subunits, 
although there is some evidence of α1 and γ within extrasynaptic GABAARs (Barnard et 
al., 1998; Nusser et al., 1998; Crestani et al., 2002; Mortensen and Smart, 2006). 
 
The γ2 subunit is thought to be crucial to the targeting and anchoring of specific 
GABAARs to GABAergic postsynaptic densities via complex interactions with 
scaffolding proteins gephyrin, collybistin and neuroligin-2 (Essrich et al., 1998; Sudhof, 
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2008; Poulopoulos et al., 2009). Targeted deletion of γ2 results in reduced synaptic 
GABAAR clustering (Essrich et al., 1998). More recent evidence suggests that in 
perisomatic postsynaptic densities, stabilisation of GABAARs and neuroligin-2, but not 
gephyrin may be mediated by the dystrophin-glycoprotein complex (Panzanelli et al., 
2011). However, γ2 has also been found to couple with α5 and α6 within extrasynaptic 
GABAARs in hippocampal and cerebellar granule cells, respectively (confirmed by lack 
of colocalisation with gephyrin), suggesting that specific subunit compositions may 
nullify the synaptic anchoring properties of the γ2 subunit (Crestani et al., 2002; Wisden 
et al., 2002). Interestingly, an alternative mRNA splicing of the γ2 subunit has been 
reported. Short (γ2S) and long (γ2L) subunits are identical except for the presence of an 
eight-amino-acid sequence that is present in the larger intracellular loop of the γ2L 
subunit (Whiting et al., 1990; Wafford et al., 1991). However, analysis of chimeric γ2 
subunits indicates that the fourth transmembrane domain (TM4) but not the major 
cytoplasmic loop domain of the γ2 subunit is essential for clustering of GABAA 
receptors at synapses (Alldred et al., 2005). Thus, the γ2S and γ2L variations of the γ2 
subunit are not likely to account for differences in the subcellular location of GABAARs 
containing γ2 subunits. 
 
1.4.3. Sensitivity to GABA and other endogenous/exogenous drugs 
 
Gating of the GABAAR chloride ion channel is mediated via a GABA binding site at the 
interface between the α and the β subunits, where the binding of two GABA molecules 
induces channel opening (Baumann et al., 2003). However, given the diversity in 
subcellular GABAAR localization it is clear that exposure to GABA will vary between 
GABAAR populations, and the GABAAR subtypes vary, accordingly, in their 
biophysical properties, including GABA sensitivity and specificity to endogenous and 
exogenous molecules. In recombinant GABAARs comprising αβ3γ2 combinations, 
GABA sensitivity is largely determined by a domain of four amino acids in the 
extracellular N-terminal region of α subunits (Böhme et al., 2004). Studies manipulating 
the α subunit reveal EC50 values of the GABA-induced chloride current to vary between 
<1 to >50 µM, with a rank order α6>α1>α2>α4>α5>α3 (Böhme et al., 2004; Minier and 
Sigel, 2004). However, sensitivity to GABA is increased in extrasynaptically located 
α4βδ extrasynaptic GABAARs compared to synaptic α4βγ2 GABAARs (Yeung et al., 
2003; Mortensen et al., 2010). Along with a higher affinity to GABA and slower 
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desensitisation in comparison to their synaptic counterparts, α4β3δ extrasynaptic 
GABAARs are also differentially sensitive to a number of allosteric modulators and 
neurosteroids. Gaboxadol® (THIP; 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol), acts 
as a high-efficacy superagonist at δ-containing extrasynaptic GABAARs due to its 
ability to increase the frequency and duration of channel opening, but has only partial 
agonist activity on αβγ-type synaptic receptors (Ebert et al., 1994; Mortensen et al., 
2004). Similarly, a higher potency agonist activity of muscimol is seen at α4β3δ 
extrasynaptic GABAARs compared to synaptic α4β3γ2 and α1β3γ2 GABAARs, though 
this difference may be caused by reduced desensitisation (Mortensen et al., 2010).  
 
1.4.4. Expression of GABAAR subunits throughout the brain  
 
Immunocytochemical and RNA analysis has revealed GABAA receptor subunit 
isoforms to each exhibit a unique distribution within the brain (Wisden et al., 1992; 
Laurie et al., 1992a; 1992b; Pirker et al., 2000). 
 
α1 and α2 subunits are found extensively throughout the brain, with expression of α1 
the most abundant (Wisden et al., 1992; Pirker et al., 2000). Expression of the α3 
subunit isoform is localised to the cerebral cortex, olfactory bulb and brain stem nuclei 
(Persohn et al., 1992; Wisden et al., 1992; Pirker et al., 2000). The α4 subunit is 
distributed throughout the thalamus, nucleus accumbens, hippocampus, neocortex and 
caudate-putamen (Wisden et al., 1992; Pirker et al., 2000; Schwarzer et al., 2001). α5 
subunits are highly expressed within the hippocampus, with further moderate expression 
within the rodent hypothalamus, neocortex and olfactory bulb (Persohn et al., 1992; 
Laurie et al., 1992a). More recently, rodent and human data indicates that there may 
also be α5-containing GABAARs within the striatum (Ade et al., 2008; Mendez et al., 
2013). Finally, expression of the α6 subunit is confined to the cerebellar granule cells, 
hippocampal pyramidal neurons, and cochlear nucleus granule cells (Wisden et al., 
1992; 2002). 
 
All three β subunits are found throughout the brain, with distribution patterns often 
overlapping (Pirker et al., 2000). β1 subunits are expressed heavily within the 
hippocampus and olfactory bulb, and to a lesser extent in the cerebral cortex, 
cerebellum, superior colliculus and substantia nigra (Persohn et al., 1992; Wisden et al., 
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1992). The wide distribution of β2 subunits often correlates with α1 subunit expression 
and is strongly expressed in the pallidum and thalamus (Wisden et al., 1992; Moreno et 
al., 1994; Pirker et al., 2000). Finally, expression of β3 subunits, which correlates highly 
with that of α2 subunits, is strongest in the striatum (Miralles et al., 1999; Pirker et al., 
2000). 
 
γ1 subunit expression shows minimal expression throughout the brain, with the highest 
distribution found in the bed nucleus of the stria terminalis (Pirker et al., 2000). 
Conversely, γ2 subunits are expressed almost ubiquitously in the brain (Wisden et al., 
1992; Pirker et al., 2000). The γ3 subunit is diffusely distributed throughout the brain at 
very low concentrations (Pirker et al., 2000). Expression of δ subunits is highest in the 
cerebellar granule cells, with further distribution found in the thalamus, striatum, 
hippocampal dentate granule cells and neocortex (Persohn et al., 1992; Wisden et al., 
1992; Pirker et al., 2000; Schwarzer et al., 2001). δ subunits are proposed to be 
expressed exclusively in extrasynaptic GABAARs, where they partner with α6 in the 
cerebellum, and α4 within the forebrain (Jones et al., 1997; Peng et al., 2002). 
Expression of ρ subunits is restricted to cerebellum, colliculi and retina (Boue-Grabot et 
al., 2002; Alakuijala et al., 2005). The θ and ε subunits show remarkably overlapping 
expression within the brain and typically form receptors with α3 subunits (Bonnert et 
al., 1999; Pape et al., 2009). Although distributed throughout the brain, strongest 
expression of these subunits is found in the dorsal raphe and the locus coeruleus (Pape 
et al., 2009). As yet there is no evidence of π subunit expression within the mammalian 
CNS, but it is known to be highly expressed within the uterus (Hedblom and Kirkness, 
1997; Quezada et al., 2006).  
1.4.5. Factors influencing expression of GABAA receptor subunits and channel kinetics 
Further to this, there are known to be over 20 intracellular proteins that act at various 
sites along the large TM3-TM4 intracellular loops of GABAARs to influence surface 
expression of receptors (Uusi-Oukari and Korpi, 2010). One such interacting protein is 
GABAA receptor-associated protein (GABARAP). This microtubule-binding protein 
has been proposed to act as a linker between GABAARs and the cytoskeleton (Wang et 
al., 1999; Wang and Olsen, 2000). Immunofluorescent staining and green fluorescent 
protein (GFP)-tagged receptor subunits revealed GABARAP to promote clustering of 
	   26	  
GABAARs (Chen et al., 2000). The inclusion of the γ2 subunit in GABAARs, and the 
tubulin-binding domain in GABARAP are critical for receptor clustering, suggesting 
that GABARAP may facilitate formation of postsynaptic receptor clusters by linking the 
intracellular domain of γ2 subunits (Chen et al., 2000). When recorded in L929 cells 
expressing α1, β1, and γ2 subunits, alongside GABARAP, GABA-activated 
recombinant single channel conductance was significantly increased (Chen et al., 2000; 
Everitt, 2004). It hypothesised that these changes in channel kinetics may occur as a 
result of protein-protein interactions between intracellular domains of GABAARs 
clustered by GABARAP, inducing cooperative opening and closing of channels 
(Everitt, 2004). 
1.4.6. Summary 
The large number of GABAARs isoforms confers these receptors with a diverse range of 
physiological and pharmacological properties. Inclusion of specific subunits allows 
them to be selectively expressed and targeted to specific subcellular localities, including 
within synapses, and also perisynaptically and extrasynaptically. Specifically, synaptic 
GABAARs are thought to mediate a phasic inhibitory control over neurons, while 
extrasynaptic GABAARs demonstrate a higher affinity to GABA and thus respond to 
ambient GABA and spillover GABA from synapses to mediate a tonic form of 
inhibition. 
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1.5. Psychostimulants  
 
1.5.1. The neurobiology of psychostimulant abuse 
 
Psychostimulants are psychoactive drugs, which produce a variety of physiological 
effects within the central and peripheral nervous systems, ultimately increasing 
psychomotor activity. Critical to the euphoric and motivational properties of 
psychostimulants, as well as many other drugs and rewarding stimuli, is the ability to 
increase dopamine transmission within the NAc (Harris and Baldessarini, 1973; Wise 
and Bozarth, 1987; Di Chiara and Imperato, 1988). Ordinarily, these transporters bind to 
dopamine released during neuronal signalling and act as a recycling mechanism by 
delivering dopamine back into storage vesicle within the presynaptic neuron. However, 
psychostimulants, including cocaine, bind to dopamine transporters, forming a complex 
that blocks the transporter's function. This results in an accumulation of dopamine 
within the synaptic cleft, producing a prolonged stimulation of postsynaptic dopamine 
receptors that is thought to alter the influence of excitatory neuronal inputs.  
 
Repeated exposure to psychostimulants results in neuroadaptations of the systems in 
which they produce their effects (Nestler, 2001). These changes are known to underlie 
the sensitisation of drug effects seen following repeated intermittent use, including the 
sensitisation of incentive motivational properties (Robinson and Berridge, 1993; 2000). 
The intermediate-term effects of psychostimulant administration include alterations to 
the amount of dopamine transporters and dopamine receptors present on the surface of 
neurons (White and Kalivas, 1998; Nestler, 2005). As well as a decrease in the density 
of glutamate but not GABA immunolabeling within the NAc, possibly indicating an 
increase in excitatory synaptic activity (Meshul et al., 1998). Furthermore, 
psychostimulant alter gene expression, including that of the transcription factor protein 
ΔFosB, thought to act as an important molecular “switch” in the transition from drug 
abuse to addiction (Nestler et al., 2001; Nestler, 2005). Longer-term psychostimulant 
use results in changes in the physical structure of neurons, including altered dendritic 
branching in the NAc (Nestler, 2001; Robinson and Berridge, 2001).  
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1.5.2. Conditioning in psychostimulant abuse 
 
In humans, addiction to psychostimulants is characterised by drug craving and high 
rates of relapse during abstinence, often thought to be triggered by re-exposure to drug-
associated cues (Stewart et al., 1984; Robinson and Berridge, 1993; Everitt et al., 2001; 
Crombag et al., 2008). Indeed, exposure to cocaine-associated cues is able to trigger 
increased physical arousal and craving for cocaine in abstinent cocaine users (Avants et 
al., 1995). Furthermore, exposure to cocaine-related stimuli results in an increase in 
striatal dopamine release (Volkow et al., 2006),  and increased electrophysiological 
brain responses, as measured by  event-related brain potentials (Franken et al., 2008). It 
is hypothesised that firing of NAc MSNs in response to reward-associated cues may 
encode both the predictive value of environmental stimuli and the specific motor 
behaviors required to respond to them (Nicola et al., 2004). 
Cue-induced reward-seeking can be explained by mechanisms of Pavlovian 
conditioning. Following repeated pairing with an unconditioned rewarding stimulus 
(US), contextual or discrete cues can acquire the motivational properties of the US and 
become conditioned stimuli (CS). These associative processes can be modelled in 
animals using a number of behavioural procedures, including cue-induced reinstatement 
of drug-seeking, conditioned place preference, conditioned reinforcement and second-
order schedules of reinforcement (see reviews (Everitt and Robbins, 2000; Tzschentke, 
2007; Crombag et al., 2008)). The use of these paradigms in combination with genetic 
and pharmacological manipulation of specific molecular targets will likely further our 
understanding of the psychological and neurobiological mechanisms by which drug-
associated stimuli elicit drug-seeking. 
1.5.3. Psychostimulant-induced GABAAR subunit regulation throughout the brain 
 
To date, research has largely focused on drug-induced changes at dopamine and 
glutamate synapses, including changes in intracellular signal transduction pathways in 
the mesolimbic dopamine system, and long-term potentiation (LTP) of glutamatergic 
synapses (see reviews (Kalivas, 2007; Wolf, 2010; Lüscher and Malenka, 2011; Pierce 
and Wolf, 2013)). However, there is a growing body of evidence that GABAergic 
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mechanisms also play an important role in mediating the physiological and behavioural 
effects of psychostimulants. 
 
Early studies exploring GABAergic mechanisms of psychostimulant abuse revealed 
systemic amphetamine administration was associated with a decline in extracellular 
GABA concentration within the ventral pallidum (Bourdelais and Kalivas, 1990). 
Similarly, chronic cocaine administration resulted in a selective attenuation of 
GABAAR function within the striatum (Peris, 1996). However, other studies have found 
no evidence of changes in either quantity or function of striatal GABAARs (Jung and 
Peris, 2001). More recently, a genetic screen revealed chronic cocaine to cause a robust 
up-regulation of α4 subunit gene expression selectively in D1-MSNs (Heiman et al., 
2008). Acutely, cocaine was associated with decreased striatal α1 subunits when 
measured 1 hour post-administration (Yamaguchi et al., 2000). However, when 
measured in cocaine self-administration, at both 1 day (acute) and 20 days (chronic), α1 
subunit mRNAs where up-regulated, with down-regulation noted for α4, α6, β2, γ2, and 
δ subunits (Backes and Hemby, 2003).  
 
In line with the genetic studies linking the GABRA2 gene with cocaine addiction 
(Dixon et al, 2010; Enoch et al, 2010), molecular investigation has also emphasized a 
pertinent role for α2-containing GABAARs. Quantitative immunohistochemistry of 
GABAAR subunit proteins following chronic cocaine administration revealed a 
significant decrease in α2 subunits within the hippocampal dentate gyrus and CA1 
regions (Lilly and Tietz, 2000). Moreover, following methamphetamine-sensitisation a 
decrease in GABAAR α2 is reported within the NAc shell and core (Zhang et al, 2006). 
Similarly, reversal of cocaine-induced behavioural sensitisation by 
pergolide/ondansetron treatment normalises GABAAR α2 expression within the NAc 
(Chen et al, 2007).  
 
1.5.3. α2-containing GABAARs in the NAc mediate cocaine effects on reward-
conditioned behaviours 
 
As well as mediating the primary rewarding effects of drugs of abuse, the NAc is 
implicated in the ability of reward-paired environmental cues to motivate drug-seeking 
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behaviour (Everitt and Robbins, 2005). It has been proposed that conditioned cues may 
influence behaviour by activating stimulus-action associations represented in individual 
NAc MSNs (Nicola et al., 2004). Moreover, GABAergic inhibition of neurons 
competing for control over basal ganglia output nuclei, by GABAergic interneurons and 
collateral connections between neighbouring MSNs, has been suggested to facilitate 
NAc-mediated action selection (Nicola, 2006). These findings raise the possibility that 
variations in the subunit composition of GABAARs may act to differentially modulate 
the activity of NAc MSNs, and alter behavioural responses to psychostimulants drugs 
and reward-conditioned cues. 
 
Indeed, targeted deletion of the GABAAR α2 subunit, known to be highly represented 
within the NAc, blocked the ability of cocaine to induce locomotor sensitisation (Morris 
et al., 2008). This phenomenon reflects the amplification of behavioural responses to 
psychostimulants, as well as other drugs of abuse, following repeated intermittent 
administration (de Wit and Stewart, 1981; Robinson and Becker, 1986). Similarly, 
selective activation of α2 receptors within the NAc using intracranial infusions of the 
GABAAR agonist Ro 15-4513, was sufficient to induce behavioural sensitisation in 
α2(H101R) mutant mice, in which the mutation results in a change in efficacy of Ro 15-
4513 from a negative allosteric action to a positive allosteric action (Dixon et al., 2010). 
Interestingly, the ability of BZs to facilitate the locomotor activating properties of 
cocaine was abolished in α2(H101R) mice, suggesting that α2 mediation of cocaine-
potentiated locomotor activity occurs downstream of facilitated NAc dopamine release. 
 
More recently, deletion of the α2 subunit did not modulate instrumental responding for 
a reward-conditioned cue, in a test of conditioned reinforcement, but was able to block 
cocaine potentiation of responding (Dixon et al, 2010). Thus, while the α2 subunit 
seems not to play a role in the formation of associations between environmental events 
and rewards, it is important for the ability of cocaine to facilitate cue-induced 
behaviours associated with reward.  As yet, limited evidence suggests that this effect is 
attributable to α2-containing receptors located on accumbens MSNs. 
 
1.5.4. GABAA receptors and psychostimulant self-administration 
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GABAARs within the VTA are predominantly located on a subpopulation of 
GABAergic neurons which provide tonic inhibitory inputs onto neighbouring DA 
neurons, as well as projecting to various other brain regions involved in mediating 
reward (Johnston & North, 1992; Churchill et al, 1992; Kalivas, 1993). Recent evidence 
reveals that optogenetic activation of VTA GABA neurons suppresses the release of DA 
within the NAc (Van Zessen et al, 2012). Moreover, firing of VTA GABA neurons is 
facilitated during cues that predict appetitive rewards (Cohen et al, 2012). Thus, it is 
hypothesised that compounds acting at GABAARs will alter neurotransmission between 
GABA and DA neurons within the VTA, as well as projections fibres to the NAc, and 
may help modulate reward processing (Van Zessen et al, 2012). 
 
Alprazolam and chlordiazepoxide, two allosteric modulators of GABAARs, decrease 
intravenous cocaine self-administration in rats (Goeders et al, 1989; 1993). In human 
studies, pre-treatment with alprazolam has been shown to reduce the subjective 
behavioural effects of amphetamine (Rush et al, 2004). Similarly, topiramate, which 
blocks mesolimbic dopamine release via potentiated GABAergic inhibition and 
inhibited glutamate function, has been shown to reduce cravings and increase abstinence 
in cocaine dependence in humans (Johnson, 2005; Reis et al., 2008). 
 
Other high-efficacy GABAAR modulators including pentobarbital and midazolam have 
also shown efficacy in selectively attenuating cocaine self-administration in mice 
(Barrett et al, 2005). Interestingly, ligands acting directly at GABAARs have been 
shown to be freely self-administered directly into the VTA, but show limited efficacy in 
altering psychostimulant self-administration (David et al, 1997; Ikemoto et al, 1997). 
Muscimol, a direct agonist at GABAARs, failed to attenuate the abuse-related effects of 
cocaine (Barrett et al, 2005).  
 
1.5.5. GABAAR pharmacogenetics of psychostimulant abuse 
 
As outlined above, the GABRA2 gene encoding GABAAR α2 subunits has consistently 
been associated with drug dependence, notably alcoholism (Edenberg et al., 2004; 
Agrawal et al., 2006; Dick et al., 2006; Edenberg and Foroud, 2006; Soyka et al., 2008). 
It has subsequently been revealed that haplotypes of the GABRA2 gene are also linked 
with cocaine addiction, with the same haplotypes as those reported in the Edenberg 
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study also shown to confer vulnerability or protection to cocaine abuse (Dixon et al., 
2010). It has further been proposed that GABRA2 haplotypes may interact with 
experience of childhood trauma to influence risk of cocaine dependence (Enoch et al, 
2010). Again, one haplotype predicted addiction, whereas another haplotype, more 
common in control subjects, was associated with resilience to addiction following 
childhood trauma.  
 
1.5.6. Summary 
 
Following repeated pairing with rewards, conditioned cues can take on the motivational 
properties of the reward and trigger reward-seeking behaviour. Psychostimulants are 
known to enhance these behavioural responses to conditioned cues by increasing 
dopamine transmission within the NAc, thus augmenting the influence of reward-related 
glutamatergic inputs from the PFC, hippocampus and amygdala. The action of GABA 
at GABAARs within the NAc is also a powerful mechanism by which competing action 
representations are modulated. It is thought that different GABAAR isoforms in specific 
subcellular localities may provide different roles in mediating behavioural responses to 
direct psychostimulant reward, as well as reward-conditioned cues and their potentiation 
by psychostimulants.  
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1.6. A role for α4-GABAARs in mediating addiction-related behaviours? 
 
Several laboratories have reported extrasynaptic GABAARs, known to mediate a tonic 
inhibition, to be particularly sensitive to low alcohol concentrations (10-30mM) 
(Sundstrom-Poromaa et al., 2002; Wallner et al., 2003; Wei et al., 2004; Wallner et al., 
2006; Santhakumar et al., 2007; Olsen, 2011). Accordingly, α4βδ GABAAR subtypes 
are the most rapidly regulated in plastic mechanisms triggered by high-dose alcohol or 
chronic exposure to alcohol in rats (Liang et al., 2007), and in mice lacking the δ-
subunit, alcohol failed to potentiate tonic GABA currents within dentate granule cells 
(Liang et al., 2006). However, a number of laboratories have failed to replicate these 
findings and suggest instead that ethanol may modulate extrasynaptic GABAAR-
mediated tonic currents indirectly via a presynaptic, or yet unidentified mechanism 
(Borghese et al., 2005; Botta et al., 2007; Korpi et al., 2007). One theory is that the 
physiological and behavioural effects of alcohol are attributable to the alcohol-induced 
neurosteroid modulation of GABAARs.  
 
Interestingly, α4βδ extrasynaptic GABAARs have also been proposed to mediate the 
rewarding and reinforcing effects of alcohol. Viral knockdown of the α4 and δ subunits 
within the medial NAc shell, but not ventral or lateral shell, or core, reduced alcohol 
intake in a two-bottle choice test (Rewal et al., 2009; Nie et al., 2011). Similarly, 
operant responding for alcohol was reduced following decreased α4 expression in the 
NAc shell, but not core (Rewal et al., 2011). These data strongly implicate extrasynaptic 
GABAARs within the medial NAc shell in the modulation of alcohol intake. This role of 
α4 receptors contrasts with the lack of effect of deletion of α5 (Stephens et al., 2005) or 
α2 subunits (Dixon et al., 2012) on alcohol self-administration, despite targeted deletion 
of GABAAR α2 subunits increasing the sedative and ataxic effects of alcohol.  
 
At present, very little is known about the possible role of α4-GABAARs in mediating 
the rewarding and reinforcing of drugs of abuse other than alcohol. However, given the 
importance of α2-GABAARs for behavioural sensitisation to cocaine and cocaine-
potentiation of conditioned reinforcement, it could be hypothesised that α4-GABAARs 
may also be important for controlling behavioural responses to cocaine. α4-GABAARs 
are widely expressed within the NAc, where they modulate a tonic form of inhibition 
that acts to control the excitability of MSNs (Maguire et al, submitted). These receptors 
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may act to alter the response of MSNs to increased NAc dopamine following cocaine, 
as well as the controlling the influence of excitatory inputs onto MSNs providing 
information about natural- or cocaine-conditioned cues.  
 
It is possible to test these hypotheses using a number of behavioural paradigms. Firstly, 
it is important to establish whether activation of α4-GABAARs is able to alter baseline 
and cocaine-potentiated locomotor activity. As well adding to the characterisation of 
these receptors, investigation of locomotor activity may have implications for further 
behavioural tests that could be facilitated or attenuated by altered locomotion. 
Subsequently, it is possible to explore the role of α4-GABAARs in natural- and cocaine-
conditioned behaviours using well-established behavioural tests, including behavioural 
sensitisation, conditioned place preference and conditioned reinforcement. 
 
1.7. Strategies for exploring the role for α4-GABAARs in mediating addiction-
related behaviours 
 
1.7.1. Genetic strategies for targeting α4-GABAARs 
 
In the last few decades, technology has evolved that allows the specific modification of 
the genetic composition of many organisms. Transgenic research has largely been 
carried out in mice rather than rats due to the technical ease of genetic manipulation of 
mouse embryos, the larger number of inbred mice strains, and the greater information 
about mice genetic locus markers. Genetic engineering has allowed researchers to study 
the role of specific genes in complex behaviours through the use of ‘knockout’ mouse 
models, in which a specific gene is inactivated. The phenotype of a knockout mouse 
provides valuable insight into the normal role of the targeted gene. Such knockout 
mouse models have been used to study many kinds of genetic disorders and diseases. In 
this thesis, mice with a deletion of the GABAAR α4-subunit gene (Gabra4) will be used 
to explore the role of α4-subunits in mediating behaviours associated with addiction to 
the psychostimulant cocaine. 
 
The main technique used to create genetic knockout mice, gene targeting, involves 
specific manipulation of a gene in the nuclei of an embryonic stem (ES) cell. One 
commonly used method of gene targeting takes advantage of the Cre/LoxP system (Fig 
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1.4.), which can be used for generating constitutive or tissue-specific gene knockout 
mice (Kos, 2004).  
 
LoxP (locus of X-over P1) is 34-base pair (bp) DNA sequence originally discovered in 
the bacteriophage P1, that is composed of an asymmetric 8-bp core, determining the 
directionality, flanked on each side by 13 bp of complementary sequences. To target a 
particular mouse gene, loxP sites are introduced on either side of a coding region of the 
gene in vitro (with an antibiotic resistance gene, to allow selection).  The manipulated 
gene is then reintroduced into the mouse genome, through transfection into ES cells. 
Cells with targeted recombination are selected through their antibiotic resistance and 
PCR confirmation. These cells are then microinjected into a blastocyst (early stage 
embryo) and the blastocyst implanted into pseudopregnant female donors, of which the 
offspring can be bred to develop mice containing the loxP sites. Chimeric offspring are 
then bred with wildtype mice and offspring screened for the presence of the genetic 
manipulation.  The gene flanked by LoxP sites is referred to as “floxed” (a contraction 
of the phrase “flanked by LoxP”). LoxP sites are placed on either side of a sequence that 
is required for correct gene expression, however it is important that the placement of 
these sites should not adversely affect gene expression in the “floxed” mouse. Thus, in 
the absence of Cre-recombinase the gene should remains functional. In the Gabra4 
“floxed” mice the loxP sites were inserted into non-coding introns, a BamHI site 625 
bps 5' to exon 3 and into an EcoRV site 118 bp 3' to exon 3 (see supplementary 
information of (Chandra et al., 2006)) 
 
The Cre-recombinase enzyme (a contraction of the phrase Causes recombination) is 
also derived from the bacteriophage P1 and consists of 4 subunits and two domains: The 
larger carboxyl (C-terminal) domain, and smaller amino (N-terminal) domain. This is 
also the catalytic site of the enzyme, therefore the Cre-recombinase can be used to 
catalyze the recombination between two specific DNA recognition sites. 
 
In mutant mice, Cre expression can be targeted to all tissues in order to make a 
constitutive knockout line, or to specific tissues or cell types to make tissue or cell-
specific knockout lines. The constitutive knockout mice are created by crossing the 
“floxed” mice with a mouse line in which the cre transgene is under the control of the 
adenovirus EIIa promoter that targets expression of Cre recombinase to the early mouse 
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embryo. The cell-specific Cre-recombinase lines are created by bacterial artificial 
chromosome (BAC) engineering. BAC engineering is used to insert an intron containing 
Cre cassettes, followed by a polyadenylation sequence to terminate transcription of the 
fusion transcript immediately after the recombinase gene, into the BAC vector at the 
initiating ATG codon in the first coding exon of the targeted gene. These BAC 
constructs have advantages over the simple promotor-gene style transgenics as they 
contain much more regulatory sequence, making them resistant to influences of the 
genome surrounding the site of insertion (King et al., 2003). These DNA constructs can 
then be microinjected into the nucleus of a single-cell embryo and implanted into a 
pseudopregnant female donor. Offspring from this mouse can then be bred to create 
lines of mice expressing Cre recombinase.  
 
When a hemizygote Cre-expressing mouse is bred with a homozygote “floxed” mouse 
approximately half of the offspring will inherit both the “floxed” gene and the Cre-
expressing transgene, and thus a recombination event is triggered, in the cells targeted 
by the BAC construct. The Cre-recombinase protein binds to the first and last 13bp 
regions of a loxP site through a transient DNA-protein covalent linkage, forming a 
dimer. This dimer then binds to a dimer on the other loxP site to form a tetramer. 
Depending on the orientation of the two repeat sites the recombination event will either 
lead to the deletion or the inversion of the DNA segment between the two loxP sites. 
When two direct repeat sites are in the same orientation, Cre cleaves the intermediate 
DNA segment and the two stands are then rejoined with DNA ligase. However, when 
the two repeat sites are inverted then the intermediate DNA segment will be inverted 
and the two loxP sites remain. Although inversion can also lead to gene inactivation, the 
DNA segment can invert-back and reactivate, and so is not used to develop knockout 
mouse constructs.  
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Figure 1.4. 
 
Fig.1.4. Cre/loxP system of transgenic gene knockout. LoxP sites inserted between the 
target gene are excised by Cre recombinase resulting in a “knockout” allele.  
 
 
However, there are a number of limitations of using transgenic mice. The site of the 
transgene insertion into the genome can adversely affect tissue specificity and levels of 
transgene expression, so a number of founder lines may need to be screened (Davey and 
MacLean, 2006). Furthermore, deletion of genes encoding for proteins can result in 
compensatory changes in expression of other proteins. Indeed deletion of the Gabra4 
gene encoding for GABAAR α4-subunits has been reported to result in a reduction of 
hippocampal GABAAR δ-subunit protein levels, but an increase in hippocampal α2- and 
γ2-subunit levels compared to wildtype controls (Suryanarayanan et al., 2011). These 
changes may occur developmentally as a mechanism to compensate for the normal role 
of α4-GABAARs.  
 
In this thesis, the Cre/loxP system will be used to delete the Gabra4 gene throughout the 
brain, thus creating constitutive GABAAR α4-subunit knockout mice (described in 
Chapter 2; 2.2.1.). Additionally, the Gabra4 gene will be deleted selectively from 
dopamine receptor D1- or D2-expressing neurons, thus creating D1- or D2-expressing 
	   38	  
neuron specific GABAAR α4-subunit knockout mice (described in Chapter 4; 4.2.1.). In 
order to confirm the gene deletion, constitutive and D1- or D2-expressing neuron 
specific GABAAR α4-subunit knockout mice were characterised molecularly using 
DNA PCR analysis from ear punches (described in Chapter 2; 2.2.2. and Chapter 4; 
4.2.2.). Furthermore, in constitutive knockout mice, western blot protein analysis of 
NAc tissue was conducted (described in Chapter 2; 2.3.1.). To further confirm the 
deletion of GABAAR α4-subunits, as well as assess possible compensatory changes in 
other subunits, quantitative-reverse transcription PCR (qRT-PCR) was used to measure 
α4-, α2-, γ2- and δ-subunit mRNA expression in the NAc in constitutive and neuron-
specific knockout mice (described in Chapter 2; 2.3.2. and Chapter 4; 4.3.1.). 
 
1.7.2. Targeting extrasynaptic α4βδ GABAARs pharmacologically 
 
As yet, there exists no method to specifically activate α4-GABAARs pharmacologically. 
The GABAAR agonist muscimol is widely used to elicit GABAergic inhibition, but it 
activates all GABAAR subtypes (Krogsgaard-Larsen et al., 1979). Interestingly, 
muscimol has a greater affinity at α4-, α6- and δ-containing GABAARs than α1-
containing GABAARs (Quirk et al., 1995; Mihalek et al., 1999; Korpi et al., 2002; 
Chandra et al., 2010). Thus, it may be that extrasynaptic GABAARs strongly contribute 
to the in vivo pharmacological effects of muscimol. Nevertheless, the use of muscimol 
is not viable as a tool for specific activation of α4βδ GABAARs. 
 
At present, the most commonly employed tool for pharmacological activation of 
extrasynaptic GABAARs is THIP. As previously described, THIP is an agonist with a 
preference for δ-containing GABAARs, (Ebert et al., 1994; Mortensen et al., 2010). In 
vitro THIP is able specifically to activate α4βδ GABAARs when administered at a 
concentration of between 1-10µM, but beyond this begins to additionally activate αβγ-
type synaptic GABAARs (Mortensen et al., 2010). However, THIP has ‘superagonist’ 
properties at α4βδ GABAARs, demonstrating increased efficacy and producing a 
maximal inhibitory current two-fold greater than that at αβγ-type GABAARs, and that of 
a saturating concentration of GABA (Mortensen et al., 2010).  
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Nevertheless, by using a combined approach of activation of δ-containing GABAARs 
using THIP and genetic deletion of α4-subunits, the role of extrasynaptic α4βδ 
GABAARs in mediating behaviours associated with addiction can be explored. 
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1.8. Aims and structure of thesis 
 
1.8.1. Chapter 2 
 
Chapter 2 explores the role of GABAAR α4-subunits in controlling locomotor activity 
and its potentiation by acute cocaine. Firstly, a cocaine dose response was performed in 
wildtype and GABAAR α4-subunit knockout mice to assess whether deletion of these 
receptors altered the locomotor response to cocaine at various doses. Following this, 
baseline and cocaine-potentiated activity were measured following activation of α4βδ-
GABAAR activation by various doses systemic THIP in wildtype and GABAAR α4-
subunit knockout mice. The NAc is thought to be an important structure in the 
mediation of locomotor activity (Costall et al., 1977; Campbell et al., 1997). Therefore, 
baseline and cocaine-potentiated activity were also measured following intra-accumbal 
infusion of THIP at various doses in wildtype mice, then repeated at behaviourally 
active doses in both wildtype and GABAAR α4-subunit knockout mice. The aim of this 
chapter is to determine the role of GABAAR α4-subunits in locomotor activity and its 
potentiation by acute cocaine. This will also allow consideration for other behaviours 
that could be affected by changes in locomotor activity, such as conditioned place 
preference.  
 
1.8.2. Chapter 3 
 
α2-containing GABAARs have previously been shown to be crucial for behavioural 
sensitisation to cocaine (Dixon et al., 2010). The aim of chapter 3 was to investigate 
whether GABAAR α4-subunits may also play a role in the control of behavioural 
sensitisation to cocaine. Wildtype and GABAAR α4-subunit knockout mice were given 
repeated, intermittent cocaine at various doses over 10 sessions. Context-specificity of 
behavioural sensitisation to cocaine was explored by testing for conditioned activity 
following saline in the drug-paired context, as well as in a novel context. GABAAR α4-
subunits are heavily expressed within the NAc (Pirker et al., 2000), an area known to 
play a critical role in behavioural sensitisation to cocaine (Everitt and Wolf, 2002). 
Therefore, the effects of pharmacological activation of α4-GABAARs using a systemic 
challenge injection THIP were investigated in wildtype and GABAAR α4-subunit 
knockout mice following behavioural sensitisation to cocaine. This chapter will provide 
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further incite into the role of GABAAR subtypes in the mediation of behavioural 
sensitisation to cocaine. Furthermore, these experiments will provide novel data into a 
possible role of NAc extrasysnatptic GABAARs in mediating behavioural responses to 
repeated cocaine administration. 
 
1.8.3. Chapter 4 
 
Environmental cues paired with repeated cocaine are known to become associated with 
the motivational properties of the drug, a phenomenon studied in laboratory animals 
using the conditioned place preference (CPP) paradigm (Cunningham et al., 2006; 
Tzschentke, 2007). The aim of chapter 4 is to explore the role of GABAAR α4-subunits 
in the acquisition and expression of cocaine-CPP. Following the acquisition of cocaine-
CPP in wildtype and GABAAR α4-subunit knockout mice, the effects of a cocaine 
challenge on CPP expression were explored. Subsequently, expression of cocaine-CPP 
and its enhancement by a cocaine challenge were explored following intraperitoneal or 
intra-accumbal THIP. Finally, the role of striatal pathways in mediating cocaine-CPP 
were investigated. Following acquisition of cocaine-CPP in dopamine D1-/D2-
expressing neuron specific GABAAR α4-subunit knockout mice and respective 
wildtypes, the effects of systemic THIP on baseline and cocaine-enhanced cocaine-CPP 
expression were explored. 
 
1.8.4. Chapter 5 
 
Chapter 5 further explores the role of GABAAR α4-subunits in mediating behavioural 
responses to reward-conditioned cues. α2-containing GABAARs have previously been 
shown to be involved in the potentiation of food conditioned reinforcement by cocaine 
(Dixon et al., 2010). Here, following Pavlovian conditioning, nose-poke responding for 
a conditioned reinforcer and its potentiation by cocaine at various doses was measured 
in wildtype and GABAAR α4-subunit knockout mice. Subsequently, the effects of intra-
accumbal THIP on baseline and cocaine-potentiated CRf responding were explored. In 
order to confirm the importance of GABAAR α4-subunits within the NAc in controlling 
CRf responding, baseline and cocaine-potentiated CRf responding was measured 
following viral knockdown of α4-subunit expression specifically within the NAc. 
Finally, the role of striatal pathways in mediating CRf responding and it potentiation by 
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cocaine were investigated. The effects of intra-accumbal THIP on baseline and cocaine-
potentiated CRf responding were explored in dopamine D1-/D2-expressing neuron 
specific GABAAR α4-subunit knockout mice and respective wildtypes. 
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Chapter 2 
 
The role of α4-containing GABAA receptors in baseline and acute cocaine-
potentiated locomotor activity 
 
2.1. Introduction 
 
Alongside physiologically essential motor behaviours, including breathing, eating and 
drinking, locomotor activity is a crucial component of all animals’ behavioural 
repertoire. Usually defined as the movement from one location to another, locomotor 
activity underlies the ability to explore the surrounding environment, critical for 
approaching salient stimuli, such as food or sex, and avoiding aversive stimuli, such as 
predators. As such, stimulus approach and avoidance can be thought of as directed 
locomotor activity. Novel, or non-habituated, stimuli or environments, where the 
salience is unknown, are associated with an initial heightened level of exploratory 
locomotor activity (Butler, 1958). This activity rapidly decreases if the salience is 
determined to be neutral (Harris, 1943). In rodents, other motor behaviours including 
rearing and head movements are also recognised as exploratory behaviour. A second 
form of locomotor activity independent of exploratory behaviour has also been 
documented. This spontaneous activity occurs in habituated environments, suggesting 
that animals also display a basal level of locomotor activity (Robbins, 1977; Paulus and 
Geyer, 1993).  
 
As well as being strongly influenced by environmental conditions, including noise, light 
and temperature, locomotor activity is affected by administration of a wide range of 
pharmacological compounds. In general, locomotor activity is enhanced by drugs that 
facilitate transmission at dopamine synapses and reduced by drugs blocking dopamine 
receptors or by lesions of dopamine systems (Andén et al., 1970; Kelly et al., 1975; 
Kelly and Iversen, 1976; Fray et al., 1980). Indeed, psychostimulant drugs, including 
cocaine, dose-dependently modulate locomotor activity in an inverted U-shaped 
function (Isaacson et al., 1978). Acute administration of cocaine facilitates locomotor 
activity up to a point, at which the dose becomes so intense as to interfere with 
organised locomotor behaviour and induces severe behavioural stereotypy (Randrup and 
Munkvad, 1967; Bhattacharyya and Pradhan, 1979).  
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Studies investigating the behavioural outcome of direct injections of dopamine agonists 
into various regions of the rat forebrain, suggest that locomotor stimulation is primarily 
mediated by the nucleus accumbens (NAc), and stereotyped behaviours from the dorsal 
striatum (Costall et al., 1977; Campbell et al., 1997). The NAc is anatomically and 
neurochemically heterogeneous, with a major subdivision between the medioventral 
shell and dorsolateral core. Behavioural evidence also suggests a functional 
compartmentalisation of these areas with intra-accumbal amphetamine microinjection 
and 6-OHDA lesion studies implicating the NAc shell in mediating the rewarding 
properties of psychostimulants (Di Chiara et al., 2004; Ikemoto and Wise, 2004), and 
the NAc core in locomotor and other behavioural activation (Boye et al., 2001; Sellings 
and Clarke, 2003; Sellings et al., 2006). However, the extent of this functional divide is 
controversial, with some laboratories reporting that microinjections of amphetamine 
into the medial shell (Heidbreder and Feldon, 1998) or both shell and core (Ikemoto, 
2002) can also facilitate locomotor activity. Furthermore, the majority of these studies 
were carried out using rats, and it is still unknown whether the NAc core/shell divide 
exists to the same extent in mouse strains.  
 
It has been theorised that potentiated locomotor responses following intra-accumbal 
dopamine agonist infusions may be the result of a more general facilitation of approach-
investigation behaviour, which is then directed by the environmental conditions 
(Ikemoto and Panksepp, 1999). Thus, in a neutral environment lacking in interactive 
stimuli, such as a standard locomotor activity chamber, increased NAc dopamine 
transmission may simply stimulate exploratory behaviour including locomotion and 
rearing, whereas in other situations other approach behaviours may be facilitated, such 
as conditioned activity in an operant task (Taylor and Robbins, 1986; Cador et al., 1991; 
Kelley and Delfs, 1991). Indeed, projections from limbic structures to regions of the 
NAc help to guide the initiation of behavioural responses following increased dopamine 
transmission. In addition to dopaminergic innervation from the VTA, the NAc receives 
strong glutamatergic inputs from the hippocampus, prefrontal cortex (PFC) and 
amygdala, and projects to the globus pallidus, making it ideally positioned for the 
integration of limbic and motor systems (Mogenson et al., 1980; Groenewegen et al., 
1996).  
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The hippocampus plays a crucial role in various cognitive functions, including spatial 
memory and navigation, and has been suggested to contribute to the initiation of 
exploratory locomotion (Roberts et al., 1962; Teitelbaum and Milner, 1963; Kleinrok et 
al., 1980). Electrical stimulation of the ventral hippocampal formation, including the 
ventral CA1 and subicular areas, which project largely to the medial NAc shell, 
increases locomotor activity; however, acute inactivation of the same area has no effect 
(Groenewegen et al., 1987; Bardgett and Henry, 1999). More recently, optogenetic 
activation of ventral hippocampal axons in the NAc increases, whilst inhibition 
decreases, cocaine-induced locomotion (Britt et al., 2012). The PFC and basolateral 
amygdala (BLA), known to play a critical role in the production of goal-orientated 
behaviours, send projections to both the NAc core and shell. Inactivation of these 
structures has opposing effects on intra-accumbal amphetamine-induced locomotion, 
with inhibition of the PFC by lidocaine potentiating, and inactivation of the BLA 
inhibiting amphetamine-induced hyperlocomotion (Rouillon et al., 2008). However, 
injection of dopamine into the central nucleus of the amygdala (CeN), which projects 
largely to the NAc core, has no effect on baseline locomotor activity (Jackson et al., 
1975).  
 
Evidence has demonstrated an important role for GABAergic inhibition in mediating 
locomotor activity. Increased whole-brain GABA levels using systemic administration 
of drugs blocking GABA breakdown, including amino-oxyacetic acid, di-n-propyl-
acetate and γ-acetylenic GABA, attenuates baseline and amphetamine-potentiated 
locomotor activity (Grimm et al., 1975; Cott and Engel, 1977; Agmo and Giordano, 
1985). Similarly, systemic injection of GABA also decreases locomotor activity in 
mice, rats and rabbits (Śmiałowski et al., 1980). Given that GABAergic MSNs are the 
primary neural type within the NAc it is likely that manipulations of GABA and 
GABAA receptors within this structure may have a significant effect on baseline and 
psychostimulant-potentiated locomotor activity. Indeed, intra-accumbal injections of 
GABA elicit a bimodal response in locomotion, with low doses inducing a small 
increase, and larger doses producing a reduction (Wachtel and Anden, 1978; Jones et 
al., 1981). Interestingly, elevation of GABA levels in the NAc using the GABA-
transaminase inhibitor ethanolamine-O-sulphate abolishes the ability of intra-accumbal 
dopamine injections to potentiation locomotor activity, but has no significant effect on 
baseline locomotor activity (Pycock and Horton, 1976b). This may potentially be 
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explained by differences in the total GABA volume within the NAc following different 
methods of intra-accumbal GABA manipulation. More recently, compounds allowing 
researchers to target GABAA receptors directly have allowed for more accurate control 
and demonstrate greater concurrence. As predicted from the earlier work, intra-
accumbal microinjections of the GABAAR antagonist picrotoxin enhance baseline and 
intra-accumbal amphetamine-potentiated locomotor responses (Pycock and Horton, 
1979; Jones et al., 1981; Wong et al., 1991). Similarly, muscimol-induced activation of 
GABAA receptors in the NAc core but not shell reduce dopamine receptor-mediated 
motor behaviour in mice (Akiyama et al., 2003; 2004). 
 
Within the VTA, infusions of the GABAAR agonist muscimol, and GABAAR antagonist 
picrotoxin, induce opposing functional effects, which also vary according to the 
infusion site (Arnt and Scheel-Krüger, 1979). Muscimol infused into the caudal VTA 
elicits a dopamine-dependent increase in locomotor activity, whilst picrotoxin produces 
a mild decrease in locomotor activity. However, when injected into the rostral VTA, 
muscimol decreases, and picrotoxin increases locomotor activity. Furthermore, the 
locomotor activating effects seen following GABA agonists and antagonists in the 
caudal and rostral VTA, respectively, are dopamine-dependent (Scheel-Krüger et al., 
1980). Dopaminergic afferents from the VTA to the NAc are organised topographically 
in a rostro-caudal arrangement; thus, GABA, within the VTA, may act to alter the 
balance between dopamine systems mediating distinct behavioural functions dependent 
on the various anatomical areas.  
 
A GABAergic projection from the NAc to the ventral globus pallidus is strongly 
implicated in the control of locomotor activity (Jones and Mogenson, 1980a; Walaas 
and Fonnum, 1980; Mogenson and Sztorc, 1982). Microinjection of picrotoxin into the 
ventral globus pallidus enhances locomotor activity in rats (Jones and Mogenson, 
1980b). Similarly, increasing globus pallidus GABA levels by infusion of the 
ethanolamine-O-sulphate (Pycock et al., 1976; Pycock and Horton, 1976a), or 
microinjection of GABA (Mogenson and Nielsen, 1983),  attenuates locomotor activity 
elicited by intra-accumbal injection of dopamine (Pycock et al., 1976; Pycock and 
Horton, 1976a). These data support the proposed role of striatopallidal GABAergic 
projection neurons within the indirect pathway (see Chapter 1; Fig.1.1.) in supressing 
motor behaviour (Kravitz and Kreitzer, 2012; Kravitz et al., 2012). 
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To conclude, whilst it is clear that dopamine release onto GABAergic MSNs within the 
NAc is the driving force in the initiation of locomotor activity and the locomotor 
potentiating effects psychostimulant drugs, it is the GABAARs within the NAc (with the 
addition of glutamatergic inputs from other brain regions) that are likely to act to control 
this dopamine-dependent locomotor activity. However, as yet, very little is understood 
about the details of accumbal GABAergic transmission, and, in particular, which 
GABAAR subtypes may be important in this process. Moreover, the research that has 
been conducted previously has largely explored the effects of GABAAR agonists and 
antagonists targeting synaptically located receptors. However, there is recent evidence 
that extrasynaptically located GABAARs may also play a functional role in mediating 
locomotor activity. Systemic administration of THIP, a GABAAR agonist with a 
preference for δ-containing receptors typically found extrasynaptically, inhibits baseline 
locomotor activity and attenuates enhanced locomotion following intra-accumbal 
administration of the glutamate agonist 6,7-ADTN (Arnt, 1981; Agmo and Giordano, 
1985; Herd et al., 2009; Vashchinkina et al., 2012). The experiments reported here will 
further investigate the involvement of extrasynaptic α4βδ receptors in mediating 
baseline and cocaine-potentiated locomotor activity, by examining the effects of 
pharmacological activation of these receptors with THIP in wildtype and GABAAR α4-
subunit knockout mice. 
  
	   48	  
2.2. Materials and Methods 
 
2.2.1. Animals 
Constitutive α4-subunit knockout mice were produced at Sussex University. “Floxed” 
α4-subunit homozygous mice (strain name; B6.129-Gabra4tm1.2Geh/J, supplied by The 
Jackson Laboratory, ME, USA), were crossed with Cre-recombinase expressing 
hemizygous transgenic mice (strain name; B6.FVB-Tg (Ella-cre)C5379Lmgd/J, 
supplied by The Jackson Laboratory, ME, USA). Offspring were genotyped and 
putative Gabra4 heterozygous mice (carrying the CRE transgene (~50% of offspring)) 
were bred together to generate homozygous knockout, heterozygous (used for breeding) 
and wildtype littermates  (Fig. 2.1.). 
 
Male and female GABAA α4 wildtype (WT) and knockout (α4-/-) mice on a C57BL/6J 
background, weighing between 20-30g and aged between 2-6 months, were housed in 
groups of 2-3, or separately for animals undergoing surgery, with food and water 
available ad libitum. A 12hr light/dark cycle was used (lights on at 7:00 A.M.) with 
holding room temperature maintained at 21±2ºC and humidity 50±5%. All injections, 
infusions and behavioural testing were performed between 2:00 P.M. and 5:00 P.M. All 
procedures were conducted in accordance to Animals (Scientific Procedures) Act 1986, 
following ethical review by the University of Sussex Ethical Review Committee. 
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Figure 2.1. 
 
Fig. 2.1. Production of α4 wildtype (WT), heterozygous (HET) and knockout (α4-/-) 
mice. (F0) α4-subunit “floxed” homozygous mice were bred with Cre-recombinase 
expressing heterozygous mice. (F1) offspring were heterozygous for the α4 allele  (+/-
), which were bred to create (F2) offspring in approximate ratios, 25% WT, 50% HET, 
25% α4-/-. 
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2.2.2. Genotyping  
 
2.2.2.1. DNA Extraction 
Mouse ear punches were collected and DNA extracted by digestion in a 20µl solution of 
a 1mg/ml proteinase K solution (50mg/ml; Roche Products Ltd., UK) and 20mM Tris 
HCl (Sigma-Aldrich, Dorset, UK) and 10mM EDTA (Sigma-Aldrich, Dorset, UK) lysis 
buffer. Solutions were overlayed with two drops of purified mineral oil (Sigma-Aldrich, 
Dorset, UK), then incubated at 55°C for 2 hours, then heated to 95°C for 15 minutes in 
a thermocycling PCR machine (G-Storm GS1, GRI Ltd., Somerset, UK). Extracted 
DNA samples were diluted to 100µl with purified PCR water, with gentle mixing. 
 
2.2.2.2. PCR  
GABAAR α4-subunit PCR primer sequences were used from those presented in the 
supplementary text of (Chandra et al, 2006). Forward and reverse cDNA primers were 
designed to target and replicate a sequence within the wildtype gabra4 gene and the 
shortened gene with a deletion of exon 3 in the α4-subunit knockout mouse. The 
wildtype primers consisted of a 156bp product (forward primer, 
AAGATCACCAAGCCAACAGG; reverse primer, TCTTTGGGGAGTTGAGGATG) 
containing the primary loxP site in the “floxed” mice, and part of the conserved region. 
The knockout primers consisted of a 241bp product (forward primer, 
AAGATCACCAAGCCAACAGG; reverse primer, TGCACACTGTAATTCCCATC), 
which flanked the primary and secondary loxP sites either side of exon 3 of the gabra4 
gene.   
 
For each reaction, 0.5µl of extracted DNA was mixed into a solution of 0.5µl of both 
forward and reverse primers and 23.5µl of Megamix-Blue (Microzone Ltd., Haywards 
Heath, UK). Solutions were overlayed with two drops of purified mineral oil, then 
incubated at 95°C for 5 minutes, followed by 35 cycles of the following; 95°C for 30 
seconds, 55°C for 30 seconds and 72°C for 1 minute, in a thermocycling PCR machine. 
Finally, PCR samples were held at 72°C for 10 minutes. 
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2.2.2.3. Gel Electrophoresis and DNA Detection 
Following PCR amplification of the targeted DNA, samples were electrophoretically 
separated on a 1.5% agorose (AGTC Bioproducts Ltd., Leicestershire, UK) gel 
containing 0.004% ethidium bromide (50mg/ml solution; Sigma-Aldrich, Dorset, UK) 
in 1% TAE buffer (242g/L tris base (Sigma-Aldrich, Dorset, UK), 57.1ml/L acetic acid 
(Sigma-Aldrich, Dorset, UK), 0.5M EDTA (14.62g of EDTA (Sigma-Aldrich, Dorset, 
UK) in 100ml/L dH2O). Gels placed within a horizontal electrophoresis tank connected 
to a power supply (BioRad Laboritories Inc., Hercules, CA, USA) were run at 120v for 
approximately 30 minutes, and then observed under UV light for the presence of the 
wildtype and knockout (Fig. 2.2.) primers. 
 
 
 
 
Figure 2.2. 
Fig. 2.2. Genotyping of GABAAR α4-subunit wildtype and knockout mice requires two 
reactions per mouse. The first reaction contains the wildtype primers, and second 
reaction contains the knockout primers for detection of the gabra4 gene. The presence 
of a band in the wildtype reaction, but not the knockout reaction indicates a wildtype 
mouse. A band in the knockout reaction, but not the wildtype reaction indicates a 
knockout mouse. A band in both reactions indicates a mouse heterozygous for both the 
wildtype and knockout gene. 
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2.2.3. Western Blot protein analysis 
 
2.2.3.1. Preparation of tissue lysates 
GABAAR α4-­‐subunit	   wildtype,	   heterozygous	   and	   knockout	   mouse	   brains	   were	  dissected	   and	   tissue	   samples	   collected	   from	   the	   prefrontal	   cortex,	   thalamus	   and	  nucleus	   accumbens	   using	   a	   1.5mm	   biopsy	   punch	   (Kai	  Medical	   Inc.,	   Seki,	   Japan).	  Tissue	  punches	  were	  homogenised	  in	  500µl of lysis buffer (10ml solution contains; 
860mg sucrose (Sigma-Aldrich, Dorset, UK), 20µl 0.5M Na Vanadate (Sigma-Aldrich, 
Dorset, UK), 10µl β-mercaptoethanol, 2ml 5X lysis buffer stock (600µl 1M Tris pH 6.8, 
0.1g SDS (Sigma-Aldrich, Dorset, UK), 1ml Glycerol (Sigma-Aldrich, Dorset, UK), 
400µl purified H2O), 1 Roche Complete Mini Protease Inhibitor cocktail tablet (Roche 
Products Ltd., Hertfordshire, UK)). 
 
2.2.3.2. SDS-PAGE electrophoresis and protein transfer 
9µl of each protein sample was mixed with 3µl of protein loading dye (10ml solution 
contains; 1ml 1M Tris, 4ml 10% SDS, 0.002g bromophenol blue (Sigma-Aldrich, 
Dorset, UK), 2ml glycerol) and separated by SDS-PAGE for 30 minutes at 200V in a 
10% acrylamide gel (10% resolving gel, 30ml solution contains; 13.9ml purified H2O, 
8ml 30% acrylamide mix (BioRad Laboritories Inc., Hercules, CA, USA), 7.5ml 1.5M 
Tris HCl pH 8.8, 0.3ml 10% SDS, 0.3ml 10% ammonium persulphate (Sigma-Aldrich, 
Dorset, UK), 0.018ml TEMED (BioRad Laboritories Inc., Hercules, CA, USA); 5% 
stacking gel, 5ml solution contains; 3.4ml purified H2O, 0.83ml 30% acrylamide mix, 
0.63ml 1.5M Tris HCl pH 6.8 with bromophenol blue, 0.05ml 10% SDS, 0.05ml 10% 
ammonium persulphate, 0.005ml TEMED, using a Mini-PROTEAN Tetra Cell 
electrophoresis system (BioRad Laboritories Inc., Hercules, CA, USA). Proteins were 
transferred to a nitrocellulose blotting membrane (BioRad Laboritories Inc., Hercules, 
CA, USA) using a Trans-Blot Turbo Transfer System (BioRad Laboritories Inc., 
Hercules, CA, USA). 
 
2.2.3.3. Primary and secondary antibody incubation 
 Blots were blocked in 15ml of TBS-T (50mM Tris, 150mM NaCl (Sigma-Aldrich, 
Dorset, UK) and 0.05% Tween 20 (Sigma-Aldrich, Dorset, UK) in 500ml of purified 
H20) with 5% milk (Marvel, Wembley, UK) for 60 minutes, then incubated in 15ml of 
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anti-GABAAR α4-subunit rabbit anti-mouse polyclonal primary antibody (1:1000; 
catalogue no. 844-GA4N, Phosphosolutions, CO, USA) in TBS-T with 1% BSA 
(Sigma-Aldrich, Dorset, UK) overnight at 4°C. Blots were then incubated in 15ml of 
goat anti-rabbit HRP (horseradish peroxidase) secondary antibody (1:10,000; catalogue 
no. ab6721, Abcam, Cambridge, UK) in TBS-T for 60 minutes. 
 
2.2.3.4. Protein detection and data analysis 
Blots were incubated in 2ml of chemiluminescence substrate (Thermo Fisher Scientific 
Inc., Waltham, MA, USA) for approximately 5 minutes, then exposed to CL-XPosure 
photographic film (Thermo Fisher Scientific Inc., Waltham, MA, USA) and developed 
in a darkroom. Developed films were scanned on an Epson 4990 Photo Scanner (Epson, 
Nagano, Japan) and quantified using NIH ImageJ (http://rsb.info.nih.gov/ij/). Integrated 
densities were used, measuring the mean intensity of each selected band. Background 
correctional values were subtracted from each lane to minimize variability across 
membranes. Integrated	  density	  results	  were	  averaged	  between	  genotypes	  and	  the	  mean	  values	  used	  to	  calculate	  the	  percentage	  change	  from	  wildtype	  mice.	  	  
 
2.2.4. Quantitative reverse transcription PCR (qRT-PCR) mRNA analysis  
 
2.2.4.1. Preparation of tissue lysates and phase separation  
Constitutive GABAA α4-­‐subunit	  wildtype,	  heterozygous	  and	  knockout	  mice	  brains	  were	  dissected	  and	  tissue	  samples	  collected	  from	  the	  nucleus	  accumbens	  using	  a	  1.5mm	   biopsy	   punch	   (Kai	   Medical	   Inc.,	   Seki,	   Japan).	   Tissue	   samples	   were	  homogenised	  in	  600µl of Trizol (Life Technologies, CA, USA) and 200µl of RNase-
free H2O (Life Technologies Corp., CA, USA), then mixed with 160µl of chloroform 
(Thermo Fisher Scientific Inc., Waltham, MA, USA) and phase separated by 
centrifuging for 15 minutes (12,000g) in pre-spun peqGOLD PhaseTrap A phase lock 
eppendorf tubes (Peqlab ltd., Erlangen, Germany). 	  
 
2.2.4.2. RNA precipitation 
The aqueous layer of each sample was decanted into an eppendorf tube (Sigma-Aldrich, 
Dorset, UK), then mixed with 0.5ml of isopropanol (Sigma-Aldrich, Dorset, UK), 50µl 
of sodium acetate (Sigma-Aldrich, Dorset, UK), and 4µl of glycoblue (Life 
	   54	  
Technologies Corp., CA, USA) and incubated at room temperature for 10 minutes. 
Samples were centrifuged (12,000g) at 4°C for 20 minutes until a RNA pellet formed, 
the supernatant was discarded and replaced with 1ml of 75% EtOH (Sigma-Aldrich, 
Dorset, UK) wash then centrifuged (7500g) for 5 minutes at 4°C. The wash was 
discarded and pellets left to air dry for 30 minutes, then resuspended in 87.5µl of 
RNase-free H2O (Sigma-Aldrich, Dorset, UK). 
 
2.2.4.3. RNA cleanup RNA	  was	  extracted	  using	  the	  RNeasy	  Mini	  Kit	  (RNeasy Mini Kit, Qiagen Ltd., West 
Sussex, UK).	  To	  each	  87.5µl solution; 10µl of buffer RDD and 2.5µl of DNase I stock 
solution were added and incubated at room temperature for 10 minutes. Then to this 
100µl solution; 350µl of buffer RLT mixed with 3.5µl of β-mercaptoethanol and 250µl 
of 96-100% EtOH were mixed and immediately transferred to a spin column in a 2ml 
collection tube, then centrifuged (13,000g) for 15 seconds. Each spin column was 
transferred to a new collection tube to which 500µl of buffer RPE was added then 
centrifuged (13,000g) for 15 seconds. Each spin column was again transferred to a new 
collection tube to which 500µl of 80% EtOH was added then centrifuged (13,000g) for 
15 seconds. Finally, each spin column was transferred to a new collection tube and 
centrifuged (13,000g) for 5 minutes with the lid open. The spin columns were 
transferred to new 1.5µl eppendorf tubes to which 14µl of RNase-free H2O was added 
and centrifuged (13,000g) for 2 minutes. Approximately 12µl of eluted RNA was 
retrieved.  
 
2.2.4.4. RNA calculation and cDNA production 
The amount of RNA was determined using a NanoDrop 2000 micro-volume 
spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA) and corrected 
for between each sample. RNA was added to the appropriate amount of RNase-free H2O 
and 2µl of oligo(dT) primer (Life Technologies, CA, USA) to make a total volume of 
15µl then incubated at 65°C for 5 minutes in a thermocycling PCR machine. Reactions 
were snap chilled on ice for 1 minute, after which 4µl of 5Xiscript select react mix (Life 
Technologies, CA, USA) and 1µl of reverse transcriptase (Life Technologies, CA, 
USA) were added to each. Finally, reactions were mixed and incubated at 42°C for 60 
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minutes then 85°C for 5 minutes in a thermocycling PCR machine, to make 20µl of 
cDNA. 
 
2.2.4.5. qRT-PCR reaction 
1µl of each cDNA (at ≤500ng) sample was amplified by PCR in a 25µl reaction 
mixture; 12.5µl of SYBRGreen mastermix (Sigma-Aldrich, Dorset, UK), 0.6-µl of 
forward primer (primer sequences were designed using BLAST search with the NCBI 
tool Primer-BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast/), presented in Table 
2.1.), 0.6-µl of reverse primer and 10.3µl of RNase-free H2O, using an Mx4000 
multiplex quantitative PCR sampler (Stratagene, La Jolla, CA, USA). Sample 
concentrations were calculated from serial dilution concentration curves, and each 
reaction was set up in triplicate, including GAPDH and 1µl RNase-free H2O no 
template controls.  
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Table 2.1. 
Primer Forward Reverse 
 
GABAAR 
α4-subunit 
 
GABAAR 
α2-subunit 
 
GABAAR 
γ2-subunit 
 
GABAAR 
δ-subunit 
 
GAPDH 
5’-
CGTATTCTGGACAGTTTGCTG
GATGGT -3’ (27) 
5’- 
AAAAGAGGATGGGCTTGGGA-
3’ (20) 
5’-
GGAGCCTGGAGACATGGGA -
3’ (19) 
5’-
GGCTCCCCAACCTGGATGGCT 
-3’ (21) 
5’- 
TGCCCCCATGTTTGTGATG  
-3’ (19) 
5’- 
ACGGGCCCAAAGCTGGTGAC
AT-3’ (22) 
5’- 
ACGGGATGTTTTCTGCCTGTA
T-3’ (22) 
5’-
TGAACAAGCAAAAGGCGGTA 
-3’ (20) 
5’-
GGCCACCTCTAGGGCAAGCG -
3’ (20) 
5’- 
TGTGGTCATGAGCCCTTCC 
-3’ (19) 
Table 2.1. Primer sequences used for qRT-PCR analysis of constitutive and D1/D2-
expressing neuron specific GABAAR α4-subunit knockout mice, heterozygous and 
relative wildtype controls. 
 
 
2.2.5. Stereotaxic Surgery 
Mice anaesthetised with isoflurane were implanted stereotaxically with bilateral guide 
cannulae (26 ga., 10mm) aimed at NAc (coordinates AP1.34; L+/− 1.00; DV −3.20, 
(Paxinos and Franklin, 2001)). Following surgery, mice were singly housed and 
underwent a one-week recovery/habituation period. A steel infuser (33 ga., 11 mm) 
connected via polyvinyl tubing to a (5 µl) Hamilton Gastight syringe was used to infuse 
0.5µl of either saline or THIP (3 mM) bilaterally across 90 seconds and left to settle for 
90 seconds before infusers were removed. Location of cannulae was confirmed 
histologically. One animal was removed from data analysis due to inexact cannulae 
placements. 
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2.2.6. Drugs 
Cocaine Hydrochloride was obtained from Macfarlan Smith (Edinburgh, UK). THIP 
(4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) was kindly donated by Bjarke Ebert 
(Lundbeck, Valby, Denmark). Both drugs were dissolved in 0.9% saline, and 
administered i.p. at an injection volume of 10 ml/kg, and intracranially as described 
above. 
 
2.2.7. Apparatus 
Locomotor activity was measured using 16 annular black Perspex runways, (diameter 
24cm, annulate width 6.5cm), placed atop of a clouded Perspex sheet on an elevated 
frame. A digital camera positioned beneath the sheet captured the silhouettes of the 
boxes’ edges and the mice within them, which was then relayed to a computer to be 
recorded. A MatLab (MathWorks, Cambridge, UK) video analysis programme and 
Excel macro converted the video data into a measure of the distance travelled in metres.  
 
2.2.8. Cocaine Dose Response 
The locomotor response to acute cocaine at various doses was tested in WT and α4-/- 
mice. In a Latin-square design, mice were administered with saline, 3, 10, 20 and 
30mg/kg cocaine directly prior to placement in the locomotor runways. 
 
 
2.2.9. Baseline and Cocaine-Potentiated Locomotor Activity 
 
2.2.9.1. Intraperitoneal THIP Dose Response 
Prior to testing there were two habituation days, on the first day mice were habituated to 
the equipment for 60 minutes, on the second day mice received a sham i.p. injection of 
saline prior to being placed in the apparatus. All animals underwent four test days in a 
Latin square design, during which they were administered saline, 5, 10, 20mg/kg. 
Saline/THIP Injections were given 20 minutes in advance, followed by a second i.p 
injection of saline or cocaine (10mg/kg) directly prior to initiating the locomotor test. 
All locomotor activity was recorded over 60 minutes. Test sessions were spaced 48 
hours apart to eliminate the possibility of lingering drug effects from the previous 
session. 
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2.2.9.2. Intra-accumbal THIP Dose Response 
As previous, mice first received two habituation days, firstly a 60 minute habituation 
session, then on the second day, a 60 minute habituation session including a sham 
intracranial infusion (infusers were inserted and left in for 3 min, but nothing was 
administered) prior to being placed in the apparatus. All animals then underwent four 
test days in a Latin square design, during which they were administered saline or intra-
accumbal THIP at either 0.3, 3, 30, 300 or 3000uM. Intra-accumbal infusions were 
given immediately prior to an i.p injection of saline or cocaine (10mg/kg). All 
locomotor activity was recorded over 60 minutes. To reduce possible structural damage 
following multiple intracranial infusions, each THIP dose was tested in separate groups 
of mice. Successive sessions were spaced by at least 48h to reduce the possibility of 
lingering drug effects from the previous session. 
 
2.2.10. Statistical Analysis 
 
2.2.10.1. Western Blot 
Developed films were scanned and quantified using NIH ImageJ 
(http://rsb.info.nih.gov/ij/). Integrated densities were used, measuring the mean intensity 
of each selected band. Background correctional values were subtracted from each lane 
to minimize variability across membranes. Integrated	  density	  results	  were	  averaged	  between	  genotypes	  and	  the	  mean	  values	  used	  to	  calculate	  the	  percentage	  change	  from	  wildtype	  mice.	  	  
 
2.2.10.2. qRT-PCR 
Quantitative RNA expression data were collected using the Mx4000 data analysis 
software (Stratagene, CA, USA), then exported to an Excel worksheet. Reaction 
triplicates were averaged, and then normalised against the control gene GAPDH to give 
a measure of the delta CT. The delta CT of the target sample was then normalised 
against the delta CT of a control sample to give a measure of the delta delta CT.  
Finally, a mathematical model was used to calculate the fold change of the target gene 
using the delta-delta CT (see (Pfaffl, 2001)). Statistical analysis of RNA expression of 
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each receptor subunit was conducted using between-subjects one-way ANOVAs, with 
genotype as the between-subjects variables, and delta CT as the dependent variable. 
 
2.2.10.3. Cocaine Dose Response 
Locomotor activity data for the cocaine dose response study were analysed using a 
three-way mixed-factors ANOVA with genotype and sex as the between-subjects 
variables, and meters travelled following each cocaine dose as the within-subjects 
dependent variable. 
 
2.2.10.4. Intraperitoneal THIP Dose Response 
Locomotor activity data for the i.p. THIP dose response study were analysed using a 
four-way mixed-factors ANOVA with genotype, sex and drug group as the between-
subjects variables, and meters travelled following each THIP dose as the within-subjects 
dependent variable. Post hoc analyses were conducted where appropriate using paired t-
tests. 
 
2.2.10.5. Intra-accumbal THIP Dose Response 
Locomotor activity data for the intra-accumbal THIP dose response study were analysed 
using a five-way mixed-factors ANOVA with sex and THIP dose as the between-
subjects variable, infusion treatment and injection treatment as the within-subjects 
variables, and meters travelled in each condition as the dependent variable. 
Subsequently, two separate five-way mixed-factors ANOVA were conducted for each 
of two THIP doses (3µM and 3mM), with sex and genotype as the between-subjects 
variables, infusion treatment and injection treatment as the within-subjects variables, 
and meters travelled in each condition as the dependent variables. Post hoc analyses 
were conducted where appropriate using paired t-tests. 
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2.3. Results  
 
2.3.1. Western Blot protein analysis 
To confirm that the knockout mice lacked the expression of Gabra4, western blot 
analysis was conducted on tissue samples from the prefrontal cortex (PFC), thalamus 
and nucleus accumbens (NAc) of WT, HET, and α4-/- mice. An α4-specific antibody 
(Bencsits, 1999) specifically recognized a ≈67kD protein in WT mice (Fig. 2.5.A.). This 
protein band is absent in tissue samples from α4-/- mice (Fig. 2.3.).  In HET mice 
Gabra4 expression was reduced in the PFC (52 ±11% reduction compared to WT 
controls), thalamus (30 ±22% reduction compared to WT controls) and NAc (70 ±12% 
reduction compared to WT controls) (Fig. 2.3.). 
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Figure 2.3. 
 
NAc GABAAR α4-Subunit Protein Expression 
       
 
Fig. 2.3. Western Blot analysis of prefrontal cortex (PFC), thalamus and nucleus 
accumbens (NAc) tissue from GABAA α4-subunit wildtype (WT, n=3), heterozygous 
(HET, n=3) and knockout (α4-/-, n=3) mouse tissue. (A) Representative images of 
western blot results for GABAA α4 and β-actin. Blots probed for β-actin show equal 
loading of samples. (B) Percentage change from WTs of the protein Gabra4 in the PFC, 
thalamus and NAc. The expression of the Gabra4 protein was lacking in all tested brain 
regions of the α4-/- mice and significantly reduced in HET mice. Error bars represent 
SEM. 
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2.3.2. qRT-PCR mRNA analysis in constitutive GABAAR α4-subunit wildtype, 
heterozygous and knockout mice 
In order to confirm the deletion of GABAAR α4-subunits, expression levels of α4-
subunit mRNA were measured in the NAc of WT, HET and α4-/- mice using qRT-PCR. 
As previous evidence has also indicated protein levels of α2-, γ2- and δ-subunits to be 
differentially modulated in hippocampus of α4-/- mice when compared to WT controls, 
the mRNA expression levels of these subunits were also measured.  
 
qRT-PCR revealed GABAAR α4-subunit mRNA levels to be reduced in NAc of HET 
mice and completely absent in α4-/- mice when compared to WT control mice, further 
confirming the success of the targeted gene knockout (Table 2.2., Fig. 2.4; significant 
main effect of genotype, F(2,15) = 4526.05, p < 0.001). Conversely, GABAAR α2-subunit 
mRNA levels were increased in the NAc of HET mice and to a greater extent α4-/- mice, 
when compared to WT controls (Table 2.2., Fig. 2.4; significant main effect of 
genotype, F(2,15)= 36.18, p < 0.001). HET and α4-/- mice did not differ significantly from 
WT controls in the expression of GABAAR γ2-subunit mRNA in the NAc (Table 2.2, 
Fig. 2.4; significant main effect of genotype, F(2,15)= 0.42, p = 0.52, NS). Finally, 
mRNA expression of GABAAR δ-subunits was unchanged in HET mice, but reduced in 
the NAc of α4-/- mice, when compared to WT controls (Table 2.2., Fig. 2.4; significant 
main effect of genotype, F(2,15) = 22.18, p < 0.001). 
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Table 2.2. 
Primer Genotype Fold change % Change from WT Sig. 
α4 WT 
HET 
α4-/- 
1 ± 0.18/0.11 
0.54 ± 0.07/0.05 
0 ± 0/0 
0% 
-46% 
-100% 
 
p < 0.001 
p < 0.001 
α2 WT 
HET 
α4-/- 
1 ± 0.39/0.17 
4.87 ± 1.58/0.78 
5.07 ± 1.79/0.84 
0% 
+ 387% 
+407% 
 
p < 0.001 
p < 0.001 
γ2 WT 
HET 
α4-/- 
1 ± 0.26/0.14 
1.15 ± 0.20/0.12 
1.11 ± 0.24/0.14 
0% 
+15% 
+11% 
 
NS 
NS 
δ WT 
HET 
α4-/- 
1 ± 0.24/0.13 
1.14 ± 0.20/0.11 
0.53 ± 0.20/0.10 
0% 
+14% 
-47% 
 
NS 
p < 0.001 
Table 2.2.1. NAc mRNA expression levels of GABAAR α4-, α2-, γ2- and δ-subunits in 
HET (n=6) and α4-/- (n=6) mice were compared in triplicate against WT (n=6) controls 
to give a measure of fold change. Fold change from WTs was tested statistically using 
Tukey’s post hoc comparisons. 
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Figure 2.4. 
 
Fig. 2.4. Fold change from WT controls of GABAAR α4, α2-, γ2- and δ-subunit mRNA 
expression in the NAc of WT (n=6), HET (n=6) and α4-/- (n=6) mice. HET mice show a 
decrease and α4-/- mice show a complete absence of expression of α4-subunit mRNA 
when compaired to WT controls. Conversely, HET and α4-/- mice show a large increase 
in expression of α2-subunit mRNA. Expression of γ2-subunit mRNA was unchanged in 
HET and α4-/- mice. Finally, expression of δ-subunit mRNA was reduced in α4-/- but not 
HET mice, when compared to WT controls. Error bars represent SEM. *p < 0.001, post 
hoc Tukey’s comparisons.  
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2.3.3. Cocaine Dose Response 
Acute administration of cocaine dose-dependently increased locomotor activity equally 
in WT and α4-/- mice (Fig. 2.5; significant main effect of dose, F(4,48)= 582.43, p < 
0.001; non significant main effect of genotype, F(1,12)= 0.29, p = NS; non-significant 
dose by genotype interaction, F(4,48)= 0.07, p = NS). Activity did not differ between 
sexes (non-significant dose by genotype by sex interaction, F(4,48)= 0.48, p = NS). 
 
 
Figure 2.5. 
 
Fig. 2.5. Effect of intraperitoneal acute cocaine on distance travelled over 60 minutes in 
wildtype and GABAA α4-subunit knockout mice. Cocaine dose-dependently increased 
locomotor activity equally in both WT (n=8; males=4, females=4) and α4-/- (n=8; 
males=4, females=4) mice. Error bars represent SEM. 
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2.3.4. Baseline and Cocaine-Potentiated Locomotor Activity 
 
2.3.4.1. Intraperitoneal THIP Dose Response 
To examine the role of accumbal α4βδ GABAARs in cocaine-potentiation of locomotor 
activity, systemic injections of the δ-GABAAR selective agonist THIP at various doses 
were paired with systemic injections of saline or cocaine (10mg/kg) in WT and α4-/- 
mice. 
 
When analysed using the total activity over 60 minutes, intraperitoneal injections of 
THIP dose-dependently decreased locomotor activity (Fig 2.6; significant main effect of 
dose, F(3,76)= 39.12, p < 0.001). Decreased locomotor activity was found to be specific 
to mice in which THIP injections were paired with i.p. injections of cocaine, but not 
saline (significant THIP dose by drug interaction, F(3,76)= 37.05, p < 0.001). There was 
also a difference between genotypes (significant THIP dose by drug by genotype 
interaction, F(3,76)= 3.27, p < 0.05), but not between sexes (non-significant THIP dose by 
drug by genotype by sex interaction, F(3,76)= 0.28, p = NS). 
 
Low (5mg/kg) to medium (10mg/kg) doses of THIP injected i.p. with a paired i.p. 
injection of cocaine (10mg/kg), significantly decreased cocaine-enhancement of 
locomotor activity in WT, but not α4-/- mice (Figure 2.6.). Nevertheless, a high 
(20mg/kg) dose of THIP decreased cocaine-enhanced locomotor activity equally for 
both genotypes. Investigation of the timecourse of activity over the 60 minute session 
revealed a genotype-specific time- and dose-dependent decrease in locomotor activity 
(significant THIP dose by genotype by time interaction, F(44,1100)= 5.25, p < 0.05). 
Activity was greatest in the first 5 minutes, suggesting that this time period may 
demonstrate the clearest differentiation of THIP dose effects (Figure 2.7.A & C). 
 
When analysed using the first 5 minutes of activity, intraperitoneal injections of THIP 
dose-dependently decreased locomotor activity in WT, but not α4-/- mice, when paired 
with i.p. injections of saline or cocaine (Figure 2.7.B & D; data split by injection group, 
Saline group; significant THIP dose by genotype interaction, F(3,42)= 3.70, p < 0.01, 
Cocaine group; significant THIP dose by genotype interaction, F(3,42)= 15.36, p < 
0.001)).  
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Figure 2.6. 
              
Fig. 2.6. Effects of intraperitoneal THIP on baseline and cocaine- (10mg/kg) potentiated 
distance travelled over 60 minutes. Intraperitoneal injections of THIP dose-dependently 
decreased cocaine-enhancement of locomotor activity in WT (n=8; males=4, 
females=4) but not α4-/-  (n=8; males=4, females=4) mice, at low (5mg/kg) to medium 
(10mg/kg) doses. Error bars represent SEM. 
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Figure 2.7. 
 
Fig. 2.7. (A) Timecourse of activity over 60 minutes following i.p. THIP and i.p. 
injections of saline. (B) Activity over the first five minutes following i.p. THIP and i.p. 
injections of saline. Locomotor activity was significantly reduced in WT but not α4-/- 
mice at a dose of 10mg/kg THIP. (C) Timecourse of activity over 60 minutes following 
i.p. THIP and i.p. injections of cocaine (10mg/kg). (D) Activity over the first five 
minutes following i.p. THIP and i.p. injections of cocaine (10mg/kg). Cocaine-
potentiated locomotor activity was significantly reduced in WT but not α4-/- mice at 
THIP doses of 5 and 10mg/kg. Error bars represent SEM.* p < 0.05, post hoc 
comparison between genotypes. 
 
 
 
 
 
Locomotor Activity (i.p. Cocaine)
5 10 15 20 25 30 35 40 45 50 55 60
0
5
10
15
20
25
30
35
40
45 Intraperitoneal Injection
Saline Saline
5mg/kg THIP 5mg/kg THIP
10mg/kg THIP 10mg/kg THIP
20mg/kg THIP 20mg/kg THIP
WT α4 -/-
Time (minutes)
Lo
co
m
ot
or
 A
ct
iv
ity
 (M
)
A B
C D
First 5 Minutes Locomotor Activity
(i.p. Saline)
0 5 10 20
0
5
10
15
20 WT
α4 -/-
*
Intraperitoneal THIP Dose (mg/kg)
Lo
co
m
ot
or
 A
ct
iv
ity
 (M
)
First 5 Minutes Locomotor Activity 
(i.p. Cocaine)
0 5 10 20
0
5
10
15
20
25
30
35
40
45
WT
α4 -/-
*
*
Intraperitoneal THIP Dose (mg/kg)
Lo
co
m
ot
or
 A
ct
iv
ity
 (M
)
Locomotor Activity (i.p. Saline)
5 10 15 20 25 30 35 40 45 50 55 60
0
5
10
15
20 Intraperitoneal Injection
Saline Saline
5mg/kg THIP 5mg/kg THIP
10mg/kg THIP 10mg/kg THIP
20mg/kg THIP 20mg/kg THIP
WT α4 -/-
Time (minutes)
Lo
co
m
ot
or
 A
ct
iv
ity
 (M
)
	   69	  
2.3.4.2. Intra-accumbal THIP Dose Response 
 
To investigate whether the attenuation of cocaine-potentiated locomotor activity seen 
with i.p. administration of low-to-medium THIP doses in WT mice was due to a 
specific action at accumbal α4βδ receptors, THIP at various doses was directly infused 
into the NAc of WT mice and paired with i.p. injections of saline or cocaine (Fig. 2.8.). 
 
Investigation of the timecourse of activity did not reveal a time-dependent difference 
between the groups over the 60 minute session (Fig. 2.9.A & B; non-significant THIP 
dose by infusion by time interaction, F(44,1100)= 0.92, p = NS). Therefore, the total 
activity over 60 minutes was analysed. Intra-accumbal THIP dose-dependently 
modulated locomotor activity (significant THIP dose by infusion interaction, F(4,93)= 
6.35, p < 0.001). Activity was altered only in mice in which THIP infusions were paired 
with i.p. injections of cocaine, but not saline (significant THIP dose by infusion by 
injection interaction, F(1,93)= 12.01, p < 0.001). There was no difference between sexes 
(non-significant THIP dose by infusion by injection by sex interaction, F(4,93)= 0.63, p = 
NS).  
 
Doses of intra-accumbal THIP between 0.3µM to 300µM, paired with i.p. saline 
produced no effects on locomotor activity (Fig 2.8.) and did not significantly differ from 
the control condition (saline infusions with an i.p. saline injection), indicating that 
accumbal THIP at this dose is neither sedative, nor stimulant. However, a 3mM dose of 
intra-accumbal THIP, paired with i.p saline, produced a large increase in locomotor 
activity (Fig 2.8.). 3µM intra-accumbal THIP paired with i.p. cocaine showed reduced 
locomotor activity compared with intra-accumbal saline and i.p. cocaine-administered 
controls (Fig 2.8.). The two active doses, 3µM and 3mM, were followed up in WT and 
α4-/- mice. 
 
 
3µM intra-accumbal THIP had no significant effect on baseline locomotor activity, but 
reduced cocaine-potentiation of locomotor activity in WT but not α4-/- mice (Fig 2.10.A; 
genotype by infusion by injection interaction, F(1,20)= 10.49, p < 0.001). Whereas, 3mM 
intra-accumbal THIP had no significant effect on cocaine potentiated locomotor 
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activity, but increased baseline locomotor activity in WT but not α4-/- mice (Fig 2.10.B; 
genotype by infusion by injection interaction, F(1,24)= 5.24, p < 0.01).   
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Figure 2.8. 
	  	  	  	  	  	  	  	  	  	    
Fig. 2.8. Intra-accumbal THIP dose-response on baseline and cocaine (10mg/kg)-
potentiated distance travelled over 60 minutes in WT mice (0.3μM n=14; males=5, 
females=9, 3μM n=11; males=5, females=6, 30μM n=12; males=6, females=6, 300μM 
n=11; males=4, females=7, 3000μM n=12; males=6, females=6). Mean locomotor 
activity of saline infused sessions (n=60; males=26, females=34, collapsed across doses 
as activity did not significantly vary between experiments) are shown as a dotted line, 
and the grey highlighting ±SEM. Error bars represent SEM. 
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Figure 2.9. 
 
Fig. 2.9. (A) Timecourse of activity over 60 minutes following intra-accumbal THIP 
and i.p. injections of saline. (B) Timecourse of activity over 60 minutes following intra-
accumbal THIP and i.p. injections of cocaine (10mg/kg). Cocaine-potentiated locomotor 
activity was significantly reduced at 5 and 10 minutes in mice receiving a THIP dose of 
3µM. Error bars represent SEM. * p < 0.05, post hoc comparison.  
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Figure 2.10. 
 
Fig. 2.10.  (A) Effects of intra-accumbal THIP (3uM) on baseline and i.p. cocaine- 
(10mg/kg) potentiated distance travelled over 60 minutes. Infusion of THIP decreased 
cocaine-potentiated locomotor actvity in WT (n=11; males=8, females=3) but not α4-/- 
(n=11; males=6, females=7) mice. (B) Effects of intra-accumbal THIP (3mM) on baseline 
and i.p. cocaine- (10mg/kg) potentiated distance travelled over 60 minutes. Infusion of 
THIP increased baseline locomotor activity greater in WT (n=13; males=7, females=6) 
than α4-/-  (n=13; males=6, females=7) mice. Error bars represent SEM. * p < 0.01, post 
hoc comparison. 
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2.4. Discussion 
 
The present data indicate that pharmacological activation of GABAA α4βδ receptors 
within the NAc by low doses of THIP attenuates cocaine-potentiation of locomotor 
activity. Furthermore, activation by high doses of intra-accumbal THIP was able to 
increase baseline locomotor activity to similar levels as are seen with systemic 
administration of cocaine (10mg/kg). 
 
Western blot and qRT-PCR analysis of NAc tissue samples confirmed the absence of 
GABAAR α4-subunit protein and mRNA expression in α4-/- mice, and a reduction of 
approximately 50% in HET mice when compared to WT controls. These data confirm 
that the cre/loxp cleavage of the intended sequence produced a functional effect, 
blocking the ability of the Gabra4 gene to produce α4-subunit proteins. 
 
The compensatory increase in GABAAR α2-subunit mRNA expression following 
deletion of α4-subunits may complicate the investigation of the role of α4-GABAARs in 
mediating addiction-associated behaviours, given the pre-established role of α2-
GABAARs in mediating a number of cocaine’s effects on mouse incentive-learning 
(Dixon et al., 2010). The Gabra4 and Gabra2 genes, encoding for α4- and α2-subunits, 
respectively, are positioned next to each other on Chromosome 5. Therefore, a mutation 
of the Gabra4 gene might be affecting the regulation of the Gabra2 gene, producing an 
artifactual, rather than a functional up-regulation of α2-subunits. Indeed, the extent to 
which this increased α2-subunit mRNA translates to functional receptors is disputed. 
Synaptic currents from α4-/- mice are reported to be more sensitive to potentiation by the 
sedative-hypnotic agent zolpidem, requiring α1-/α2-, and inactive at α4-GABAARs, than 
those from WT mice (Suryanarayanan et al., 2011). However, recent 
electrophysiological evidence indicates that deletion of α4- or δ-subunits has no impact 
on the kinetics of the phase currents mediated by synaptic receptors within the NAc 
(Maguire et al, submitted). Moreover, expression of functional receptors requires the 
presence of other GABAAR subunits for the α2-subunits to co-assemble with. In the 
NAc, synaptic α2βγ2 GABAARs are the most widely expressed GABAAR (Pirker et al., 
2000). However, qRT-PCR analysis indicated that there was no change in the 
expression levels of γ2-subunits in the α4-/- mice. Therefore, it is unlikely that the 
increase in α2-subunits in the NAc is translated into functional receptors.  
	   75	  
In the current studies, deletion of GABAAR α4-subunits had no effect on baseline 
locomotor activity. This adds to previous data demonstrating deletion of GABAAR δ-
subunits, often paired with α4-subunits in extrasynaptic α4βδ GABAARs, to similarly 
have no influence on baseline locomotion (Herd et al., 2009). Additionally, GABAAR 
α4-subunit knockout mice showed no difference from wildtype mice in the direct 
stimulatory effects of cocaine at various doses, suggesting that these receptors are not 
normally engaged as a consequence of increased synaptic dopamine.  
 
When targeted pharmacologically using intraperitoneal injections of THIP at various 
doses, both wildtype and α4-subunit knockout mice did not differ significantly from 
saline-treated controls at any dose, when measured across a 60 minute session. It could 
be argued that since locomotor activity scores following systemic saline administration 
were already extremely low, it was not possible to decrease locomotion further than 
these baseline levels of spontaneous activity. However, this result is surprising given 
that previous evidence has repeatedly demonstrated systemic administration of THIP to 
dose-dependently attenuate locomotor activity (Agmo and Giordano, 1985; 
Vashchinkina et al., 2012). This decrease at low-to-medium (2-10mg/kg) doses of 
systemic THIP is absent in GABAAR δ-subunit knockout mice, suggesting a direct 
action of THIP at δ-containing extrasynaptic GABAARs (Herd et al., 2009). The 
apparent inconsistency between the findings of previous studies and the current 
experiment may be explained by the timecourse over which activity was analysed. 
While previous studies similarly begin analysis between 15-30 minutes post-
administration of THIP, activity was analysed over a total of 10 (Agmo and Giordano, 
1985) or 20 (Herd et al., 2009) minutes. Indeed, when the current experiment was 
analysed using only the first 5 minutes of activity, i.p. injections of 10mg/kg THIP 
significantly reduced baseline locomotor activity in wildtype but not α4-subunit 
knockout mice (Fig. 2.7.B). Thus the effects of THIP likely decrease following the 
initial phase of the session and are diluted beyond significance when analysed over the 
course of 60 minutes beginning 20 minutes post-administration of THIP. The natural 
decrease in spontaneous activity observed within a 60 minute session may also reduce 
locomotor activity to a basal level of activity that it could not be further reduced.  
 
A role for α4-GABAARs in opposing cocaine was revealed by an intraperitoneal THIP-
induced reduction of cocaine-potentiated locomotor activity in wildtype, but not α4-
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subunit knockout mice. Systemic THIP reduced cocaine-induced stimulation of 
locomotor activity over a wide dose range, an effect absent in α4-/- mice except at a high 
dose, suggesting that cocaine antagonism at low THIP doses is due to activation of α4βδ 
GABAARs. At a high dose, THIP began to decrease cocaine-potentiated locomotor 
activity in α4-subunit knockout as well as wildtype mice, until both genotypes’ activity 
fell to the levels associated with saline-treated controls. Decreased cocaine-potentiated 
activity may be attributable to THIP action at δ-containing GABAARs coupled with 
subunits other than α4, such as α6βδ GABAARs within the cerebellum (Farrant and 
Nusser, 2005). Alternatively, it is possible that at high doses THIP may be losing 
specificity for δ-containing GABAARs and additionally activating other GABAARs. 
Indeed, rotorod studies have similarly demonstrated that in the first 30 minutes 
following injection, i.p. THIP at 10mg/kg was ataxic in wildtype but not δ-subunit 
knockout mice, but at 30mg/kg was ataxic in both genotypes (Herd et al., 2009).  
 
The decrease in locomotor activity following i.p. THIP is interesting given that α4-
subunit knockout mice showed no significant difference to wildtype mice in their 
locomotor response to injections of saline, or cocaine at various doses. These data 
suggest that α4-GABAARs are not important for the initiation of locomotion, but their 
activation is able to attenuate baseline and cocaine-potentiated locomotor activity. 
 
This effect was found to be mediated within the NAc as intra-accumbal infusions of 
THIP at a low dose (3µM) similarly attenuated intraperitoneal cocaine-potentiated 
locomotor activity, indicating that when NAc α4βδ GABAARs are engaged 
pharmacologically, they are able to functionally oppose cocaine’s effects. Cocaine 
potentiates locomotor activity by prolonging the action of dopamine, released from 
VTA–NAc projections, on dopamine receptors located on the apical dendrites of the 
MSNs (Costall et al., 1984). Dopamine may impact upon the sensitivity of MSNs to 
neighbouring glutamatergic inputs from areas such as frontal cortex, amygdala and 
hippocampus, thereby influencing the ability of such excitatory drive to generate a 
signal in the MSN (O'Donnell and Grace, 1995). In vivo, MSNs have been suggested to 
exist in two main states; 1) a “downstate” where the membrane potential is 
hyperpolarised and the neuron is relatively unexcitable, and 2) an upstate, caused by a 
synchronous barrage of glutamatergic drive producing a prolonged depolarisation and 
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consequent action potential discharge. In vivo recordings of MSN activity, subjected to 
local antagonism of the MSN GABAARs (by the intracellular GABAAR antagonist 
picrotoxin), reveals the antagonist to reduce the proportion of silent MSNs, suggesting 
relief from a resident tonic inhibition (Calhoon & O’Donnell, 2013). When injected 
directly into the NAc, the predominant effect of THIP is probably postsynaptic upon the 
MSNs. Although MSNs in vitro already exhibit a relatively hyperpolarised resting 
membrane potential (Maguire et al, submitted), THIP activation of their dendritic and 
somatic δ-GABAARs will further stabilise/promote this hyperpolarised state. This, 
together with the associated decrease in input resistance, will enhance neural inhibition, 
consequently reducing the impact of glutamatergic excitation on both dendrites and cell 
soma. Therefore, in vivo intra-accumbal THIP is likely to be promoting a downstate of 
the MSNs, thereby decreasing the ability of cocaine-enhanced synaptic dopamine to 
facilitate glutamatergic inputs and to potentiate locomotor activity 
 
Interestingly, high dose (3mM) intra-accumbal THIP was able to potentiate baseline 
locomotor activity in wildtype, and to a lesser extent in α4-subunit knockout mice, 
unmasking an additional locomotor-activating role of α4-GABAARs. Thus it appears 
that the sedative effect seen with high doses of intraperitoneal THIP are mediated 
outside of the accumbens, most likely by activation of extrasynaptic GABAARs within 
the thalamus (Belelli et al., 2005; Wafford and Ebert, 2006). The coincident but 
significantly smaller locomotor increase in α4-subunit knockout mice at intra-accumbal 
3mM THIP suggests that at this dose THIP is also acting at GABAARs independent of 
those containing α4-subunits. It is possible that these may be δ-containing GABAARs 
comprising α-subunits other than α4, such as the α1βδ and α6βδ GABAARs reported in 
hippocampal and neocortical interneurons, or cerebellar granule cells respectively 
(Brickley and Mody, 2012). However, as yet, there is little evidence to support the 
existence of such receptors in the NAc (Belelli et al., 2009; Brickley and Mody, 2012). 
Further investigation will be needed to elucidate which receptors may be contributing to 
high-dose THIP-induced hyperlocomotion.  
 
Interestingly, in addition to the α4-independent increase in locomotion, wildtype mice 
also show an α4-dependent increase, demonstrated by a locomotor response two-fold 
higher than the α4-subunit knockout mice. The reason for this α4 GABAAR mediated 
increase is similarly still unclear, but a possible explanation may be that at particular 
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doses intra-accumbal THIP may differentially modulate the activity of dopamine D1- or 
D2-expressing MSNs through α4-GABAAR-mediated inhibition. It could be speculated 
that high-dose THIP may have a greater inhibitory response at α4-GABAARs on 
dopamine D2-expressing MSNs, known to contribute to the indirect striatal pathway, 
which when activated attenuates locomotion. This would shift the balance of activity in 
favour of dopamine D1-expressing MSNs in the direct pathway, increasing locomotor 
activity. However, while most evidence supports the role of D1 receptors in stimulating 
locomotor activity (Bruhwyler et al., 1991; Mazurski and Beninger, 1991), evidence for 
a D2 receptor-mediated attenuation of locomotion is inconclusive (Gong et al., 1999; 
Stuchlik et al., 2007), and may be dose- and time-dependent (Horvitz et al., 2001; 
Schindler and Carmona, 2002).  
 
To conclude, deletion of GABAAR α4-subunits had no affect on baseline or acute 
cocaine-potentiated locomotor activity. However, activation of α4βδ-GABAARs using 
systemic or intra-accumbal THIP was able to reduce cocaine-potentiated locomotor 
activity. These data indicate that α4-GABAARs within the NAc provide an efficacious 
target for control of the locomotor-activating properties of cocaine.  
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Chapter	  3	  
 
The role of α4-containing GABAA receptors in behavioural sensitisation to cocaine 
 
3.1. Introduction 
 
Behavioural sensitisation describes the enhanced stimulant effects of a drug following 
repeated, intermittent administration (Tilson and Rech, 1973; Segal and Mandell, 1974; 
Browne and Segal, 1977; Bailey and Jackson, 1978; Hirabayashi and Alam, 1981; Leith 
and Kuczenski, 1982; Robinson and Becker, 1986). By analogy, the sensitisation 
phenomenon has also been proposed for incentive mechanism, and in this context is 
thought to play a role in the acquisition and maintenance of behaviours that are 
characteristic of drug addiction, including craving and relapse (Robinson and Berridge, 
1993). The enhanced behavioural response has been found to be enduring, persisting up 
to a year after the final drug exposure, and possibly longer (Paulson et al., 1991; Boileau 
et al., 2006). It is also known that expression of behavioural sensitisation is enhanced by 
the learned association of the drug administration with the environmental context 
(Anagnostaras and Robinson, 1996; Badiani and Robinson, 2004; Crombag and 
Robinson, 2004). Behavioural sensitisation has been reported following repeated 
administration of a variety of different drugs, including the psychostimulants; 
amphetamine (Robinson and Becker, 1986; Cador et al., 1999), cocaine (Post et al., 
1987; Kalivas and Stewart, 1991) and methylphenidate (Shuster et al., 1982; McDougall 
et al., 1999), as well as opiates (Babbini and Davis, 1972; Shuster et al., 1975), nicotine 
(Benwell and Balfour, 1992; Kita et al., 1992), ethanol (Cunningham and Noble, 1992; 
Phillips et al., 1997) and natural food rewards (Le Merrer and Stephens, 2006). Given 
the evidence of cross-sensitisation between drugs of abuse, it has been proposed that 
these effects may be mediated by common neural mechanisms (Akimoto et al., 1990; 
Kalivas and Stewart, 1991; Cunningham and Kelley, 1992; Horger et al., 1992). 
Alternatively, such cross sensitisation (e.g. between food sensitisation and cocaine) may 
reflect the ability of psychostimulants to facilitate locomotor activation caused by 
environmental stimuli conditioned to reward (Le Merrer and Stephens, 2006).  
 
Studies exploring the neurobiological basis of cocaine-induced behavioural sensitisation 
have largely focussed on the mesolimbic dopamine system due to the established role of 
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this system in mediating the locomotor activating properties of cocaine (Robinson and 
Berridge, 1993; Pierce and Kalivas, 1997). Most evidence indicates that neural 
processes underlying the induction and expression of cocaine sensitisation may be 
anatomically distinct. Dopamine neurons within the VTA have been described to play a 
critical role in the induction of sensitisation to cocaine and other psychostimulants, 
while the NAc neurons to which they project are proposed to play a primary role in 
expression of sensitisation (Robinson et al., 1988; Kalivas and Stewart, 1991; Le Moal 
and Simon, 1991; Pierce and Kalivas, 1997; White and Kalivas, 1998). Repeated intra-
VTA, but not intra-accumbal, injections of psychostimulants potentiate the locomotor 
stimulant effects of a systemic or intra-accumbal challenge of the same or other such 
psychostimulants demonstrating the expression of sensitisation (Dougherty and 
Ellinwood, 1981; DuMars et al., 1988; Kalivas and Weber, 1988; Hooks et al., 1992; 
Cornish and Kalivas, 2001). During induction of cocaine sensitisation, repeated 
intermittent cocaine administration is associated with an elevated basal extracellular 
level of dopamine within the NAc (Di Chiara and Imperato, 1988; Kalivas and Duffy, 
1990; Kalivas and Stewart, 1991). This increased basal concentration of dopamine has 
been found to gradually decline to the level of saline-treated controls following 
cessation of cocaine treatment (Segal and Kuczenski, 1992; Weiss et al., 1992; 
Heidbreder et al., 1996; Johnson et al., 2000). Interestingly, after extended periods of 
withdrawal, expression of behavioural sensitisation is associated with increased 
dopamine transmission and a sensitised locomotor response higher than that found 
immediately following cessation (Weiss et al., 1992; King et al., 1993; Heidbreder et 
al., 1996). Thus, activation of VTA neurons, and the resulting increase in basal NAc 
dopamine levels, appears to be a critical mechanism for the induction of sensitisation to 
psychostimulants. Yet, despite the principle contribution of dopamine effects, it is 
possible they may represent only one aspect in a complex spectrum of changes 
mediating behavioural sensitisation.  
 
GABAergic MSNs are the major neuronal type within the striatum where GABA serves 
as a major modulator of nigrostriatal dopamine transmission (Scheel-Krüger, 1986; 
Gerfen, 1992; Pierce and Kalivas, 1997). It is thought that repeated exposure to cocaine 
induces changes in GABA systems, resulting in a dysregulation of the neural circuitry 
mediating behaviour responses to drugs (Koob, 2001). Indeed, whilst GABA binding is 
unaffected (Jung and Peris, 2001), a decrease in pre- and post-synaptic GABA 
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transmission (Jung et al., 1999), and function of GABAARs is reported in the striatum of 
cocaine-sensitised rats (Peris, 1996). Conversely, following withdrawal from cocaine 
sensitisation or repeated cocaine administration in mice, cocaine challenges increase 
GABA transmission in the medial-PFC (Jayaram and Steketee, 2005) and NAc (Xi et 
al., 2003). However, the role of GABA in mediating behavioural sensitisation to 
psychostimulants is complex and is still largely undetermined. Both systemic 
administration of clonazepam, a benzodiazepine increasing GABAergic transmission 
(Ito et al., 1997), and systemic and intra-striatal administration of bicuculline, a 
GABAAR antagonist, block the induction of behavioural sensitisation to amphetamine 
(Bedingfield et al., 1997). However, it is possible that these observations are artifactual, 
as while repeated co-administration of the benzodiazepine chlordiazepoxide (CDP) with 
amphetamine does not block locomotor sensitisation (Stephens et al., 2000), the 
expression of the sensitized response to amphetamine is seen only when co-
administered with CDP, and, in agreement with the previous studies, is absent if 
amphetamine is given alone, i.e., is state-dependent. GABA-mimetic drugs, which do 
not bind directly or indirectly at GABAARs, but increase GABA transmission through 
different mechanisms, are also able to modulate behavioural sensitisation to cocaine. 
Vigabatrin, an irreversible inhibitor of GABA breakdown by GABA transaminase, 
attenuates the expression of behavioural sensitisation to cocaine, as does gabapentin, a 
cyclic analogue of GABA that either directly stimulates GABA release or indirectly 
increases GABA synthesis (Gardner et al., 2002; Filip et al., 2006).  
 
The GABAAR α2-subunit is the predominant alpha subunit within the NAc and thus is 
likely to play an important role in mediating behavioural responses to cocaine 
(Schwarzer et al., 2001). Indeed, the Gabra2 gene encoding GABAAR α2-subunits has 
consistently been linked with drug addiction (Edenberg et al., 2004; Agrawal et al., 
2006; Soyka et al., 2008), and different single nucleotide polymorphisms of Gabra2 
have been shown to confer vulnerability or protection for cocaine dependence (Dixon et 
al., 2010; Enoch et al., 2010). Following amphetamine-sensitisation a decrease in 
GABAAR α2-subunits is reported within the NAc shell and core (Zhang et al., 2006),  
and reversal of cocaine-sensitisation by combined treatment with the dopamine receptor 
agonist pergolide and 5-HT3 receptor antagonist ondansetron is accompanied by 
normalised NAc GABAAR α2-subunit expression (Chen et al., 2007). Furthermore, 
targeted deletion of the GABAAR α2-subunit blocks the ability of cocaine to induce 
	   82	  
behavioural sensitisation (Dixon et al., 2010), an effect subsequently demonstrated to be 
mediated within the NAc. Selective activation of α2-containing GABAARs within the 
NAc using intracranial infusions of the atypical benzodiazepine Ro 15-4513, were 
sufficient to induce behavioural sensitisation in α2(H101R) mutant mice (Dixon et al., 
2010). Interestingly, in opposition to previous reports (Bedingfield et al., 1997),  
benzodiazepine administration was able to facilitate the locomotor activating properties 
of cocaine, an effect absent in α2(H101R) mice (Morris et al., 2008). These data 
indicate that GABAAR α2-subunit mediation of cocaine-potentiated locomotor activity 
occurs downstream of increased NAc dopamine release.  
 
A role of GABAAR α4 subunits in mediating behavioural sensitisation to cocaine has 
also been suggested. Systemic administration of THIP blocks both the induction and 
expression of behavioural sensitisation to amphetamine (Karler et al., 1997), though the 
state-dependency notion has not been tested. Similarly, a single dose of isoflurane, an 
anaesthetic agent acting as a potent modulator of α4βδ extrasynaptic GABAARs, is 
sufficient to attenuate expression of cocaine-induced behavioural sensitisation in female 
rats (Jia et al., 2007; Siegal and Dow-Edwards, 2009). In order to further probe the role 
of GABAAR α4 subunits in mediating behavioural sensitisation to cocaine, the effects of 
targeted deletion of GABAAR α4 subunits in a mutant mouse strain and 
pharmacological activation using THIP were examined.  
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3.2. Materials and Methods 
 
3.2.1. Animals 
Male and female GABAA α4 WT and α4-/- mice on a C57BL/6J background strain, 
weighing between 20-30g and aged between 2-6 months, were housed in groups of 2-3, 
with food and water available ad libitum. A 12 hr light/dark cycle was used (lights on at 
7:00 A.M.) with holding room temperature maintained at 21 ±2ºC and humidity 50 
±5%. All injections and behavioural testing were performed between 2:00 P.M. and 
5:00 P.M. All procedures were conducted in accordance to Animals (Scientific 
Procedures) Act 1986, following ethical review by the University of Sussex Ethical 
Review Committee.  
 
3.2.2. Drugs 
Cocaine Hydrochloride was obtained from Macfarlan Smith (Edinburgh, UK). THIP 
(4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) was kindly donated by Bjarke Ebert 
(Lundbeck, Valby, Denmark). Both drugs were dissolved in 0.9% saline, and 
administered i.p. at an injection volume of 10 ml/kg. 
 
3.2.3. Apparatus 
Behavioural sensitisation was measured by recording locomotor activity in 16 annular 
black Perspex runways, (diameter 24cm, annula width 6.5cm), placed atop a clouded 
Perspex sheet on an elevated frame. A digital camera positioned beneath the sheet 
captured the silhouettes of the boxes’ edges and the mice within them, which was then 
relayed to a computer to be recorded. A MatLab (MathWorks, Cambridge, UK) video 
analysis programme and Excel macro converted the video data into a measure of the 
distance travelled in metres.  
 
Locomotor activity in a novel environment was measured in a rectangular chamber (200 
x 450 x 200cm). Five infrared photobeams spaced evenly across the length of the box 
recorded the activity and location of the mouse and relayed the information to a PC 
running data collection and analysis software.  
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3.2.4. Dose Response for Behavioural Sensitisation to Cocaine 
Before all sessions mice were allowed to habituate to the equipment for 30 minutes 
before being returned to their homecage. After 5 minutes, mice were dosed if necessary 
and entered into the appropriate session. Prior to testing, mice underwent two 
habituation sessions. On the first day mice were habituated to the equipment for 60 
minutes, then, on the second, mice received sham i.p. injections of saline followed by a 
60-minute habituation session. Subsequently, mice received repeated, intermittent 
treatment of : 3, 10 or 20mg/kg cocaine or saline for 10 consecutive daily sessions. 
Activity was recorded for 60 minutes each session. 
 
3.2.4.1. Conditioned Activity 
Mice were placed in the locomotor runways as described above, with all animals 
receiving 10ml/kg saline injections. Activity was recorded for 60 minutes.  
 
3.2.4.2. Activity in a Novel Environment 
To investigate whether any conditioned activity is specific to the context of the 
locomotor runways, locomotor activity in a novel environment was tested by 
measurement in rectangular locomotor boxes. All mice were administered 10ml/kg 
saline injections and activity was recorded for 60 minutes. 
 
3.2.5. Behavioural Sensitisation to Cocaine with Intraperitoneal THIP Challenge 
Mice were tested using the same protocol as above with the cocaine group receiving 
injections of 10mg/kg cocaine. The day after the last session, mice received a challenge 
i.p. injection of THIP (8mg/kg) 20 minutes prior to start, followed by a second i.p. 
injection of saline or cocaine (10mg/kg), directly prior to initiation of the locomotor 
test. Activity was recorded for 60 minutes each session. 
 
3.2.6. Statistical Analysis 
 
3.2.6.1. Dose Response for Behavioural Sensitisation to Cocaine 
Dose response for behavioural sensitisation to cocaine was analysed using a four-way 
mixed-factors ANOVA with genotype, sex, and drug dose as the between-subjects 
variables, day as the within-subject variable, and meters travelled in each session as the 
dependent variable. Following this treatment, behavioural sensitisation to cocaine was 
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confirmed using a four-way mixed-factors ANOVA with genotype, sex, and drug dose 
as the between-subjects variables, day as the within-subject variable, and meters 
travelled in sessions 1 and 10 as the dependent variable. Post hoc analyses were 
conducted using paired t-tests and Tukey’s tests.  
 
In order to evaluate whether any differences were present in baseline locomotor 
behaviour before the test sessions, a four-way mixed-factors ANOVA was conducted 
with genotype, sex, and drug dose as the between-subjects variables, day as the within-
subject variable, and meters travelled during each habituation session as the dependent 
variable. Baseline locomotor behaviour before the test sessions was further investigated 
using another four-way mixed-factors ANOVA with genotype, sex, and drug dose as the 
between-subjects variables, day as the within-subject variable, and meters travelled 
during the session 1 habituation and session 10 habituation as the dependent variable. 
 
3.2.6.2. Conditioned Activity 
Conditioned activity following behavioural sensitisation to cocaine was analysed using 
a three-way independent-factors ANOVA, with genotype, sex and drug dose as the 
independent variables and meters travelled in the locomotor runways following a saline 
injection as the dependent variable. Post hoc analyses were conducted using paired t-
tests. 
 
3.2.6.3. Activity in a Novel Environment  
Activity in a novel environment following behavioural sensitisation to cocaine was 
analysed using a three-way independent-factors ANOVA, with genotype, sex and drug 
dose as the independent variables and locomotor activity in the rectangular locomotor 
boxes following a saline injection as the dependent variable. 
 
3.2.6.4. Behavioural Sensitisation to Cocaine with Intraperitoneal THIP Challenge 
Behavioural sensitisation to cocaine was analysed using a four-way mixed-factors 
ANOVA with genotype, sex, and drug treatment as the between-subjects factors, day as 
the within-subject variable, and meters travelled in sessions 1 and 10 as the dependent 
variable. Following this, a four-way mixed-factors ANOVA was conducted using 
genotype, sex and drug treatment as the between-subjects variables, day as the within-
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subject variable, and meters travelled in the last session and THIP challenge session as 
the dependent variables. Post hoc analyses were conducted using paired t-tests. 
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3.3. Results 
 
 
3.3.1. Dose Response for Behavioural Sensitisation to Cocaine 
Repeated, intermittent injections of cocaine induced an increase in locomotor activity 
over the course of 10 sessions (Fig. 3.1.A; significant main effect of session, F(9,432) 
=20.05, p < 0.001). This increase was dose-dependent and did not occur following 
repeated, intermittent saline treatment (significant session by drug dose interaction, 
F(27,432) = 8.21, p < 0.001). There was no significant difference between genotypes or 
sexes (non significant session by drug dose by genotype interaction, F(27,432) = 0.81, p = 
0.72, NS; non significant session by drug dose by sex interaction, F(27,432) = 0.69, p = 
0.81, NS; non significant session by drug dose by genotype by sex interaction, F(27,432) = 
1.21, p = 0.21, NS).  
 
Comparison of the difference between session 1 and session 10 confirmed that the 
behavioural sensitisation to cocaine was similar in both genotypes and sexes (Fig. 3.1.B; 
significant main effect of session, F(1,48) = 81.6, p < 0.001, non significant session by 
drug dose by genotype interaction, F(3,48) = 1.43, p = 0.24, NS; non significant session 
by drug dose by sex interaction, F(3,48) = 0.65, p = 0.58, NS; non significant session by 
drug dose by genotype by sex interaction, F(3,48) = 1.26, p = 0.29, NS). 
 
 
During the course of 10 sessions mice habituated to the runways, as indicated by a 
decrease in locomotor activity during the 30 min pre-test habituation sessions (Fig. 
3.2.A; significant main effect of session, F(9,432) = 11.34, p < 0.01). This was found to be 
equivalent in all drug doses, genotypes and sexes (non-significant session by drug dose 
interaction, F(27,432) = 0.23, p = 0.71, NS; non-significant session by genotype 
interaction, F(27,432) = 0.55, p = 0.47, NS; non-significant session by sex interaction, 
F(9,432) = 1.22, p = 0.23, NS; non-significant session by drug dose by genotype by sex 
interaction, F(27,432) = 1.05, p = 0.33, NS). This was subsequently confirmed by analysis 
of habituation sessions 1 and 10 (Fig. 3.2.B; significant main effect of session, F(1,48) = 
64.01, p < 0.001; non-significant session by drug dose interaction, F(3,48) = 0.72, p = 
0.49, NS; non-significant session by genotype interaction, F(1,48) = 0.63, p = 0.55, NS; 
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non-significant session by sex interaction, F(1,48) = 1.66, p = 0.20, NS; non-significant 
session by drug dose by genotype by sex interaction, F(3,48) = 1.30, p = 0.25, NS). 
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Figure 3.1.  
          
Fig. 3.1. Effects of repeated intermittent cocaine (3, 10 and 20 mg/kg) on locomotor 
activity in wildtype (saline n=8; males=5, females=3, cocaine 3mg/kg n=8; males=5, 
females=3, cocaine 10mg/kg n=8; males=4, females=4, cocaine 20mg/kg n=8; males=4, 
females=4) and GABAAR α4-subunit knockout (saline n=8; males=5, females=3, 
cocaine 3mg/kg n=8; males=4, females=4, cocaine 10mg/kg n=8; males=4, females=4, 
cocaine 20mg/kg n=8; males=5, females=3) mice. (A) Locomotor activity was dose-
dependent and increased over the course of 10 sessions of repeated, intermittent cocaine 
administration (p < 0.001), equally in both genotypes (p = 0.72, NS) and sexes (p = 
0.81, NS). (B) Activity was dose-dependently higher on session 10 compared to session 
1 after repeated cocaine administration (p < 0.001), independent of genotype (p = 0.47, 
NS) or sex (p = 0.58, NS). Error bars represent SEM. 
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Figure 3.2. 
        
Fig. 3.2. Locomotor activity during habituation sessions prior to each test session  (A) 
Activity did not differ according to drug dose (p = 0.71, NS), genotype (p = 0.47, NS) 
or sex (p = 0.23, NS). (B) Comparison of habituation sessions 1 and 10 indicates no 
effect of drug dose (p = 0.49, NS), genotype (p = 0.55, NS) or sex (p = 0.20, NS). Error 
bars represent SEM. 
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3.3.1.1. Conditioned Activity 
Following 10 days of repeated saline or cocaine at various doses, mice showed dose-
dependent conditioned increases in activity following a saline injection (Fig. 3.3.A; 
significant main effect of previous drug dose, F(3,48) = 6.41, p < 0.001). Conditioned 
activity did not differ according to genotype or sex (non-significant previous drug dose 
by genotype interaction F(3,48) = 0.52, p = 0.66, NS; non-significant previous drug dose 
by sex interaction F(3,48) = 0.67, p = 0.41, NS; non-significant previous drug dose by 
genotype by sex interaction F(3,48) = 0.60, p = 0.61, NS).  
 
 
Figure 3.3. 	  
 
Fig. 3.3. Conditioned Activity (A) Conditioned activity following saline administration 
in the previously saline- or cocaine-paired locomotor runway was significantly 
increased in mice that had previously received repeated intermittent administration of 
10 or 20mg/kg cocaine (p < 0.001). There was no difference between genotypes (p = 
0.66, NS) or sexes (p = 0.41, NS) (B) Activity in a novel environment following saline 
administration did not differ with previous drug administration (p = 0.36, NS), genotype 
(p = 0.15, NS) or sex (p = 0.34, NS). Error bars represent SEM. * p < 0.01, post hoc 
comparison.  
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3.3.1.2. Activity in a Novel Environment 
Saline administration within a novel environment following behavioural sensitisation to 
cocaine did not differ according to previous drug administration, genotype or sex (Fig. 
3.3.B; non-significant main effect of drug group, F(3,48)= 1.08, p = 0.36, NS; non-
significant drug group by genotype interaction, F(3,48)= 1.83, p = 0.15, NS; non-
significant drug group by sex interaction, F(3,48)= 1.13, p = 0.34, NS; non-significant 
drug group by genotype by sex interaction, F(3,48)= 0.32, p = 0.80, NS). 
 
3.3.2. Behavioural Sensitisation to Cocaine with Intraperitoneal THIP Challenge 
As previously, repeated, intermittent injections of cocaine (10mg/kg), but not saline, 
induced an increase in locomotor activity over the course of 10 sessions, irrespective of 
genotype and sex (significant session by drug interaction, F(9,216) = 5.78, p < 0.001; non 
significant session by drug by genotype by sex interaction, F(9,216) = 0.67, p = 0.73, NS). 
 
Following a challenge systemic injection of THIP (8mg/kg) locomotor activity was 
significantly reduced in wildtype, but not GABAAR α4-subunit knockout mice, paired 
with cocaine, but not saline administration, when compared to the sensitised activity on 
session 10 (Fig. 3.4; significant challenge by drug by genotype interaction, F(1,24) = 6.86, 
p < 0.01). There were no difference between sexes (non significant challenge by drug 
by genotype by sex interaction, F(1,24) = 0.01, p = 0.90, NS).  
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Figure 3.4. 
 
Fig. 3.4. Effects of an intraperitoneal THIP (8mg/kg) challenge on behavioural 
sensitisation to cocaine (10mg/kg) in WT (saline; n=8; males=5, females=3, cocaine; 
n=8; males=4, females=4) and α4-/- (saline; n=8; males=4, females=4, cocaine; n=8; 
males=4, females=4) mice. THIP significantly reduced sensitised locomotor activity in 
cocaine-, but not saline-paired, wildtype, but not GABAAR α4-subunit knockout mice 
(p < 0.001). Error bars represent SEM. * p < 0.01, post hoc comparison.  
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3.4. Discussion 
The current experiments suggest that GABAA α4βδ receptors are not involved in the 
induction of behavioural sensitisation to cocaine. Nevertheless, their activation by THIP 
was able to attenuate sensitised locomotor activity.  
 
In the previous chapter it was demonstrated that GABAAR α4-subunit knockout mice do 
not show a significant difference from their wildtype counterparts in their locomotor 
response to acute cocaine at various doses. Here, these findings were extended to reveal 
that repeated intermittent cocaine was able to dose-dependently increase locomotor 
activity equally in both wildtype and GABAAR α4-subunit knockout mice across the 
course of 10 sessions, demonstrating locomotor sensitisation. Sensitisation was further 
confirmed in wildtype and GABAAR α4-subunit knockout mice by a test of conditioned 
activity in which mice previously treated with 10 or 20, but not 3mg/kg cocaine showed 
an increased locomotor response to saline administration compared to those previously 
receiving repeated saline, when tested in the same environment. However, when a saline 
challenge was given in a novel environment there was no effect of either genotype or 
previous drug-treatment, indicating the importance of conditioned environmental cues 
in the expression of locomotor sensitisation to cocaine. These data also suggest that α4-
GABAARs are functionally distinct from α2-GABAARs, which have been reported to be 
essential for the induction of locomotor sensitisation to cocaine (Morris et al., 2008; 
Dixon et al., 2010).  
 
The distinct roles of GABAAR α2- and α4-subunits are not surprising given the 
difference in location and physiology between receptors comprising these two subunits. 
In the NAc, GABAAR α2-subunits are typically found in α2βγ2 GABAARs within 
synapses where they mediate “fast” neuronal inhibition of MSNs, while GABAAR α4-
subunits largely form α4βδ extrasynaptic GABAARs, which mediate a tonic form of 
inhibition via their sensitivity to ambient GABA spillover from synapses (Pirker et al., 
2000; Wei et al., 2003) It is still unclear how these features of α2-GABAARs mediate 
locomotor sensitisation to cocaine, but it has been hypothesised that their influence may 
occur downstream of NAc dopaminergic mechanisms; one possibility is that they form 
the target of MSN axon collaterals that allow lateral inhibition between MSNs 
competing for behavioural control (Dixon et al., 2010). 
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Stimuli conditioned to cocaine administration during the sensitisation procedure may 
control which NAc neurons are subsequently activated by cocaine (Mattson et al., 
2008). Information about these stimuli is received within the NAc via glutamatergic 
afferents from the amygdala, hippocampus and PFC, activating specific populations of 
MSNs (Pennartz et al., 1994; French and Totterdell, 2003; O'Donnell, 2003). Indeed, 
histochemical and electrophysiological investigation suggests that a small neuronal 
ensemble of sparsely distributed NAc MSNs are selectively activated by drug 
administration in the drug-paired context (Mattson et al., 2008), and that their 
inactivation can prevent context-specific sensitisation (Koya et al., 2009). However, 
given the multitude of competing motivational inputs onto NAc MSNs from 
environmental stimuli, there must exist a method to enhance the activity of selected 
neurons, while suppressing the activity of surrounding non-selected neurons. One 
hypothesis is that GABAARs may mediate the activity of distributed networks within 
the NAc by inhibition of neighboring MSNs, allowing the reinforcement of selected un-
inhibited ensembles by NAc dopamine transmission (Plenz, 2003; Taverna et al., 2004; 
Nicola, 2006). The organization of the NAc into networks of MSNs interconnected by 
GABAergic synapses on axon collaterals is perfectly suited for this lateral inhibition 
(Czubayko and Plenz, 2002; Taverna et al., 2004). It has been hypothesized that 
activation of α2-GABAARs within the NAc may contribute to this lateral inhibition 
(Dixon et al., 2010). Thus, in GABAAR α2-subunit knockout mice, the lack of 
inhibitory control over competing motivational inputs into the NAc may result in the 
inputs important for producing a sensitised response being overruled. This would 
explain the lack of behavioural sensitisation to cocaine in these mice (Dixon et al., 
2010). However, deletion of GABAAR α4-subunits did not affect the expression of 
behavioural sensitisation to cocaine, indicating that in this model they are likely not to 
be involved in mediating GABAergic lateral inhibition of NAc MSNs. 
 
It is conceivable that the lack of effects seen following deletion of GABAARs α4-
subunits may be the result of compensatory neuronal mechanisms, including a 
compensatory increase in GABAAR α2-subunits. As described in chapter 2 (Fig 2.3.2.), 
qRT-PCR analysis revealed a large increase in the expression of α2-subunit RNA within 
the NAc of GABAARs α4-subunit knockout mice compared with wildtype counterparts. 
Given the above-mentioned role of GABAARs α2-subunits in mediating locomotor 
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sensitisation to cocaine it could be predicted that these physiological changes would 
alter behavioural responses to repeated cocaine. However, despite the overexpression of 
GABAAR α2-subunit RNA, GABAAR α4-subunit knockout mice do not show a 
facilitated locomotor sensitisation to cocaine. This may indicate that although GABAAR 
α2-subunit RNA transcription is increased in GABAAR α4-subunit knockout mice, this 
RNA is not translated into functional GABAAR α2-subunits. Indeed, 
electrophysiological evidence indicates that deletion of GABAARs α4-subunits has no 
impact on the kinetics of the phase currents mediated by synaptic receptors within the 
NAc (Maguire et al, submitted).  
Following behavioural sensitisation to cocaine, a systemic THIP challenge reduced 
sensitised locomotor activity in wildtype, but not GABAAR α4-subunit knockout mice, 
to the level of that seen following acute cocaine administration during the first session. 
These data are consistent with existing evidence that THIP administered directly into 
the striatum is able to reduce the locomotor response of mice sensitised to amphetamine 
(Bedingfield et al., 1997), and that boosting GABA transmission, which should also 
increase the activity of these receptors, opposes the expression of behavioural 
sensitisation to cocaine (Gardner et al., 2002; Filip et al., 2006). In these animals, a 
THIP-induced increase in α4βδ GABAAR-mediated tonic inhibition may act to suppress 
the activity of NAc MSNs, thus reducing locomotor activity. Under this hypothesis, 
activation of α4βδ GABAARs by THIP produces a general decrease in locomotor 
activity, rather than a blockade of sensitisation. Alternatively, it is possible that 
increased tonic inhibition of NAc MSNs may attenuate the influence of glutamatergic 
inputs providing contextual information, thought to be required to produce a sensitised 
increase in locomotor activity (Mattson et al., 2008). This uncertainty may be elucidated 
by administration of THIP during a test of conditioned activity in the cocaine-paired 
environment. 
Interestingly, previous evidence suggests that co-administration of systemic THIP is 
able to block induction of amphetamine-induced behavioural sensitisation (Karler et al., 
1997). It is possible that this blockade is mediated by THIP activation of α4βδ-
GABAARs within the NAc. However, it is difficult to test this hypothesis empirically 
with intra-accumbal THIP administration due to the complications of tissue damage 
following multiple intracranial infusions (our sensitisation paradigm requires 10 
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consecutive days of cocaine injection to see robust sensitisation. This problem may be 
overcome with an alternative two-injection protocol of sensitisation, in which two 
administrations of psychostimulants spaced several days apart are sufficient to induce 
behavioural sensitisation (Valjent et al., 2010). This protocol would allow systemic 
cocaine injections to be paired with intra-accumbal THIP infusions, and may help to 
uncover whether NAc α4βδ-GABAARs in the NAc are able to modulate the induction of 
locomotor sensitisation to cocaine.  
 
Finally, although global deletion of GABAAR α4-subunits does not alter behavioural 
sensitisation to cocaine, it is still unclear what effect deletion of α4-GABAARs 
specifically from D1- or D2-expressing neurons may have. Recent evidence 
demonstrates that transient disruption of D1-expressing direct pathway neurons or D2-
expressing indirect pathway neurons in the striatum using a synthetic inhibitory Gαi- 
coupled DREADD (designer receptor exclusively activated by a designer drug) receptor 
is able to impair or facilitate, respectively, behavioural sensitisation to amphetamine 
(Ferguson et al., 2011). Thus it could be predicted that removal of α4-GABAAR-
mediated inhibition from dopamine D1- or D2-expressing neurons would increase or 
decrease, respectively, behavioural sensitisation to cocaine. If this was the case, then the 
lack of change in behavioural sensitisation to cocaine following global knockout of 
GABAAR α4-subunits could be explained by the dissociable effects in dopamine D1- or 
D2-expressing neurons cancelling each other out and resulting in no overall change. 
This could be tested using dopamine D1- or D2-expressing neuron specific GABAAR 
α4-subunit knockout mice. 
 
To conclude, GABAAR α4-subunits do not appear to play a role in the development of 
behavioural sensitisation to cocaine, as a sensitised response was observed in both 
wildtype and GABAAR α4-subunit knockout mice following repeated, intermittent 
cocaine at various doses. However, activation of α4βδ GABAARs by systemic THIP 
was able to attenuate sensitised locomotor activity in wildtype but not GABAAR α4-
subunit knockout mice. 
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Chapter 4 
 
 
The role of α4-containing GABAA receptors in conditioned place preference to 
cocaine 
 
4.1. Introduction 
 
Remembering and actively seeking reward-associated cues are crucial abilities for 
survival in animals. However, the same learning processes can also lead to the 
development of maladaptive behaviours, including drug-seeking actions associated with 
addiction to drugs of abuse. As described in the previous chapter, environments 
associated with repeated drug experience can become potent modulators of a number of 
the drug’s effects, including their psychomotor properties. Initially neutral 
environmental cues can also become associated with the motivational properties of 
rewarding stimuli, including drugs of abuse, a phenomenon routinely studied in 
laboratory animals using the conditioned place preference (CPP) paradigm 
(Cunningham et al., 2006; Tzschentke, 2007). CPP describes the preference of one 
location over another as a result of a previous pairing with a rewarding stimulus. This 
paradigm has been widely employed as a tool to assess the reward potential of natural 
and pharmacological stimuli (Bardo and Bevins, 2000).  
 
Although the psychological underpinnings of CPP are not fully understood, the most 
widely assumed explanation holds that CPP is an incentive-driven behaviour derived 
from Pavlovian conditioning. During a typical CPP paradigm, two distinct 
environmental (contextual) cues, are differentially paired with the stimulus of interest, 
such as a drug, or a second neutral control stimulus, such as saline solution. Following 
conditioning, animals typically occupy the reward-paired context when allowed to roam 
freely, demonstrating the development of a conditioned preference. The primary 
rewarding properties of the drug serve as an unconditioned stimulus (US), that on 
repeated pairing, allows previously neutral contextual cues to acquire secondary 
rewarding properties, such that they are able to act as conditioned stimuli (CS) to which 
the animal is attracted. Under this hypothesis, CPP expression can be described as a 
form of Pavlovian conditioned approach, comparable to that of sign-tracking behaviour, 
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in that the animal orients towards the CS (Skinner, 1948). Thus, neural circuits 
contributing to the development and expression of CPP must be capable of encoding 
and retrieving memories of the association between contextual cues and the affective 
state produced by the treatment, as well as initiating directed motor responses.  
 
The NAc acts as an intermediate between limbic and motor systems (Mogenson et al., 
1980; Bardo and Bevins, 2000), and is hypothesized to translate information carried by 
excitatory glutamatergic inputs into relevant reward-seeking behavioural responses 
during the acquisition and expression of CPP (Skinner, 1948; Cador et al., 1989; Everitt 
et al., 1991). Lesion studies indicate that pre-conditioning disruption of the NAc shell, 
but not core, impair acquisition of food place-conditioning (Ferbinteanu and McDonald, 
2001; Meyers et al., 2003; 2006; Ito et al., 2008). Similarly, post-conditioning lesions of 
the NAc shell, but not core, reduce expression of amphetamine-CPP (White and 
McDonald, 1993; Ferbinteanu and McDonald, 2001; Sellings and Clarke, 2003; Sellings 
et al., 2006), and infusions of cocaine directly into NAc shell, but not core, are sufficient 
to produce CPP (Groenewegen et al., 1987; Liao et al., 2000; French and Totterdell, 
2003; Di Ciano, 2004; Ambroggi et al., 2008).  
 
The NAc shell receives strong glutamatergic projections from hippocampal ‘place’ 
neurons demonstrating location-specific firing and thought to be integral for the 
processing of associative information embedded within a spatial context (O'Keefe and 
Dostrovsky, 1971; O'Keefe and Conway, 1978; Britt et al., 2012). Multi-neuron 
recordings reveal that hippocampal-striatal ensembles involved in the CPP learning 
experience are reactivated during sleep, and likely contribute to the consolidation and 
strengthening of associative place-reward information (Lansink et al., 2009). However, 
the exact contribution of the hippocampus appears complex and may be region-specific. 
While lesions and muscimol-inhibition of the dorsal hippocampus block acquisition and 
expression of food- or cocaine-CPP (Ferbinteanu and McDonald, 2001; Meyers et al., 
2003; 2006), lesions of the ventral hippocampus lead to an increased preference for a 
food-paired location, indicating enhanced conditioning (White and McDonald, 1993; 
Ferbinteanu and McDonald, 2001).  
The amygdala complex also sends glutamatergic projections to the NAc shell that are 
thought to provide information about associations between the affective states produced 
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by a rewarding stimulus and discrete cues (Groenewegen et al., 1987; French and 
Totterdell, 2003; Di Ciano, 2004; Ambroggi et al., 2008). Pre-conditioning lesions of 
the amygdala block acquisition of food- (McDonald and White, 1993), amphetamine- 
(Hiroi and White, 1991a) and cocaine- (Brown and Fibiger, 1993) CPP. Similarly, pre-
training or pre-test inactivation of the amygdala by intracranial infusions of 
bupivacaine, a local anesthetic drug, block the acquisition and expression of systemic 
amphetamine-CPP, respectively, however 1-hour post-training infusions have no effect 
(Hsu et al., 2002). Thus, unlike the hippocampus, the amygdala does not appear to be 
involved in memory consolidation processes underlying CPP, but is likely to be 
involved in mediating information about the affective ‘state’ following rewarding 
stimuli.  
The NAc also receives a dopaminergic projection from the ventral tegmental area 
(VTA), which triggers dopamine release in response to conditioned incentive cues 
(White and McDonald, 2002; Roitman et al., 2004; Yun et al., 2004; Day et al., 2007). 
Accordingly, amphetamine infused directly into the NAc, known to increase dopamine 
transmission, is sufficient to induce CPP (O'Keefe and Dostrovsky, 1971; O'Keefe and 
Conway, 1978; Carr and White, 1983; Josselyn and Beninger, 1993; McBride et al., 
1999), and systemic amphetamine-CPP is blocked by excitotoxic or 6-
hydroxydopamine lesions of the NAc (Spyraki et al., 1982; Olmstead and Franklin, 
1996; Lansink et al., 2009). However, it appears that the actions of dopamine D1 and 
D2 receptor agonists and antagonists on psychostimulant-CPP acquisition and 
expression are varied (see Table 4.1.).  
 
When given during conditioning, systemic administration of the D1 receptor antagonist 
SCH23390 blocks acquisition of both amphetamine-CPP (Hiroi and White, 1991b) and 
cocaine-CPP (Cervo and Samanin, 1995), and intra-accumbal injections of SCH23390 
block acquisition of intra-accumbal amphetamine-CPP (Liao, 2008). Similarly, 
systemic administration of the D1 antagonist SCH23390 during testing blocked 
expression of amphetamine-CPP and cocaine-CPP (Hiroi and White, 1991b; Cervo and 
Samanin, 1995). Interestingly, systemic administration of the D1 receptor agonists SKF 
38393, SKF 82958, SKF 81297 and ABT-431 during testing also blocked all blocked 
expression of cocaine-CPP (Graham et al., 2007; Sabioni et al., 2012). Similarly, 
systemic administration of the D2 antagonist sulpiride given during conditioning blocks 
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acquisition of amphetamine-CPP (Hiroi and White, 1991b) and intra-accumbal 
injections of the D2 antagonist raclopride block acquisition of intra-accumbal 
amphetamine-CPP (Liao, 2008). However, systemic injection of sulpiride does not 
effect acquisition of cocaine-CPP (Cervo and Samanin, 1995). When given during 
testing, systemic administration of the D2 agonists quinperole and 7-OH-DPAT both 
blocked expression of cocaine-CPP (Graham et al., 2007). However, the D2 antagonists 
flupentixol or metoclopramide have no effect on amphetamine-CPP (Hiroi and White, 
1991b). Although it is clear that both D1 and D2 receptors act to modulate acquisition 
and expression of psychostimulant-CPP, studies employing the use of D1 or D2 
agonists and antagonists do not give a clear indication of the exact role of these 
receptors, possibly due to the crudeness of these compounds (Gerfen and Surmeier, 
2011). Contemporary techniques allowing for more direct modulation of the excitability 
of NAc neurons expressing dopamine D1 or D2 receptors may help to elucidate 
neuronal mechanisms controlling the acquisition and expression of psychostimulant-
CPP.  
 
Indeed, separate striatal pathways have been shown to play an important role in guiding 
the direction of place conditioning. Reversible neurotransmitter blockade of the 
dopamine D1-receptor-expressing direct pathway attenuates acquisition of food-CPP 
but does not affect acquisition of electric shock-induced conditioned place avoidance 
(CPA), while the reverse is observed following blockade of the dopamine D2-receptor-
expressing indirect pathway (Brown and Fibiger, 1993; Hikida et al., 2010). Similarly, 
optogenetic activation of D1-expressing NAc MSNs during cocaine-paired chamber 
conditioning enhanced acquisition of cocaine-CPP, while activation of D2-expressing 
NAc MSNs in the same conditions attenuated acquisition (Lobo et al., 2010). 
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Table 4.1. 
 Acquisition Expression 
Systemic Intra-accumbal Systemic Intra-accumbal 
D1 agonist ? ? Block cocaine-
CPP (Graham et 
al., 2007; Sabioni 
et al., 2012) 
? 
D2 agonist ? ? Block cocaine-
CPP (Graham et 
al., 2007) 
? 
D1 antagonist Block cocaine-
CPP (Cervo and 
Samanin, 1995) 
Block 
amphetamine-
CPP (Hiroi and 
White, 1991b)  
Block intra-NAc 
amphetamine-
CPP (Liao, 
2008) 
No change 
cocaine CPP 
(Cervo and 
Samanin, 1995) 
Block 
amphetamine-
CPP (Hiroi and 
White, 1991b) 
Block 
amphetamine-
CPP (Hiroi and 
White, 1991b) 
D2 antagonist  No change 
cocaine-CPP 
(Cervo and 
Samanin, 1995) 
Block 
amphetamine-
CPP (Hiroi and 
White, 1991b) 
Block intra-NAc 
amphetamine-
CPP (Liao, 
2008) 
No change 
cocaine-CPP 
(Cervo and 
Samanin, 1995) 
No change 
amphetamine-
CPP (Hiroi and 
White, 1991b) 
No change 
amphetamine-
CPP (Hiroi and 
White, 1991b) 
 
Table 4.1. The effect of systemic or intra-accumbal administration of dopamine D1 or 
D2 receptor agonists and antagonists on acquisition and expression of psychostimulant-
CPP.  
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Given that neurons within the NAc are predominantly GABAergic MSNs it is possible 
that GABAARs may be involved in the acquisition of CPP. Benzodiazepines, which act 
to enhance the effect of GABA at GABAARs, have largely been reported to be unable to 
induce CPP when administered alone. Systemic administration of alprazolam, zolpidem, 
oxazepam and diazepam all fail to produce CPP (Meririnne et al., 1999; Walker and 
Ettenberg, 2001; Le Pen et al., 2002; Walker and Ettenberg, 2003; Goeders and 
Goeders, 2004). However, others find that at higher doses, diazepam administration 
results in a significant CPP effect (Gray et al., 1999; Papp, 2002). Drugs acting directly 
at GABAARs, including the antagonists bicuculine and picrotoxin, similarly do not 
produce a place conditioning effect (Chester and Cunningham, 1999; Bossert and 
Franklin, 2001). However, THIP, a GABAAR agonist with a preference for δ-containing 
receptors, is able to produce persistent CPA in rodents (Vashchinkina et al., 2012).  
 
Interestingly, when administered directly into specific brain regions, drugs modulating 
GABAergic inhibition show a different pattern of effects. Indeed, there appears to be a 
rostrocaudal gradient within the NAc in the ability of GABAAR agonists to induce CPP. 
Muscimol delivered directly into the rostral NAc shell produces a significant CPP, 
however, administration into the caudal shell produced a strong CPA (Reynolds and 
Berridge, 2002). Similar such injections of muscimol or bicuculine into the BLA have 
been reported not to produce any effects (Zarrindast et al., 2004), although others find 
significant CPA following intra-BLA bicuculine (Thielen and Shekhar, 2002). 
Interestingly, in the VTA, administration of a GABAAR agonist and antagonist produce 
the same result, with muscimol and bicuculine both inducing significant CPP 
(Laviolette and van der Kooy, 2001). 
 
GABAergic inhibition has also been reported to modulate psychostimulant-CPP. The 
acquisition and expression of amphetamine- and cocaine-CPP are blocked by systemic 
diazepam administration (Leri and Franklin, 2000a). Similarly, pre-treatment of GVG, 
an irreversible GABA-transaminase inhibitor, abolished both the acquisition and 
expression of cocaine-CPP in rodents, but did not effect CPP for food reward (Dewey et 
al., 1998). Co-administration of Gastrodia elata Bl, an oriental herb agent known to 
enhance GABAergic transmission, and post-conditioning treatment with 1R,4S-4-
amino-cyclopent-2-ene-carboxylic acid (ACC), a reversible inhibitor of GABA 
transaminase, are also reported to attenuate acquisition and expression of cocaine-CPP, 
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respectively (Ashby et al., 2002; Shin et al., 2011). Evidence that expression of 
amphetamine-CPP is blocked by intra-NAc administration of diazepam indicates that 
GABA transmission within the NAc is able to modulate psychostimulant-CPP (Leri and 
Franklin, 2000b). 
 
As of yet, little is known about the role of individual GABAAR subtypes in the 
mediation of cocaine-CPP. Targeted deletion of synaptically located α2-containing 
GABAARs does not affect acquisition of cocaine-CPP (Dixon et al., 2010). However, 
the possible contribution of extrasynaptic α4βδ GABAARs, thought to mediate the 
excitability of NAc MSNs through a tonic form of inhibition, is yet to be revealed. Here, 
the effects of targeted deletion of GABAAR α4-subunits are explored in a cocaine-CPP 
paradigm. Additionally, the effects of THIP, given either systemically or infused 
directly into the NAc at behaviourally relevant doses (see Chapter 3), were observed in 
a test of cocaine-CPP. As THIP was previously shown to also modulate behaviours 
when cocaine was still onboard (see Chapters 3 & 4), in a separate test, THIP was also 
co-administered with a cocaine challenge. Finally, the contribution of GABAAR α4-
subunits in specific striatal pathways were assessed using dopamine D1- or D2-
expressing cell-specific GABAAR α4-subunit knockout mice and systemic THIP 
administration using the same experimental design.  
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4.2. Materials and Methods 
 
4.2.1. Animals 
Conditional dopamine D1/D2 expressing neuron specific α4-subunit knockout mice 
were created by crossing “Floxed” Gabra4 homozygous transgenic mice (strain name; 
B6.129-Gabra4tm1.2Geh/J, supplied by The Jackson Laboratory, ME, USA) with either 
dopamine receptor D1 or D2 neuron specific Cre-recombinase hemizygous transgenic 
mice (strain name; α4D1-/- = B6.FVB(Cg)-Tg(Drd1a-cre)EY217Gsat/Mmucd, α4D2-/- =  
B6.FVB(Cg)-Tg(Drd2-cre)ER44Gsat/Mmucd, supplied by Mutant Mouse Regional 
Resource Centers (MMRRC), ME, USA). Breeding was conducted as described in Fig. 
4.1.  
 
Male GABAAR α4 wildtype (WT), knockout (α4-/-), and dopamine D1- or D2-
expressing neuron specific α4 wildtype (α4D1 WT/α4D2 WT) and knockout (α4D1-/-/α4D2-
/-) mice on a C57Bl/6J background strain, weighing between 20-30g, were housed in 
groups of 2-3, or separately for surgery animals, with food and water available ad 
libitum. A 12hr light/dark cycle was used (lights on at 7:00 A.M.) with holding room 
temperature maintained at 21 ±2ºC and humidity 50 ±5%. All injections, infusions and 
behavioural testing were performed between 2:00 P.M. and 5:00 P.M. All procedures 
were conducted in accordance to Animals (Scientific Procedures) Act 1986, following 
ethical review by the University of Sussex Ethical Review Committee. 
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Figure 4.1.  
 
Fig. 4.1. Production of D1 expressing neuron specific α4-subunit wildtype (α4D1 WT), 
and knockout (α4D1-/-) mice. (F0) α4-subunit “floxed” homozygous mice were bred with 
D1-expressing neuron specific Cre-recombinase expressing heterozygous mice. (F1) 
offspring heterozygous for the α4 allele (+/-), and heterozygous for D1/D2-CRE or 
homozygous for no-CRE were bred to create (F2) offspring of approximately; 
heterozygous α4 allele/homozygous no-D1/D2-CRE (25%), heterozygous α4 
allele/heterozygous D1/D2-CRE (25.5%), homozygous α4 allele/heterozygous D1/D2-
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CRE (12.5%), homozygous α4 allele/homozygous no-D1/D2-CRE (12.5%). Finally, 
homozygous α4 “floxed” allele/homozygous no-D1/D2-CRE (12.5%) and homozygous 
α4 “floxed” allele/heterozygous D1/D2-CRE (12.5%) were used to breed the 
experimental wildtype (50%) and knockout (50%) experimental mice, respectively. The 
same strategy was used using D2-CRE mice.   
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4.2.2. Genotyping 
Genotyping procedure as described in Chapter 2 (2.2.2.)  
 
4.2.2.1. Conditional dopamine D1-/D2-expressing neuron specific GABAAR α4-
subunit knockout mice PCR 
Forward and reverse cDNA primers were designed to target and replicate a sequence 
contained within the integrated Cre recombinase transgene. The Cre primer consisted of 
a 102bp product (forward primer; GCGGTCTGGCAGTAAAACTATC, reverse primer; 
GTGAAACAGCATTGCTGTCACTT). 
 
Figure 4.2. 
Fig. 4.2. Genotyping of dopamine D1/D2-expressing neuron specific GABAA α4-
subunit wildtype and knockout mice requires a reaction for the detection of Cre. The 
absence of a Cre band indicates a wildtype mouse, whilst the presence of a Cre band 
indicates a knockout mouse. 
 
4.2.3. Quantitative reverse transcription PCR (qRT-PCR) mRNA analysis  
GABAAR α4-, α2-, γ2- and δ-subunit mRNA expression was analysed from NAc tissue 
samples from α4D1-/-, α4D2-/- and respective WT control mice (as described in Chapter 2; 
2.2.4.).  
 
4.2.4. Stereotaxic Cannulation.  
Mice anaesthetised with isoflurane were implanted stereotaxically with bilateral guide 
cannulae (26 ga., 10mm) aimed at NAcc (coordinates AP1.34; L+/− 1.00; DV −3.20, 
(Paxinos and Franklin, 2001)). Following surgery, mice were singly housed and 
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underwent a one-week recovery/habituation period. A steel infuser (33 ga., 11 mm) 
connected via polyvinyl tubing to a (5 µl) Hamilton Gastight syringe was used to infuse 
0.5µl of either saline or THIP (3 mM) bilaterally across 90 seconds and left to settle for 
90 seconds before infusers were removed. Location of cannulae was confirmed 
histologically.  
 
4.2.5. Drugs 
Cocaine Hydrochloride was obtained from Macfarlan Smith (Edinburgh, UK). THIP 
(4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) was kindly donated by Bjarke Ebert 
(Lundbeck, Valby, Denmark). Both drugs were dissolved in 0.9% saline, and 
administered i.p. at an injection volume of 10 ml/kg. 
 
4.2.6. Apparatus 
Conditioned place preference was measured using eight three-chamber place 
conditioning boxes (outer two conditioning chambers measured 200 X 200 X 200 mm 
and were separated by a central chamber measuring 200 X 50 X 200 mm). One 
conditioning chamber was white with meshed metal flooring. The other chamber was 
black and white (each wall was split along the diagonal, with the top and bottom halves 
colored black and white, respectively) with a smooth clear Perspex floor. The central 
chamber had grey walls and a smooth clear Perspex floor and could be closed off from 
the outer chambers during the conditioning phase using clear Perspex doors to prevent 
movement between chambers. The movement and location of animals was recorded 
using infra-red beam breaks (Mead et al., 1999). 
 
4.2.7. Conditioned Place Preference to Cocaine 
Animals received saline injections in their home cages the day before the first 
experimental session, following which the experiment was divided into three phases:  
 
Pre-conditioning phase (day 1): Mice were allowed free access to the apparatus for 20 
min., during which the time in each chamber was measured in order to exclude the 
possibility of a chamber bias.  
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Conditioning phase (days 2-11): Mice were administered cocaine (10 mg/kg, i.p.) and 
were confined to one of the outer chambers for 40 min. On alternate daily sessions the 
mice were administered saline and confined to the other outer chamber. Mice received a 
total of 10 pairings during the conditioning phase (5 with cocaine, and 5 with saline). 
The side of the chamber assigned to cocaine-administration was counterbalanced 
between mice.  
 
Test Phase (days 12-16): On the first test day mice were allowed free access to the 
entire chamber for 20 min and time spent in each chamber was recorded for analysis of 
place conditioning. On the following four test days mice received THIP (i.p. at 8mg/kg 
administered 20 minutes prior to test, or intra-accumbal infusions at 3uM/3mM directly 
prior to test), or saline, and an i.p. injection of cocaine (10mg/kg), or saline, directly 
prior to testing. Drugs were administered in a latin square design and sessions were 
recorded for 20 min. 
 
4.2.8. Statistical Analysis 
 
4.2.8.1. qRT-PCR 
Quantitative RNA expression data were collected using the Mx4000 data analysis 
software (Stratagene, CA, USA), then exported to an Excel worksheet. Reaction 
triplicates were averaged, and then normalised against the control gene GAPDH to give 
a measure of the delta CT. The delta CT of the target sample was then normalised 
against the delta CT of a control sample to give a measure of the delta delta CT.  
Finally, a mathematical model was used to calculate the fold change of the target gene 
using the delta-delta CT (see (Pfaffl, 2001)). Statistical analysis of RNA expression of 
each receptor subunit was conducted using between-subjects one-way ANOVAs, with 
genotype as the between-subjects variables, and delta CT as the dependent variable. 
 
4.2.8.2. Conditioned Place Preference to Cocaine in Wildtype and GABAAR α4-
subunit Knockout Mice with Intraperitoneal THIP 
Acquisition of CPP to cocaine was assessed by measuring the difference in time spent 
in the cocaine-paired chamber minus the time spent in the saline-paired chamber from 
the pre- to the post-conditioning drug-free session. These data were analysed using a 
three-way mixed-factors ANOVA, with genotype as the between-subjects factor, 
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conditioning as the within-subjects factor, and time spent in the cocaine-paired chamber 
minus saline-paired chamber as the dependent variable. Subsequently, the ability of 
cocaine and i.p. THIP to modulate cocaine-CPP was measured using a five-way mixed 
factors ANOVA, with genotype as the between-subjects factor, cocaine/saline injection 
and THIP/saline injection as the within-subjects factors, and time spent in the cocaine-
paired chamber minus saline-paired chamber as the dependent variable. 
 
4.2.8.3. Conditioned Place Preference to Cocaine in Wildtype and GABAAR α4-
subunit Knockout Mice with Intra-accumbal THIP 
As previous, acquisition of CPP to cocaine data were analysed using a three-way mixed-
factors ANOVA, with genotype as the between-subjects factor, conditioning as the 
within-subjects factor, and time spent in the cocaine-paired chamber minus saline-
paired chamber as the dependent variable. Cocaine-CPP data were analysed 
independently for each THIP dose using five-way mixed-factors ANOVAs, with 
genotype as the between-subjects factor, cocaine/saline injection and THIP/saline 
infusion as the within-subjects factors, and time spent in the cocaine-paired chamber 
minus saline-paired chamber as the dependent variable. 
 
4.2.8.4. Conditioned Place Preference to Cocaine in Wildtype and Dopamine 
D1/D2-expressing neuron specific GABAAR α4-subunit Knockout Mice with 
Intraperitoneal THIP 
Acquisition of CPP to cocaine were analysed independently for α4D1-/- and α4D2-/- mice 
and their respective wildtype control mice using three-way mixed-factors ANOVAs, 
with genotype as the between-subjects factor, conditioning as the within-subjects factor, 
and time spent in the cocaine-paired chamber minus saline-paired chamber as the 
dependent variable. The ability of cocaine and i.p. THIP to modulate cocaine-CPP was 
again analysed independently for each knockout group and it’s respective wildtype 
control mice using five-way mixed factors ANOVAs, with genotype as the between-
subjects factor, cocaine/saline injection and THIP/saline injection as the within-subjects 
factors, and time spent in the cocaine-paired chamber minus saline-paired chamber as 
the dependent variable. 
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4.3. Results 
 
4.3.1. qRT-PCR mRNA analysis in dopamine D1-/D2-expresing neuron specific 
GABAAR α4-subunit wildtype and knockout mice 
In order to confirm the deletion of GABAAR α4-subunits from D1 or D2-expressing 
neurons, expression levels of α4-subunit mRNA were measured in the NAc of α4D1-/-, 
α4D2-/- and respective WT controls using qRT-PCR. In addition, NAc mRNA expression 
levels of α2-, γ2- and δ-subunits were also measured.  
 
GABAAR α4-subunit mRNA levels were reduced by approximately half of that of 
respective WT controls in the NAc of α4D1-/- (Table 4.2., Fig. 4.3; significant main 
effect of genotype, F(1,10) = 22.05, p < 0.001) and α4D2-/- mice (Table 4.2., Fig. 4.3; 
significant main effect of genotype, F(1,10) = 27.12, p < 0.001). Expression of GABAAR 
α2-subunit mRNA was increased to a similar degree in the NAc of α4D1-/- (Table 4.2., 
Fig. 4.3; significant main effect of genotype, F(1,10) = 55.36, p < 0.001) and α4D2-/- mice 
(Table 4.2., Fig. 4.3; significant main effect of genotype, F(1,10) = 42.01, p < 0.001), 
when compared with respective WT controls. GABAAR γ2-subunit mRNA levels did 
not differ from respective WT controls in the NAc of α4D1-/- (Table 4.2., Fig. 4.3; non-
significant main effect of genotype, F(1,10) = 0.65, p = 0.45, NS) and α4D2-/- mice (Table 
4.2., Fig. 4.3; non-significant main effect of genotype, F(1,10) = 1.15, p = 0.32). Finally, 
expression of GABAAR δ-subunit mRNA was decreased in the NAc of α4D1-/- (Table 
4.2., Fig. 4.3; significant main effect of genotype, F(1,10) = 51.28, p < 0.001) and α4D2-/- 
mice (Table 4.2., Fig. 4.3; significant main effect of genotype, F(1,10) = 32.18, p < 0.001), 
when compared with respective WT controls. 
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Table 4.2. 
Primer Genotype Fold change % Change from WT Sig. 
α4 α4D1 WT 
α4D1-/- 
α4D2 WT 
α4D2-/- 
1 ± 0.11/0.06 
0.54 ± 0.22/0.12 
1 ± 0.15/0.08 
0.45 ± 0.18/0.11 
0% 
-46% 
0% 
-55% 
 
p < 0.001 
 
p < 0.001 
α2 α4D1 WT 
α4D1-/- 
α4D2 WT 
α4D2-/- 
1 ± 0.07/0.05 
6.97 ± 1.76/0.88 
1 ± 0.23/0.14 
 7.23 ± 1.50/0.78 
0% 
+597% 
0% 
+623% 
 
p < 0.001 
 
p < 0.001 
γ2 α4D1 WT 
α4D1-/- 
α4D2 WT 
α4D2-/- 
1 ± 0.10/0.05 
1.15 ± 0.21/0.11 
1 ± 0.23/0.12 
1.07 ± 0.25/0.14 
0% 
+15% 
0% 
+7% 
 
NS 
 
NS 
δ α4D1 WT 
α4D1-/- 
α4D2 WT 
α4D2-/- 
1 ± 0.12/0.06 
0.44 ± 0.26/0.15 
1 ± 0.06/0.04 
 0.47 ± 0.21/0.10 
0% 
-66% 
0% 
-53% 
 
p < 0.001 
 
p < 0.001 
Table 4.2. NAc mRNA expression levels of GABAAR α4-, α2-, γ2- and δ-subunits in 
dopamine D1- or D2-expressing neuron specific α4-subunit knockout (α4D1-/-; n=4, 
α4D2-/-; n=4) mice were compared in triplicate against wildtype (α4D1 WT; n=4, α4D2 
WT; n=4) controls in the NAc, to give a measure of fold change. Percentage change 
from WTs was tested statistically using post hoc paired t tests. 
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Figure 4.3. 
 
Figure 4.3. Fold change from wildtype controls of GABAAR α4-subunit mRNA 
expression in the NAc of wildtype (α4D1 WT; n=4 and α4D2 WT; n=4) and dopamine D1-
/D2-receptor expressing neuron specific α4-subunit knockout (α4D1-/-; n=4 and α4D2-/-; 
n=4) mice. α4D1-/- and α4D2-/- mice show a decrease in expression of NAc α4-subunit 
mRNA when compaired to WT controls. Conversely, α4D1-/- and α4D2-/- mice show a 
large increase in expression of α2-subunit mRNA. Expression of γ2-subunit mRNA was 
unchanged in α4D1-/- and α4D2-/- mice. Finally, expression of δ-subunit mRNA was 
reduced in α4D1-/- and α4D2-/- mice, when compared to WT controls. Error bars represent 
SEM. *p < 0.001, post hoc paired t test. 
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4.3.2. Conditioned Place Preference to Cocaine in Wildtype and GABAAR α4-
subunit Knockout Mice with Intraperitoneal THIP  
A pre-conditioning test found no bias in preference for the two outer chambers (Fig. 
4.4.A; non-significant main effect of genotype, F(1,20) = 0.16,  p = 0.69, NS). 
Subsequently, the ability of cocaine to support the formation of a conditioned place 
preference was unaltered by a constitutive deletion of the α4 subunit. WT and α4-/- mice 
demonstrated an equal preference for the cocaine-paired chamber under drug-free (Fig 
4.4.A; significant main effect of conditioning, F(1,20) = 82.49, p < 0.001, non-significant 
conditioning by genotype interaction, F(1,20) = 0.56,  p = 0.45, NS) and saline (Figure 
4.4.B; main effect of conditioning, F(1,20) = 12.70, p < 0.001, non-significant main effect 
of genotype, F(1,20) = 0.23, p = 0.63, NS) conditions. 
 
A challenge injection of cocaine (10mg/kg i.p.) given directly prior to the test 
significantly increased time in the cocaine-paired chamber compared with mice given 
saline (Fig. 4.4.B; main effect of drug, F(1,20) = 18.65, p < 0.001, non-significant drug by 
genotype interaction, F(1,20) = 2.27, p = 0.83 ,NS). To test whether α4βδ GABAARs were 
mediating this effect, systemic THIP (8mg/kg) was administered 20 min prior to CPP 
testing. There was no effect of THIP alone on time spent in the cocaine-paired chamber 
(Fig. 4.4.B; non-significant main effect of THIP, F(1,20) = 3.1, p = 0.95, NS, non-
significant THIP by genotype interaction, F(1,20) = 1.58, p = 0.22, NS), however, THIP 
significantly reduced cocaine enhancement of cocaine-CPP for WT, but not α4-/- mice 
(Fig. 4.4.B; significant drug by THIP by genotype interaction, F(1,20) = 12.40, p < 0.01).   
 
As seen in Chapter 3, locomotor activity measured during the control CPP test session 
did not differ between WT and α4-/- mice under drug-free (Fig 4.4.C; non-significant 
main effect of genotype, F(1,20) = 0.33, p = 0.57, NS) and saline (Fig 4.4.C; non-
significant main effect of genotype, F(1,20) = 0.27, p = 0.60, NS) conditions. A cocaine 
challenge potentiated activity equally in both genotypes (Fig. 4.4.C; significant main 
effect of drug, F(1,20) = 96.28, p < 0.001, non-significant drug by genotype interaction, 
F(1,20) = 0.28, p = 0.65, NS). Intraperitoneal injections of THIP (8mg/kg) did not effect 
baseline locomotor activity in either WT or α4-/- mice (Fig. 4.4.C; non-significant main 
effect of THIP, F(1,20) = 0.40, p = 0.53, NS, non-significant THIP by genotype 
interaction, F(1,20) = 0.09, p = 0.76, NS), and although cocaine-potentiated locomotor 
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activity appeared to be reduced in WT but not α4-/- mice, this result was not found to be 
significant (Fig. 4.4.C; non-significant drug by THIP by genotype interaction, F(1,20) = 
1.02, p = 0.32, NS).  
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Figure 4.4. 
         
 
Fig. 4.4. The effect of challenge injections of THIP (8mg/kg)/vehicle and cocaine 
(10mg/kg)/vehicle on cocaine-CPP in a 20 minute test. (A) WT (n=11) and α4-/- (n=11) 
mice do not show any pre-conditioning preference for either chamber, but following 
conditioning equally demonstrate a preference for the cocaine-paired chamber in a drug-
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free test, indicating significant place conditioning. (B) Cocaine induced a significant 
CPP in both WT and α4-/- mice. A challenge dose of cocaine increased cocaine-CPP 
equally in WT and α4-/- mice. Systemic THIP had no effect on preference in either 
genotype, but blocked the cocaine potentiating effect in WT but not α4-/- mice. (C) 
Locomotor activity during CPP. WT and α4-/- mice did not show any differences in 
activity during CPP, and were both equally potentiated by a cocaine challenge. THIP 
did not affect baseline or cocaine-potentiated locomotor activity in either genotype. 
Error bars represent SEM. * p < 0.01 post hoc comparisons. 
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4.3.3. Conditioned Place Preference to Cocaine in Wildtype and GABAAR α4-
subunit Knockout Mice with Intra-accumbal THIP  
A pre-conditioning test found no bias in preference for the two outer chambers (Fig. 
4.5.C; non-significant main effect of genotype, F(1,14) = 0.60,  p = 0.44, NS, Fig. 4.5.D; 
non-significant main effect of genotype, F(1,14) = 0.19,  p = 0.65, NS). To test whether 
accumbal α4βδ GABAARs were mediating the THIP-induced decrease in cocaine-
potentiated cocaine-CPP, mice were cannulated and tested in the same paradigm. The 
intra-accumbal THIP doses used were based upon the active doses revealed in the 
locomotor activity experiments (see Chapter 2), and consisted of a low-dose (3µM) and 
a high-dose (3mM). As expected, cocaine induced a significant CPP in both WT and α4-
/- mice under drug-free (Fig. 4.5.C; main effect of conditioning: F(1,14) = 55.43, p < 
0.001, non-significant conditioning by genotype interaction, F(1,14) = 0.19, p = 0.66, NS, 
Fig. 4.5.D; main effect of conditioning: F(1,14) = 41.53, p < 0.001, non-significant 
conditioning by genotype interaction, F(1,14) = 0.63, p = 0.43, NS) and saline (Fig. 4.5.E; 
significant main effect of conditioning, F(1,14) = 23.28, p < 0.001, non-significant 
conditioning by genotype interaction, F(1,14) = 0.02, p = 0.86, NS, Fig. 4.5.F; significant 
main effect of conditioning, F(1,14) = 12.98, p < 0.001, non-significant conditioning by 
genotype interaction, F(1,14) = 0.07, p = 0.79, NS) conditions.  
 
Intra-accumbal 3µM or 3mM THIP had no effect on preference in either genotype 
(Fig.4.5.E; non-significant main effect of THIP infusion, F(1,14) = 2.39, p = 0.14, NS, 
non-significant THIP infusion by genotype interaction, F(1,14) = 1.94, p = 0.18, NS, 
Fig.4.5.F; non-significant main effect of THIP infusion, F(1,14) = 3.30, p = 0.09, NS, 
non-significant THIP infusion by genotype interaction, F(1,14) = 3.39, p = 0.08, NS). 
Again, a challenge dose of cocaine enhanced preference in both genotypes (Fig. 4.5.E; 
significant main effect of drug, F(1,14) = 29.71, p < 0.001, non-significant drug by 
genotype interaction, F(1,14) = 0.63, p = 0.43, NS, Fig. 4.5.F; significant main effect of 
drug, F(1,14) = 15.38, p < 0.001, non-significant drug by genotype interaction, F(1,14) = 
0.65, p = 0.43, NS). Cocaine challenge enhancement of CPP was blocked by intra-
accumbal 3mM but not 3µM THIP in WT, but not in α4-/- mice (Fig. 4.5.E; non-
significant drug by THIP infusion by genotype interaction, F(1,14) = 0.97, p = 0.34, NS, 
Fig. 4.5.F; significant drug by THIP infusion by genotype interaction, F(1,14) = 6.12, p < 
0.05). 
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Locomotor activity recorded during the CPP sessions indicated that as previous WT and 
α4-/- mice did not differ in their activity under drug-free (Fig. 4.5.G; non-significant 
main effect of genotype, F(1,14) = 0.24, p = 0.67, NS, Fig. 4.5.H; non-significant main 
effect of genotype, F(1,14) = 0.32, p = 0.58, NS) and saline (Fig. 4.5.G; non-significant 
main effect of genotype, F(1,14) = 0.17, p = 0.77, NS, Fig. 4.5.H; non-significant main 
effect of genotype, F(1,14) = 0.02, p = 0.88, NS) conditions. Similarly, a cocaine 
challenge potentiated locomotor activity equally in both genotypes (Fig. 4.5.G; 
significant main effect of drug, F(1,14) = 161.57, p < 0.001, non-significant drug by 
genotype interaction, F(1,14) = 0.01, p = 0.91, NS, Fig. 4.5.H; significant main effect of 
drug, F(1,14) = 68.02, p < 0.001, non-significant drug by genotype interaction, F(1,14) = 
0.81, p = 0.37, NS). As with intraperitoneal THIP injections, both 3µM and 3mM intra-
accumbal THIP alone did not effect locomotor activity in both genotypes (Fig. 4.5.G; 
non-significant main effect of THIP infusion, F(1,14) = 0.38, p = 0.54, NS, non-
significant THIP infusion by genotype interaction, F(1,14) = 0.01, p = 0.89, NS, Fig. 
4.5.H; non-significant main effect of THIP infusion, F(1,14) = 3.38, p = 0.08, NS, non-
significant THIP infusion by genotype interaction, F(1,14) = 0.95,  p = 0.34, NS). THIP 
infusions at either dose were similarly unable to effect cocaine-challenge-potentiated 
locomotor activity in WT or α4-/- mice (Fig. 4.5.G; non-significant drug by THIP 
infusion by genotype interaction, F(1,14) = 0.06, p = 0.80, NS, Fig. 4.5.H; non-significant 
drug by THIP infusion by genotype interaction, F(1,14) = 0.95, p = 0.34, NS). 
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Figure 4.5. 
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Fig 4.5. The effect of 3µM or 3mM intra-accumbal infusions of THIP/vehicle and  
intraperitoneal injections of cocaine (10mg/kg)/vehicle on cocaine-CPP in a 20 minute 
test. (A) Histology of intra-accumbal saline/THIP (3µM) infusions in WT (n=8) and α4-
/- (n=8) mice. (B) Histology of intra-accumbal saline/THIP (3mM) infusions in WT 
(n=8) and α4-/- (n=8) mice. (C & D) WT and α4-/- mice do not show any pre-
conditioning preference for either chamber, but following conditioning equally 
demonstrate a preference for the cocaine-paired chamber in a drug-free test. (E & F) A 
cocaine challenge enhanced cocaine-CPP in both genotypes. Intra-accumbal infusion of 
3µM or 3mM THIP had no effect on cocaine-CPP in both genotypes. An infusion of 
3mM but not 3µM intra-accumbal THIP blocked the ability of a cocaine challenge to 
enhance cocaine-CPP in WT but not α4-/- mice. (G & H) Cocaine potentiated locomotor 
activity equally in WT and α4-/- mice. Intra-accumbal infusion of 3µM or 3mM THIP 
had no effect in either genotype on locomotor activity during cocaine-CPP or cocaine-
potentiated cocaine-CPP. Error bars represent SEM. * p < 0.01 post hoc comparisons. 
 
	   123	  
4.3.4. Conditioned Place Preference to Cocaine in Wildtype and Dopamine D1/D2-
expressing neuron specific GABAAR α4-subunit Knockout Mice with 
Intraperitoneal THIP  
GABAAR α4 subunits are expressed on both dopamine D1- or D2-expressing neurons 
within the NAc. To investigate possible pathway specific roles of α4 subunits in 
mediating cocaine-CPP, α4 subunits were knocked out in a cell-specific manner from 
cells expressing D1 or D2 dopamine receptors respectively.  
 
All genotypes showed no pre-conditioning bias in preference for the two outer chambers 
(Fig 4.6.A; non significant main effect of genotype F(1,18) = 0.50,  p = 0.48, NS, Fig. 
4.6.B; non significant main effect of genotype, F(1,18) = 1.35,  p = 0.25, NS). 
Subsequently, following place conditioning, WT mice (“floxed α4” mice) in these 
experiments performed in the same manner as WT mice in the previous experiments 
(Fig. 4.6.A&B) confirming that the manipulations of the gabra4 gene necessary to make 
the cell specific knockouts were silent (introduction of LoxP sites (Chandra et al., 
2006)). Interestingly, the cell specific knockouts did not perform in the same way as the 
constitutive knockouts. Mice with the α4 subunit selectively ablated from D1-
expressing neurons (α4D1-/-) showed enhanced CPP to cocaine (Drug-free conditions, 
Fig. 4.6.A; significant main effect of conditioning F(1,18) = 79.71, p < 0.001, significant 
conditioning by genotype interaction, F(1,18) = 6.61, p < 0.05, Saline conditions, Fig. 
4.6.C; significant main effect of conditioning F(1,18) = 55.38, p < 0.001, significant 
conditioning by genotype interaction, F(1,18) = 9.86, p < 0.05), whereas performance in 
the mice with the α4 subunit selectively ablated from D2-containing neurons (α4D2-/-) 
was unaffected (Drug-free conditions, Fig. 4.6.B; significant main effect of 
conditioning, F(1,18) = 54.35, p < 0.001, non significant conditioning by genotype 
interaction, F(1,18) = 0.52, p = 0.47, NS, Saline conditions, Fig. 4.6.D; significant main 
effect of conditioning, F(1,18) = 43.73, p < 0.001, non significant conditioning by 
genotype interaction, F(1,18) = 1.08, p = 0.31, NS). 
 
A cocaine challenge enhanced cocaine-CPP in WT and α4D1-/- mice (Fig. 4.6.C; main 
effect of drug, F(1,18) = 22.44, p < 0.001, non-significant drug by genotype interaction, 
F(1,18) = 1.12, p = 0.30, NS). α4D2-/- mice, on the otherhand showed no cocaine 
enhancement (Fig. 4.6.D; non-significant main effect of drug, F(1,18) = 3.85, p = 0.06, 
NS, significant drug by genotype interaction, F(1,18) = 18.31, p < 0.001). THIP (8mg/kg 
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i.p.) alone had no effect on expression of CPP in any genotype (Fig. 4.6.C; non-
significant THIP by genotype interaction, F(1,18) = 0.05, p = 0.81, NS, Fig. 4.6.D; non-
significant THIP by genotype interaction, F(1,18) = 1.12, p = 0.30, NS), however, when 
co-administered with cocaine, THIP was able to block cocaine-enhanced CPP in WT 
but not α4D1-/- mice (Fig. 4.6.C; drug by THIP injection by genotype interaction, F(1,18)= 
7.33, p < 0.01). THIP in combination with cocaine had no effect on α4D2-/- mice (Fig. 
4.6.D; genotype by drug by THIP injection interaction, F(1,18) = 9.12, p < 0.01). 
 
Locomotor activity measured during the drug-free and saline CPP tests did not differ 
between any of the genotypes (Drug-free conditions, Fig 4.6.E; non-significant main 
effect of genotype, F(1,18) = 0.81, p = 0.37, NS, Fig. 4.6.F; non-significant main effect of 
genotype, F(1,18) = 0.35, p = 0.55, NS, Saline conditions, Fig 4.6.E; non-significant main 
effect of genotype, F(1,18) = 0.40, p = 0.84, NS, Fig. 4.6.F; non-significant main effect of 
genotype, F(1,18) = 0.27, p = 0.60, NS). A challenge injection of cocaine potentiated 
activity equally in all genotypes (Fig. 4.6.E; significant main effect of drug, F(1,18) = 
77.56, p < 0.001, non-significant drug by genotype interaction, F(1,18) = 2.02, p = 0.17, 
NS, Fig. 4.6.F: significant main effect of drug, F(1,18) = 88.50, p < 0.001, non-significant 
drug by genotype interaction, F(1,18) = 0.29, p = 0.59, NS). Intraperitoneal injections of 
THIP (8mg/kg) did not effect locomotor activity during CPP in either genotype (Fig. 
4.6.E; non-significant main effect of THIP, F(1,18) = 0.01, p = 0.89, NS, non-significant 
THIP by genotype interaction, F(1,18) = 0.65, p = 0.43, NS, Fig. 4.6.F; non-significant 
main effect of THIP, F(1,18) = 1.43, p = 0.24, NS, non-significant THIP by genotype 
interaction, F(1,18) = 0.51, p = 0.48, NS). Cocaine-potentiated locomotor activity was not 
significantly effected by THIP administration in either WT, α4 D1-/- or α4 D2-/- mice (Fig. 
4.6.E; non-significant drug by THIP by genotype interaction, F(1,18) = 1.68, p = 0.21, 
NS, Fig. 4.6.F; non-significant drug by THIP by genotype interaction, F(1,18) = 0.01, p = 
0.93, NS).  
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Figure 4.6. 
 
Fig 4.6. The effect of challenge injections of THIP (8mg/kg)/vehicle and cocaine 
(10mg/kg)/vehicle on cocaine-CPP in a 20 minute test. (A) WT (n=10) and α4D1-/-  
(n=10) mice do not show any pre-conditioning preference for either chamber, but 
following conditioning α4D1-/- mice show a preference for the cocaine-paired chamber 
greater than that of their WT counterparts in a drug-free test. (B) WT (n=10) and α4D2-/- 
(n=10) mice do not show any pre-conditioning preference for either chamber, but 
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following conditioning equally demonstrate a preference for the cocaine-paired chamber 
in a drug-free test. (C) A cocaine challenge enhanced cocaine-CPP equally in both 
genotypes. Intraperitoneal THIP (8mg/kg) did not effect CPP in either genotype, but 
blocked cocaine enhancement of CPP in WT, but not α4D1-/- mice. (D) Cocaine 
challenge enhancement of Cocaine-CPP seen in WTs was not present in α4D2-/- mice. 
Intraperitoneal THIP (8mg/kg) did not effect CPP in either genotype, but blocked 
cocaine challenge enhancement of CPP in WT mice. (E) WT and α4D1-/- mice did not 
show any differences in locomotor activity during CPP, and activity was equally 
potentiated in both genotypes by a cocaine challenge. THIP did not affect locomotor 
activity during CPP, or cocaine-enhanced CPP in either genotype. (F) WT and α4D2-/- 
mice did not show any differences in activity during CPP, and were both equally 
potentiated by a cocaine challenge. THIP did not effect locomotor activity during CPP, 
or cocaine-enhanced CPP in either genotype. Error bars represent SEM. * p < 0.01 post 
hoc comparisons. 
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4.4. Discussion 
 
In the current experiments both WT and constitutive α4-/- mice show equivalent levels 
of cocaine-CPP suggesting GABAAR α4-subunits are not involved in the acquisition of 
cocaine-CPP. However, dopamine receptor D1- or D2-expressing MSNs of the direct or 
indirect striatal pathways, respectively, can exert opposing actions on certain 
psychostimulant-induced behaviours, including CPP and locomotor sensitisation 
(Hikida et al., 2010; Lobo et al., 2010; Beutler et al., 2011; Ferguson et al., 2011). 
During cocaine-CPP it appears that the balance between these opposing neuronal groups 
is shifted in favour of activation of the D1-containing direct pathway, thus eliciting a 
preference for the cocaine-paired chamber. The role of α4-subunits on these two 
pathways may be masked in the constitutive KO by the absence of the α4-containing 
GABAAR from all neurons. Therefore, cocaine-CPP was investigated in mice with the 
α4-subunit ablated from either D1- or D2-expressing neurons. Removal of α4-
containing GABAAR-mediated inhibition of D1-expressing cells resulted in an 
increased cocaine-CPP compared with WT controls, whereas similar removal from D2-
expressing cells did not affect cocaine-CPP.  
qRT-PCR analysis indicated that expression of α4-subunit mRNA was reduced by 
approximately 50% in the NAc of α4D1-/- and α4D2-/- mice when compared to respective 
WT control mice. Immunohistochemical evidence indicates that dopamine receptors D1 
and D2 are largely segregated on MSNs within the NAc (Gerfen et al., 1990; Surmeier 
et al., 1996), with α4-subunits expressed equally on each neuronal type (Maguire et al, 
submitted). Thus, the extent of the reduction in α4-subunit mRNA expression observed 
in α4D1-/- and α4D2-/- mice is as might be expected from a deletion specifically from 
either dopamine receptor D1- or D2-expressing neurons. In α4D1-/- and α4D2-/- mice, 
expression of α2-subunit mRNA expression was increased, and δ-subunit mRNA 
reduced in the NAc, when compared to respective WT controls. However, γ2-subunit 
mRNA expression was unaltered in the NAc in α4D1-/- and α4D2-/- mice. These data 
indicate that the Gabra4 gene deletion was successful in dopamine D- or D2-expressing 
neurons and that these mice demonstrate similar changes to constitutive knockout mice 
in that there is an increase in α2-subunit mRNA expression and a decrease in δ-subunit 
mRNA expression. 
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Deletion of the α4-subunit specifically from D1-neurons facilitated conditioning, 
resulting in more time spent in the cocaine-paired chamber during the test phase. Thus, 
by increasing the excitability of D1-MSNs, through the removal of tonic GABAergic 
inhibition, mice showed greater CPP to cocaine. This result is in agreement with an 
optogenetic study demonstrating that activation of D1-MSNs during training enhances 
cocaine-CPP (Lobo et al., 2010), and supports a model of striatal processing suggesting 
that activation of the direct pathway is rewarding (Kravitz and Kreitzer, 2012). Given 
that optogenetic evidence suggests that activation of D2-MSNs attenuates cocaine-CPP 
(Lobo et al., 2010), it might be predicted that the removal of α4βδ GABAAR-mediated 
tonic inhibition from D2-MSNs would produce a similar result, however this was not 
the case. Although α4D2-/- mice appeared to show a reduced preference for the cocaine-
paired chamber when compared to WT mice, this result was not significant. Thus it 
appears that the increased neuronal excitation produced by removal of inhibition from 
D2-MSNs following deletion of α4-containing GABAARs is not sufficient to produce an 
attenuation of cocaine-CPP such as that reported when D2-MSNs are optogenetically 
stimulated (Lobo et al., 2010).  
It has been reported that activation of α4βδ GABAARs is able to attenuate the 
potentiation of certain behaviours, including locomotor activity (see Chapter 2, Fig.2.6. 
& Fig.2.8.) and conditioned reinforcement (CRf) responding (see Chapter 5, Fig.5.2.F, 
Fig.5.5.G. & Fig.5.5.H.) by cocaine. Therefore we tested expression of cocaine-CPP in 
the presence of a cocaine challenge. Previous studies have demonstrated that preference 
for a drug-paired environment can be extinguished and subsequently reinstated by drug 
priming injections (Parker and Mcdonald, 2000). Indeed, drug priming injections have 
been shown to reinstate CPP for amphetamine (Cruz et al., 2008), cocaine (Mueller and 
Stewart, 2000), nicotine (Biala and Budzynska, 2006), morphine (Parker and Mcdonald, 
2000) and alcohol (Font et al., 2008), following extinction. However, studies exploring 
the effect of drugs administered during the CPP test have produced mixed findings. 
Morphine has been shown to enhance expression of morphine-CPP, and naltrexone, an 
opioid receptor antagonist, enhances expression of naltrexone-CPA (Bespalov et al., 
1999). Similarly, methamphetamine enhances expression of methamphetamine-CPP, 
but only at high doses (Cunningham and Noble, 1992; Shabani et al., 2011). However, 
ethanol is reported to suppress expression of ethanol-CPP in DBA/2 mice, and have no 
effect on ethanol-CPP expression in NZB mice (Gremel and Cunningham, 2007). To 
	   129	  
our knowledge, the current experiments are the first to show the effects of a cocaine 
challenge on expression of cocaine-CPP.  
 
Cocaine administered during the test session enhanced cocaine-CPP in both WT and α4-
/- mice. This finding may be explained by the interoceptive properties of cocaine 
increasing the salience of the CPP. Previous evidence has indicated that the sensation 
caused by the drug stimuli is an important component that is conditioned to the CS 
during Pavlovian associative learning, and may enhance the retrieval of stimulus-
response associations upon exposure to the CS in the drug-paired chamber 
(Cunningham and Noble, 1992; Bespalov et al., 1999). The ability of α4βδ GABAARs 
to modulate enhancement of CPP expression by a cocaine challenge was further 
explored through pharmacological activation of these receptors by THIP. The acute 
effect of cocaine, to increase CPP, is blocked in WT mice by the application of THIP, 
both systemically and intra-accumbally.  This suggests that although α4βδ GABAARs 
do not participate in the cocaine enhancement per se, upon additional activation the 
increased tonic inhibition opposes that behaviour. The glutamatergic projection from the 
amygdala to the NAc is thought to provide information about affective states produced 
by a rewarding stimuli (Groenewegen et al., 1987; French and Totterdell, 2003; Di 
Ciano, 2004; Ambroggi et al., 2008). It is possible that activation of α4βδ GABAARs by 
THIP may inhibit the arrival or processing of this information within the NAc, thus 
blocking the state-induced enhancement of cocaine-CPP by a cocaine challenge. This 
effect of THIP is mediated by α4βδ GABAARs on D1-containing neurons as the agonist 
does not block the cocaine-enhancement in either constitutive α4-/- mice or α4D1-/- mice.  
 
Interpretation of systemic THIP effects are complex as it will activate δ-GABAARs 
expressed elsewhere (e.g. thalamus, hippocampus, cerebellum, ventral tegmental area) 
and at higher doses may engage additional GABAAR isoforms (Mortensen et al., 2010). 
However, the effects of systemic THIP were demonstrated to be specific to α4 subunit-
containing GABAARs as the suppression of cocaine enhanced CPP evident in WT, is 
absent in α4-/- mice. Furthermore, infusion of THIP directly into the NAc was equally 
effective in blocking the cocaine enhancement of CPP in WT, but not α4-/- mice, 
revealing that the principal site of action of systemic THIP in our behavioural studies is 
α4βδ GABAARs of the NAc. 
	   130	  
 
These data indicate that α4βδ-GABAARs of D1-MSNs may act as an immediate 
homeostatic control to prevent excessive neuronal excitation by dopamine, as their 
activation blocks cocaine enhancement of cocaine-CPP. The actions of dopamine on 
D1-MSNs are complex, causing both complementary excitatory, but additionally 
opposing inhibitory effects. D1-receptors stimulate Gs and Golf proteins, which stimulate 
adenylyl cyclase, increasing intracellular levels of cyclic adenosine monophosphate 
(cAMP) and activating protein kinase A (PKA). Activation of D1-receptors and PKA 
increases Cav1 L-type calcium channel currents and decreases somatic potassium 
channel currents, as well as enhancing AMPA and NMDA receptor function and 
trafficking (Gerfen and Surmeier, 2011). However, D1 receptor activation also reduces 
the availability of voltage-gated sodium channels to conduct (Gerfen and Surmeier, 
2011). Thus, even at the level of a single D1-MSN, there are multiple homeostatic 
control mechanisms. Interestingly, recent evidence has also demonstrated that the 
magnitude of the GABAergic tonic current in D1-MSNs is dynamically increased by D1 
receptor activation, achieved either directly by a selective dopamine receptor D1 
agonist, or indirectly by amphetamine (Maguire et al, submitted), thereby presumably 
limiting the excitatory effects of dopamine. The enhanced tonic current is unlikely to be 
caused indirectly (e.g. by changes of GABA release), but probably occurs within the 
D1-MSN, as it was prevented by blockade of G-protein coupling by intracellular GDP-
βs (Maguire et al, submitted). By contrast, prolonged, but not acute, D2 receptor 
activation caused a modest decrease of the tonic conductance of D2-MSNs (Maguire et 
al, submitted). A similar differential effect of dopamine receptor activation on the tonic 
conductance of D1- and D2-MSNs occurs in the dorsal striatum, reflecting the distinct 
effects of these G-protein coupled receptors on PKA activity (Janssen et al., 2009). 
Furthermore, chronic cocaine produces an up-regulation of the Gabra4 gene, encoding 
for α4-subunits, specifically in D1-MSNs (Heiman et al., 2008). This observation 
suggests that in addition to providing a short term homeostatic role, when excessively 
stimulated, expression of these opposing α4βδ-GABAARs may be increased, thereby 
strengthening an intrinsic “brake” on these D1-MSNs.  
 
Interestingly, in α4D2-/- mice, there is no cocaine enhancement of cocaine-CPP. This 
suggests an important role of tonic inhibition of the indirect pathway in mediating the 
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cocaine enhancement. As previously described, D2 receptor activation results in a 
decrease in the D2-MSN tonic GABA current and is likely to increases their excitability 
(Maguire et al, submitted). The absence of α4βδ-GABAARs should further disinhibit 
D2-MSNs, therefore increasing activity of the indirect pathway. Acute cocaine appears 
to enhance the expression of cocaine-CPP by an action of dopamine at D1-MSNs, 
therefore given the typically opposing roles of striatal pathways, activation of D2-MSNs 
might be hypothesised to oppose cocaine enhancement of cocaine-CPP. Indeed, 
dopamine acting at D2-receptors triggers an intracellular signaling cascade that is 
ultimately thought to inhibit the cell, and thus would act in partnership with D1-MSN 
activation to enhance the CPP effect. Thus, absence of α4-GABAAR-mediated 
inhibition in D2-MSNs may override the inhibition of D2-MSNs normally caused by 
cocaine-induced dopamine release, resulting in α4D2-/- mice not showing the cocaine 
enhancement of cocaine-CPP. Deletion of α4-GABAARs from D2-MSNs presumably 
also blocks the effect of cocaine-induced dopamine acting at D1-MSNs to enhance 
cocaine-CPP. A mechanism for the action of D2 excitation on D1 MSN activity whether 
might be a direct inhibitory effect of D2-MSN collaterals onto D1-MSNs (Taverna et 
al., 2004), or via an indirect route. However, the D2-MSN α4βδ-GABAAR effect on 
cocaine enhancement of preference must occur upstream of the D1-MSN effect as when 
D1-MSNs cannot be inhibited (in the constitutive KO), the absence of receptors from 
D2 MSNs does not impact on the phenotype: the α4D1-/- phenotype predominates in the 
constitutive α4 knockout. 
 
Neither systemic or intra-accumbal THIP alone, affected the expression of cocaine-CPP 
in WT and constitutive α4-/- mice in the absence of a cocaine challenge. It is possible 
that the effects of inhibition of both D1- and D2-MSNs in WT mice may cancel each 
other out and result in no overall change in the expression of cocaine-CPP. However, 
THIP alone had no effect on preference in the α4D1-/- or α4D2-/- mice. It is still unknown 
what effect activation of α4βδ-GABAARs by THIP may have on the acquisition of 
cocaine-CPP. It is possible that activation of α4βδ-GABAARs by THIP during training 
may block the conditioning of cocaine place preference.  
 
It has previously been reported that THIP can reduce baseline and cocaine-potentiated 
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locomotor activity when given i.p. or intra-accumbally (see Chapter 2, Fig.2.6. & 
Fig.2.8. and Herd et al., 2009; Vashchinkina et al., 2012. This may confound the 
interpretation of the reported CPP effects as sedation may inhibit the ability of the 
animal to freely move between chambers, thus increasing or reducing the apparent 
‘place preference’. Indeed, some studies have reported locomotor activity can be 
inversely proportional to CPP magnitude (Gremel and Cunningham, 2007), and so a 
small sedative effect of THIP might be expected to increase CPP. In the current studies, 
a sedative effect of i.p. or intra-accumbal THIP was not detected. The discrepancy 
between these findings and those reported previously (see Chapter 2, Fig.2.6. & 
Fig.2.8.) may be explained by a lack of sensitivity in the method used to record 
locomotor activity in the CPP apparatus. In the CPP boxes locomotion is detected in just 
one dimension, using beam breaks. While the narrow locomotor runways used in 
previous experiments (see Chapter 2, Fig.2.6. & Fig.2.8.) are designed specifically to 
measure locomotor activity and the tracking software provides a more accurate analysis 
of activity. 
To conclude, these data indicate that α4βδ-GABAAR-mediated inhibition of NAc MSNs 
plays an important role in modulating cocaine-CPP and its enhancement by a cocaine 
challenge. Deletion of the α4 subunit selectively from D1-MSNs resulted in greater 
cocaine-CPP, presumably reflecting an increase in D1-MSN excitability. Furthermore, 
when these GABAARs are directly activated by THIP, they suppress cocaine 
enhancement of the CPP effect. Thus α4βδ-GABAARs modulation of MSN excitability 
plays a role in regulating dopamine’s effects in the NAc. By increasing α4βδ-GABAARs 
inhibition of D1-MSNs, dopamine counteracts its own excitatory actions, stabilizing 
MSN output.  The multiple actions of dopamine on MSNs allows downstream tuning of 
the dopamine signal.  
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Chapter 5 
 
The role of α4-containing GABAA receptors in food conditioned reinforcement and 
its potentiation by cocaine 
 
5.1. Introduction 
 
In the previous chapter it was described how neutral stimuli can acquire incentive 
motivational properties following Pavlovian association with an unconditioned 
rewarding stimulus, such as cocaine, and can subsequently elicit approach responses. 
Appetitive Pavlovian conditioned stimuli (CS) can also act as conditioned (secondary) 
reinforcers to control and maintain instrumental behaviour in the absence of the 
unconditioned (primary) rewarding stimulus (US), a process known as conditioned 
reinforcement (CRf). Understanding such appetitive processes and the neural substrates 
underlying them will be critical for elucidating mechanisms of learning and motivation, 
and their maladaption in drug addiction.  
 
Much work has been done to resolve the neuroanatomical substrates of CRf, and the 
NAc, once again, appears to be a key integrating centre for excitatory inputs carrying 
information about stimulus-reward associations. Interestingly, there is a functional 
dissociation between NAc subregions in terms of the relative roles they play in 
mediating conditioned behaviours. Lesions of the NAc core impair Pavlovian 
associative learning, as well as reducing the associative control over specific 
instrumental responding (for a reward-paired vs non-rewarding reinforcer) following 
intra-accumbal amphetamine potentiation of CRf (Parkinson et al., 1999; Kravitz and 
Kreitzer, 2012). Conversely, lesions of the NAc shell do not affect Pavlovian or 
instrumental conditioning (Hall et al., 2001; Lobo et al., 2010), but are able to 
completely abolish the potentiating effects of intra-accumbal amphetamine on 
responding with CRf (Parkinson et al., 1999; Lobo et al., 2010). Thus, the NAc core is 
thought to be integral for instrumental learning and behavioural responses to incentive-
motivational conditioned stimuli (Kelley et al., 1997; Bassareo and Di Chiara, 1999; 
Parkinson et al., 1999; Ito et al., 2000; Parker and Mcdonald, 2000; Parkinson et al., 
2000). Whereas the NAc shell is implicated in the primary rewarding effects of 
unconditioned stimuli, as well as well as the potentiative effects of psychostimulants 
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(Chiara et al., 1993; Pontieri et al., 1995; Bassareo and Di Chiara, 1999; Cruz et al., 
2008).  
The NAc core receives efferent projections from the basolateral amygdala (BLA) that 
are reported to be critical for instrumental behaviour in response to Pavlovian stimulus-
reward associations (Everitt et al., 2000; Mueller and Stewart, 2000). Excitotoxic 
lesions of the BLA impair responding for conditioned reinforcers, but do not affect 
Pavlovian conditioning (Everitt and Robbins, 1992; Gallagher and Holland, 1994; 
Everitt et al., 1999; Biala and Budzynska, 2006). Furthermore, BLA-lesioned rats fail to 
spontaneously adjust their responding to the CS after reinforcer devaluation (Hatfield et 
al., 1996; Parker and Mcdonald, 2000). Thus, the BLA is suggested to underlie the 
ability to use the CS to access the value of a specific US to guide behavioural responses 
(Everitt et al., 2003; Font et al., 2008).  
 
Much less clear is the role that hippocampal projections to the NAc play in mediating 
CRf. Inactivation of the hippocampus by tetrodotoxin is known to block reinstatement 
for cocaine seeking by contextual cues (Bespalov et al., 1999; Fuchs et al., 2004), and 
lesions of the dorsal hippocampus block acquisition of food- and cocaine-induced CPP 
(Cunningham and Noble, 1992; Meyers et al., 2003; 2006; Shabani et al., 2011). These 
data support the notion that the hippocampus mediates conditioning for contextual or 
spatial stimuli, whereas the amygdala underlies conditioning to discrete CS (Selden et 
al., 1991; Gremel and Cunningham, 2007). It has been hypothesised that the 
hippocampal contextual information and amygdala discrete CS information may 
compete within the NAc for control over goal-directed behaviour (Cunningham and 
Noble, 1992; Bespalov et al., 1999; Everitt and Robbins, 2005). Indeed, selective 
lesions of the hippocampus not only disrupt behavioural responses under the control of 
contextual cues, but facilitate control by discrete cues, with the reverse being observed 
following amygdala lesions (Groenewegen et al., 1987; French and Totterdell, 2003; Di 
Ciano, 2004; Ito et al., 2006; Ambroggi et al., 2008). Interestingly, lesions of the 
hippocampus block the ability of intra-accumbens amphetamine to potentiate 
responding for CRf, suggesting that the hippocampal projection to the NAc shell may 
also act to mediation of dopaminergic tone (Burns et al., 1993; Ito et al., 2004; Everitt 
and Robbins, 2005; Mortensen et al., 2010). 
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The importance of NAc dopamine transmission in appetitive conditioning is confirmed 
by evidence that dopamine depletion of the NAc impairs the acquisition and expression 
of Pavlovian approach (Parkinson et al., 2002; Gerfen and Surmeier, 2011). It appears 
that dopamine is also implicated in mediating instrumental responses to conditioned 
stimuli as intra-accumbens dopamine or amphetamine produce dose-dependent 
increases responding with CRf (Cador et al., 1991; Gerfen and Surmeier, 2011). This 
responding was similarly blocked by dopamine depletion in the ventral, but not the 
dorsal striatum (Taylor and Robbins, 1986; Janssen et al., 2009). Interestingly, CRf 
responding is also dose dependently potentiated by systemic administration of 
dopamine receptor D2 agonists quinpirole and bromocriptine, but not D1 agonist SKF 
38393 (Beninger et al., 1989; Beninger, 1992; Heiman et al., 2008). Indeed, D1 agonists 
SKF 82958, SKF 81297, SKF 77434 and CY 208-243 have been reported to impair 
responding for a conditioned reinforcer (Beninger and Rolfe, 1995; Taverna et al., 
2004). However, when infused directly into the NAc, both D1 (SKF 38393) and D2 
(quinpirole) agonists are able to potentiate CRf responding, and intra-accumbal D1 
antagonist SCH 23390 and D2 antagonist raclopride block intra-accumbal 
amphetamine-induced potentiation of CRf responding (Wolterink et al., 1993; Herd et 
al., 2009; Vashchinkina et al., 2012). Furthermore, systemic administration of D1 
antagonist SCH 23390 or D2 antagonist raclopride during Pavlovian training, increase 
or decrease, respectively, responding for the conditioned reinforcer on a drug-free test 
day (Eyny and Horvitz, 2003; Gremel and Cunningham, 2007). Although the specificity 
of current dopamine D1 and D2 receptor agonists/antagonists has been questioned 
(Gerfen and Surmeier, 2011), these data indicate that both D1 and D2 receptors may be 
involved in mediating CRf responding and psychostimulant potentiation of CRf 
responding (summarised in Table 5.1.).  
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Table 5.1.  
 CRf responding Psychostimulant potentiation 
of CRf responding 
Systemic Intra-accumbal Systemic Intra-accumbal 
D1 agonist No change/ 
decreased 
(Beninger et 
al., 1989; 
Beninger and 
Ranaldi, 1992) 
Increased 
(Wolterink et 
al., 1993) 
Decreased 
potentiation 
(Ranaldi et 
al., 1995) 
? 
D2 agonist Increased 
(Beninger et 
al., 1989; 
Beninger and 
Ranaldi, 1992) 
Increased 
(Wolterink et 
al., 1993) 
? ? 
D1 antagonist No change/ 
decreased 
(Beninger et 
al., 1987; 
Sanger, 1987; 
Beninger et al., 
1989) 
? ? Decreased 
potentiation 
(Wolterink et al., 
1993) 
D2 antagonist Decreased 
(Beninger et 
al., 1987; 
1989) 
? ? Decreased 
potentiation 
(Wolterink et al., 
1993) 
 
Table 5.1. The effect of systemic or intra-accumbal administration of dopamine D1 or 
D2 receptor agonists and antagonists on CRf responding, and psychostimulant-
potentiated CRf responding.  
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As previously described, the NAc is an area predominantly expressing GABAergic 
neurons, however it is still unclear what role GABA and GABAARs in the NAc may 
play in controlling appetitive conditioning and instrumental responding for conditioned 
reinforcers. Given the multitude of inputs onto NAc MSNs vying for control over goal-
directed behaviour, it has been hypothesised that GABAergic inhibition may function to 
supress the activity of unwanted competing neurons (Taverna et al., 2004; Nicola, 
2006). In-vivo electrophysiological studies demonstrate that NAc neuronal firing is 
correlated with the onset of reward-conditioned stimuli, as well as for instrumental 
responses for conditioned reinforcers (Nicola et al., 2004). Thus it is clear that 
subpopulations of NAc neurons encode the predictive value of reward-paired cues, and 
the instrumental behaviours required to respond to them (Nicola et al., 2004). 
Interestingly, response to reward-related stimuli is also associated with inhibition of a 
subset of accumbens neurons during appetitive behaviors (Nicola et al., 2004; Taha and 
Fields, 2006). It is suggested that sustained inhibition of NAc MSNs, perhaps through 
activation of fast-spiking GABAergic interneurons (Tepper et al., 2004), disinhibits 
target regions, permissively gating and maintaining appetitive behaviors (Taha and 
Fields, 2006). However, infusion of the GABAAR agonist muscimol directly into the 
NAc does not affect second-order instrumental responding for food rewards (Pulman et 
al., 2012). Similarly, deletion of GABAAR α2-subunits, the most widely found 
GABAAR subunit within the NAc (Pirker et al., 2000), does not affect Pavlovian 
conditioning or instrumental responding for CRf (Dixon et al., 2010). However, 
interestingly, α2-subunit knockout mice fail to show a potentiation of CRf responding 
by systemic cocaine administration (Dixon et al., 2010).  
 
Here the effects of deletion of GABAARs α4-subunits on Pavlovian conditioning, 
instrumental responding for conditioned reinforcers and potentiation of CRf by systemic 
cocaine are explored. Subsequently, α4βδ GABAARs within the NAc were activated 
using intra-accumbal THIP during expression of CRf and cocaine-potentiated CRf in 
wildtype and α4-subunit knockout mice. To confirm the involvement of α4βδ 
GABAARs within the NAc, CRf and its potentiation by cocaine were repeated using 
control and NAc-specific α4-subunit viral knockdown mice. Finally, mice in which α4-
subunit were specifically ablated in either dopamine D1- or D2-expressing neurons 
were used to explore striatal pathway-specific effects of α4-GABAARs (α4-GABAARs) 
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in Pavlovian conditioning and CRf. Intra-accumbal THIP was similarly used to 
specifically activate NAc α4βδ GABAARs in these mice. 
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5.2. Materials and Methods 
 
5.2.1. Animals 
GABAAR α4 wildtype (WT) and knockout (α4-/-), and dopamine D1-/D2-specific α4 
wildtype (WT) and knockout (α4D1-/- and α4D2-/-) mice were on a C57Bl/6J background 
strain. WT littermate controls were used for each knockout line. C57Bl/6J mice (Charles 
River Laboratories, Kent, UK) were used for virus experiments. All mice weighed 
between 20-30g, were housed in groups of 2-3, or separately for surgery animals, with 
food and water available ad libitum. A 12hr light/dark cycle was used (lights on at 7:00 
A.M.) with holding room temperature maintained at 21±2ºC and humidity 50±5%. All 
injections, infusions and behavioural testing were performed between 2:00 P.M. and 
5:00 P.M. All procedures were conducted in accordance to Animals (Scientific 
Procedures) Act 1986, following ethical review by the University of Sussex Ethical 
Review Committee. 
 
5.2.2. Stereotaxic Cannulation.  
Mice anaesthetised with isoflurane were implanted stereotaxically with bilateral guide 
cannulae (26 ga., 10mm) aimed at NAcc (coordinates AP1.34; L+/− 1.00; DV −3.20, 
(Paxinos and Franklin, 2001)). Following surgery, mice were singly housed and 
underwent a one-week recovery/habituation period. A steel infuser (33 ga., 11 mm) 
connected via polyvinyl tubing to a (5 µl) Hamilton Gastight syringe was used to infuse 
0.5µl of either saline or THIP (3 mM) bilaterally across 90 seconds and left to settle for 
90 seconds before infusers were removed. Location of cannulae was confirmed 
histologically. Two mice were removed from data analysis due to inexact cannulae 
placement. 
 
5.2.3. Stereotaxic Viral Infusion 
C57BL/6J mice anesthetised with isoflurane were stereotaxically infused with Ad-NSS 
or Ad-shα4 (Rewal et al., 2009), bilaterally into the NAc (coordinates AP1.34; L+/− 
1.40; DV −4.20, (Paxinos and Franklin, 2001)). A steel infuser (33ga) connected via 
polyvinyl tubing to a (5µl) Hamilton Gastight syringe was used to infuse 1ul (0.5µl per 
side) of virus at a rate of 0.2µl/min for 5 minutes, then left to settle for an additional 5 
minutes. Following surgery mice were singly housed and allowed to recover for 7 days. 
Both viruses contained GFP under control of the CMV promoter allowing location of 
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infusion to be confirmed using immunohistochemistry. Ad-NSS and Ad-shα4 
adenoviruses were kindly donated by Patricia Janak (Ernest Gallo Clinic). 
5.2.4. Immunohistochemistry  
Mice brains were perfused via the aorta with 25ml (5 minutes of 5ml/min) of phosphate 
buffer solution (PBS) followed by 75ml (15 minutes of 5ml/min) of 4% 
paraformaldehyde (PF) (Sigma-Aldrich, St. Lois, MO, USA) in PBS. After perfusion, 
brains were removed and post-fixed overnight in 4% PF in PBS at 4°C, then transferred 
into 30% sucrose solution in PBS and left overnight again at 4°C. Coronal sections 
(60µm thick) were cut on a microtome and collected in PBS. 
 
Free-floating sections were incubated in 50% alcohol, rinsed	   twice	   in	   PBS	   for	   1	  minute	   each	  with	   gentle	   agitation, and then incubated in blocking solution (normal 
donkey serum 10% in PBS,	   pH	   7.4) for 1 hour at room temperature with gentle 
agitation. Slices were washed twice	   in	  PBS	  for	  1	  minute	  each	  with	  gentle	  agitation,	  then incubated overnight in rabbit anti-GFP polyclonal primary antibody (1:10,000, 
Abcam, Cambridge, UK). Slices were again washed twice	   in	  PBS	   for	  1	  minute	  each	  with	   gentle	   agitation, and then incubated for two hours in donkey anti-rabbit 
secondary antibody (1:3000, Jackson ImmunoResearch, West Grove, PA, USA). 
Following two final washes in	  PBS	  for	  2	  minutes	  each	  with	  gentle	  agitation,	  sections 
were mounted on Superfrost plus microscope slides (Fisher, MA, USA) and air-dried.  
Images were acquired using a confocal laser scanning microscope (LSM) (Zeiss, Jena, 
Germany) and visualized using LSM software (Zeiss, Jena, Germany).  
 
5.2.5. Quantitative reverse transcription PCR (qRT-PCR) RNA analysis 
qRT-PCR was conducted according to the protocol previously described (see Chapter 2; 
2.2.6.). Tissue punches from the NAc and dorsal striatum were collected and processed 
10 days post-infusion for measuring GABAAR α4 mRNA levels in Ad-NSS control 
adenovirus-infused mice and Ad-shα4 adenovirus-infused α4-subunit knockdown mice. 
Untreated mice, which did not undergo any surgery, were also used as a control 
measure. GAPDH was used as an internal control (see α4 and GAPDH primer 
sequences described in Chapter 2; Table 2.1.). 
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5.2.6. Drugs 
Cocaine Hydrochloride was obtained from Macfarlan Smith (Edinburgh, UK). THIP 
(4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) was kindly donated by Bjarke Ebert 
(Lundbeck, Valby, Denmark). Both drugs were dissolved in 0.9% saline, and 
administered i.p. at an injection volume of 10 ml/kg. 
 
5.2.7. Apparatus 
Conditioned reinforcement was measured using 8 operant chambers (Med Associates 
Inc, Vermont, USA), each housed within a light-resistant, sound-attenuating cubicle. 
Each unit consisted of two nose-poke inputs and a food magazine delivering 20mg 
sweetened pellets (5TUL, Cat no. 1811142; Test Diets, Indiana, USA). Head entries 
into the food magazine were detected using an infrared beam. A tone generator (2.9 
KHz, 5 dB above background) was located above the food magazine, and two LED 
stimulus lights positioned on the opposite wall. 
 
5.2.8. Pavlovian Conditioning 
Following food deprivation to maintain approximately 85% of baseline body weight, 
mice underwent 10 consecutive daily 60 minute Pavlovian training sessions during 
which they were presented with the two stimuli, 16 presentations of a 10-second tone 
and 16 presentations of 10-second LED flashing lights.  One was always associated with 
a food reward (CS+), and the other with no outcome (CS-). The order of stimulus 
presentations was randomly determined and each stimulus trial was separated by a 
variable, no stimulus, intertrial interval (ITI) (range of 80-120 seconds; mean (M) = 100 
seconds). A single food pellet delivery occurred 5 seconds after CS+ onset. Food 
magazine entries during presentation of each stimulus trial (CS+ or CS-) were expressed 
as a percentage of total magazine entries during the session (CS+ + CS- + ITI) to give a 
measure of Pavlovian conditioning. 
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5.2.9. Conditioned Reinforcement (CRf)  
On completion of Pavlovian conditioning, two nose-poke inserts were added to the 
operant chamber, each triggering presentation of either the CS+ or the CS-. Rates of 
nose-poke responses for the CS+ and CS- were measured over 60 minute sessions.  
 
5.2.9.1. Conditioned Reinforcement in Wildtype and GABAAR α4-Subunit 
Knockout Mice with Cocaine Potentiation Dose-Response 
Rates of nose-poke responses were recorded following i.p. cocaine (0, 3, 10, 30 mg/kg, 
test sessions on consecutive days in a latin square design) in WT and α4-/- mice.  
 
5.2.9.2. Conditioned Reinforcement in Wildtype and GABAAR α4-Subunit 
Knockout Mice with Cocaine Potentiation and Intra-accumbal THIP  
Mice underwent stereotaxic surgery to insert guide cannulae bilaterally into the NAc, 
and following recovery received 10 days of Pavlovian conditioning. Cannulated WT 
and α4-/- mice then underwent four test days (in a latin square design, with a day off 
between test days) during which they were administered intra-accumbal infusions of 
either saline or THIP (3µM or 3mM), followed by an i.p. injection of saline or cocaine 
(10mg/kg), directly prior to testing. 
 
5.2.9.3. Conditioned Reinforcement in Scrambled Virus Control (Ad-NSS) and α4 
Adenoviral Knockdown (Ad-shα4) Mice with Cocaine Potentiation and 
Intraperitoneal THIP 
Mice underwent stereotaxic surgery to infuse Ad-shα4 adenovirus or Ad-NSS 
scrambled control adenovirus bilaterally into the NAc. Following recovery for 7 days, 
all mice underwent 10 days of Pavlovian conditioning. Control and α4-knockdown mice 
then underwent four test days (in a latin square design, on consecutive days) during 
which they were administered i.p. injections of either saline or THIP (8mg/kg) 20 
minutes prior to an i.p. injection of saline or cocaine (10mg/kg) directly prior to testing. 
The CRf tests were conducted on days 18-21 post-infusion of the viruses, previously 
demonstrated to be a behaviourally relevant timescale for this virus (Rewal et al., 2009). 
 
 
5.2.9.4. CRf in Wildtype and α4D1 and α4D2 Knockout Mice with Cocaine 
Potentiation and Intra-accumbal THIP 
	   143	  
Following stereotaxic surgery, cannulated WT, and conditional knockout (α4D1-/- and 
α4D2-/-) mice, were given 10 days of Pavlovian training and then underwent four CRf 
test days, during which they were administered intra-accumbal infusions of saline or 
THIP (3uM or 3mM) 20 min prior to an i.p. injection of saline or cocaine (10mg/kg), 
directly prior to testing (in a latin square design, with a day of between test days).  
 
5.2.10. Statistical Analysis 
 
5.2.10.1. Conditioned Reinforcement in Wildtype and GABAAR α4-Subunit 
Knockout Mice with Cocaine Potentiation Dose-Response 
Pavlovian conditioning data were assessed in WT and α4-/- mice using a four-way 
mixed-factors ANOVA, with genotype as the between-subjects factor, conditioned 
stimulus (CS+ or CS-) and session as the within-subjects factors, and magazine entries 
made during the first five seconds of conditioned stimulus presentation as the dependent 
variable. The dose-response of cocaine-potentiation of CRf data were analysed using a 
four-way mixed-factors ANOVA, with genotype as the between-subjects factor, 
conditioned stimulus and drug dose as the within-subjects factors, and nose-poke 
responses as the dependent variable.  
 
5.2.10.2. Conditioned Reinforcement in Wildtype and GABAAR α4-Subunit 
Knockout Mice with Cocaine Potentiation and Intra-accumbal THIP  
Pavlovian conditioning data were assessed in WT and α4-/- mice using four-way mixed-
factors ANOVAs, with genotype as the between-subjects factor, conditioned stimulus 
and session as the within-subjects factors, and magazine entries made during the first 
five seconds of conditioned stimulus presentation as the dependent variable. CRf data 
were analysed independently for each THIP dose using five-way mixed-factors 
ANOVAs, with genotype as the between-subjects factor, conditioned stimulus, 
infusions and injections as the within-subjects factors, and nose-poke responses as the 
dependent variable. Post hoc analyses were conducted where appropriate using paired t-
tests. 
 
 
 
	   144	  
5.2.10.3. RNA Analysis of Ad-shα4 Adenovirus Knockdown of GABAAR α4-
Subunits 
Quantitative RT-PCR data were analysed using a three-way mixed-factors ANOVA, 
with virus group (Ad-NSS, Ad-shα4 or untreated) as the between-subjects factor, brain 
region (NAc or dorsal striatum) as the within-subjects variable, and the GAPDH-
controlled α4-subunit mRNA expression delta ct (see explanation in Chapter 2, 
2.2.10.2.) as the dependent variable. 
 
 
5.2.10.4. Conditioned Reinforcement in Scrambled Virus Control (Ad-NSS) and α4 
Adenoviral Knockdown (Ad-shα4) Mice with Cocaine Potentiation and 
Intraperitoneal THIP 
Pavlovian conditioning data were assessed in control and α4-subunit knockdown mice 
using a four-way mixed-factors ANOVA, with virus group as the between-subjects 
factor, conditioned stimulus and session as the within-subjects factors, and magazine 
entries made during the first five seconds of conditioned stimulus presentation as the 
dependent variable. CRf data were analysed using a five-way mixed-factors ANOVA, 
with virus group as the between-subjects factor, conditioned stimulus, drug injection 
and THIP injection as the within-subjects factors, and nose-poke responses as the 
dependent variable. Post hoc analyses were conducted where appropriate using paired t-
tests. 
 
 
5.2.10.5. Conditioned Reinforcement in Wildtype and α4D1 / α4D2 Knockout Mice 
with Cocaine Potentiation and Intra-accumbal THIP 
Pavlovian conditioning data were assessed in WT and conditional knockout (α4D1-/- and 
α4D2-/-) mice using four-way mixed-factors ANOVAs, with genotype as the between-
subjects factor, conditioned stimulus and session as the within-subjects factors, and 
magazine entries made during the first five seconds of conditioned stimulus presentation 
as the dependent variable. CRf data were analysed independently for each THIP dose 
using five-way mixed-factors ANOVAs, with genotype as the between-subjects factor, 
conditioned stimulus, infusions and injections as the within-subjects factors, and nose-
poke responses as the dependent variable. Post hoc analyses were conducted where 
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appropriate using paired t-tests.  The conditional knockout lines with their littermate 
WT controls were each tested in independent experiments.  
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5.3. Results 
 
5.3.1. Conditioned Reinforcement in Wildtype and GABAAR α4-Subunit Knockout 
Mice with Cocaine Potentiation Dose-Response  
Both wildtype and α4-subunit knockout mice demonstrated a similar ability to learn the 
reward predictive properties of the CS+ as assessed by increased approaches to the food 
delivery chamber on CS+ presentation (Fig. 5.1.A; significant conditioned stimulus by 
session; F(9,162) = 36.42, p < 0.001; non-significant session by genotype interaction; 
F(9,162) = 0.32, p =0.96, NS). Similarly, both genotypes accurately learned to elicit 
presentation of the cues via nose-poke responding, demonstrating robust conditioned 
responses (Fig. 5.1.B; significant main effect of conditioned stimulus, F(1,18) = 334.36, p 
< 0.001). However, in comparison to their WT counterparts, α4-/- mice displayed 
increased instrumental responding (Fig. 5.1.B; significant conditioned stimulus by 
genotype interaction; F(1,18) = 36.78, p < 0.001). Administration of cocaine dose-
dependently potentiated instrumental responding for the conditioned reinforcer equally 
across both genotypes, amplifying the initial cocaine-free pattern of responding (Fig. 
5.1.C; significant conditioned stimulus by drug dose interaction, F(3,51) = 23.97, p < 
0.001, non-significant conditioned stimulus by drug dose by genotype interaction; F(3,51) 
= 1.99, p =0.12, NS).  
 
5.3.2. Conditioned Reinforcement in Wildtype and GABAAR α4-Subunit Knockout 
Mice with Cocaine Potentiation and Intra-accumbal THIP  
Following surgery, mice underwent 10 days Pavlovian training. As previously seen, WT 
and α4-/- mice learnt the reward predictive properties of the CS+ to a similar degree, as 
assessed by increased approaches to the food delivery chamber on CS+ presentation 
(3µM THIP group, Fig 5.2.C; significant conditioned stimulus by session; F(9,243) = 
67.69, p < 0.001; non-significant session by genotype interaction; F(9,243) = 1.38, p 
=0.19, NS, 3mM THIP group, Fig 5.2.D; significant conditioned stimulus by session; 
F(9,126) = 24.27, p < 0.001; non-significant session by genotype interaction; F(9,126) = 
0.36, p =0.95, NS).  
 
As previously seen, α4-/- mice displayed increased instrumental responding in 
comparison to WT mice (Fig. 5.2.E; significant conditioned stimulus by genotype 
interaction; F(1,28) = 36.78, p < 0.001, Fig. 5.2.F; significant conditioned stimulus by 
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genotype interaction; F(1,14) = 83.34, p < 0.001). Similarly, as previous observed, a 
cocaine (10mg/kg) challenge potentiated the initial pattern of responding to a similar 
degree in WT and α4-/- mice (Fig. 5.2.E; significant main effect of drug, F(1,28) = 50.14, p 
< 0.001, non-significant drug by genotype interaction, F(1,28) = 0.35, p = 0.55, NS, Fig. 
5.2.F; significant main effect of drug, F(1,14) = 81.68, p < 0.001, non-significant drug by 
genotype interaction, F(1,14) = 4.23, p = 0.06, NS). 
 
Local infusion of 3µM or 3mM THIP into the NAc via indwelling bilateral cannulae did 
not alter baseline CRf responding, however, 3mM but not 3µM THIP was able to 
decrease cocaine-potentiated responding in WT but not α4-/- mice (3µM THIP, Fig. 
5.2.E; significant conditioned stimulus by infusion by injection by genotype interaction; 
F(1,28) =2.78, p = 0.11, NS, 3mM THIP, Fig. 5.2.F; significant conditioned stimulus by 
infusion by injection by genotype interaction; F(1,14) = 20.63, p < 0.001).  
  
	   148	  
Figure 5.1. 
 
Fig. 5.1. Conditioned reinforcement in wildtype and GABAAR α4-subunit knockout 
mice. (A) Pavlovian training over 10 consecutive days of 60 minute sessions; both WT 
(n=10) and α4-/- (n=10) mice learnt the association between a Pavlovian cue and a food 
reward to a similar degree. (B) Instrumental responding for a conditioned stimuli during 
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a 60 minute session: both genotypes preferentially responded on a nose-poke that led to 
CS+ presentations, compared with a CS− paired nose-poke. However, α4-/- mice made 
significantly more CS+ paired lever responses than WT mice. (C) Cocaine facilitation 
of conditioned reinforcement in WT and α4-/- mice during 60 minute sessions. 
Responding for the CS+ showed a dose-dependent potentiation following cocaine 
administration, to a similar degree across genotypes. Error bars represent SEM. *p < 
0.05, post hoc paired t test.  
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Figure 5.2 
3µM THIP     3mM THIP 
A 
Fig. 5.2. Conditioned reinforcement in wildtype and GABAAR α4-subunit knockout 
mice with intra-accumbal THIP. (A) Histology of intra-accumbal infusions in WT 
(n=12) and α4-/- (n=11) mice in the 3µM THIP experiment. (B) Histology of intra-
accumbal infusions in WT (n=8) and α4-/- (n=8) mice in the 3mM THIP experiment. 
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previously seen, both WT and α4-/- mice learnt the association between a Pavlovian cue 
and delivery of a food reward to a similar degree. (E&F) Nose-poke responses for the 
CS+ during 60 minute sessions following local NAc infusion of saline/THIP and an i.p 
injection of saline/cocaine (10mg/kg). As seen previously, responding for the CS+ was 
greater in α4-/- than wildtype mice, and cocaine potentiated CS+ responding equally in 
both genotypes. WT but not α4-/- mice display an attenuation of cocaine-potentiated 
CS+ responding following intra-NAc 3mM but not 3µM THIP infusion. Error bars 
represent SEM. *p < 0.05, post hoc paired t test.  
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5.3.3. RNA Analysis of Ad-shα4 Adenovirus Knockdown of GABAAR α4-Subunits 
qRT-PCR analysis revealed that GABAA R α4-subunit mRNA levels were reduced 
within the NAc but not dorsal striatum 10 days after infusion in Ad-shα4 adenovirus α4-
subunit knockdown (66 ±6.7% reduction), but not Ad-NSS adenovirus control when 
compared to untreated control mice (Fig. 5.3.B; significant virus group by brain region 
interaction, F(2,15) = 32.16, p < 0.001).  
 
5.3.4. Conditioned Reinforcement in Scrambled Virus Control (Ad-NSS) and α4 
Adenoviral Knockdown (Ad-shα4) Mice with Cocaine Potentiation 
As with wildtype and constitutive knockout mice, both control and α4-subunit viral 
knockdown mice learnt the food-predictive properties of the CS+ to a similar degree 
(Fig. 5.4.A; significant conditioned stimulus by session interaction; F(9,162) = 28.13, p < 
0.001, non significant conditions stimulus by session by genotype interaction; F(9,162) = 
0.29, p =0.96, NS). Similarly, α4-subunit viral knockdown mice showed an increased 
instrumental responding for the conditioned reinforcer relative to controls (Fig. 5.4.B; 
significant conditioned stimulus by virus interaction, F(1,18) = 431.85, p < 0.001). CRf 
responding was also equally potentiated by cocaine in both control and α4-subunit viral 
knockdown mice (Fig 5.4.B; significant main effect of drug injection; F(1,18) = 36.57, p 
< 0.001, non-significant drug injection by virus interaction F(1,18) = 0.12, p = 0.97, NS). 
However following i.p. THIP (paired with either saline or cocaine) CRf responding 
decreased drastically to minimal levels in both control and α4-subunit viral knockdown 
mice (Fig 5.4.B; significant THIP injection by drug injection interaction; F(1,18) = 9.87, p 
< 0.01, non-significant THIP injection by drug injection by virus interaction F(1,18) = 
0.13, p = 0.91, NS).  
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Figure 5.3. 
    
Fig. 5.3 Adenovirus knockdown of α4-subunits (A) Histological examination of GFP 
expression after virus infusion into the NAc. (B) Ad-shα4 but not Ad-NSS scrambled 
adenovirus reduced α4 mRNA expression in the NAc. Histogram depicts the mean ratio 
of α4 to GAPDH ±SEM (n=6 per group). Error bars represent SEM.* p < 0.05 post 
hoc paired t test.  
 
 
Figure 5.4. 
 
Fig. 5.4. Conditioned reinforcement in control and GABAAR α4-subunit viral 
knockdown mice. (A) Pavlovian training over 10 consecutive days of 60 minute 
sessions; both Ad-NSS scrambled virus control (n=10) and Ad-Shα4 α4-subunit viral 
knockdown (n=10) mice learnt the association between a Pavlovian cue and delivery of 
a food reward to a similar degree. (B) Ad-Shα4 α4-subunit viral knockdown mice 
demonstrate greater responding for the CS+ than Ad-NSS scrambled virus control mice. 
This effect was potentiated by cocaine to the same extent in both genotypes. Error bars 
represent SEM.* p < 0.05 post hoc paired t test.  
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5.3.5. Conditioned Reinforcement in Wildtype and α4D1 / α4D2 Knockout Mice with 
Cocaine Potentiation and Intra-accumbal THIP 
As with the previous experiments, no differences were seen between any of the 
genotypes in their ability to learn the reward-predictive properties of the CS+ (Fig. 
5.5.C; significant session by conditioned stimulus interaction, F(9,279) = 70.69, p < 0.001, 
non significant session by genotype interaction, F(9,279) = 1.12, p = 0.35, NS; Fig.5.5.D; 
significant main effect of session, F(9,279) = 53.98, p < 0.001, non significant session by 
genotype interaction, F(9,279) = 0.19, p = 0.99, NS). 
 
Similarly to global KOs, dopamine D2-specific GABAAR α4-subunit knockout mice 
demonstrated increased CRf responding for the CS+ when compared to wildtype 
controls (Fig. 5.5.F&H; significant main effect of conditioned stimulus, F(1,28) = 
3903.12, p < 0.001, significant conditioned stimulus by genotype interaction; F(1,28) = 
229.89, p < 0.001). However, this increase was absent in dopamine D1-specific 
GABAAR α4-subunit knockout mice (Fig. 5.5.E&G; significant main effect of 
conditioned stimulus, F(1,28) = 972.74, p < 0.001, non-significant conditioned stimulus 
by genotype interaction; F(1,28) = 0.37, p = 0.54, NS).  
 
A cocaine (10mg/kg) challenge potentiated the initial pattern of responding to a similar 
degree in all genotypes (Fig. 5.5.E&G; significant main effect of drug, F(1,28) = 50.14, p 
< 0.001, non-significant drug by genotype interaction, F(1,28) = 0.35, p = 0.55, NS, Fig. 
5.5.F&H; significant main effect of drug, F(1,28) = 211.63, p < 0.001, non-significant 
drug by genotype interaction, F(1,28) = 0.06, p = 0.79, NS). 
 
Local infusion of 3µM or 3mM THIP into the NAc did not effect CRf responding in any 
genotype, however, 3mM but not 3µM intra-accumbal THIP blocked potentiation of 
CRf responding in all WT and α4D1-/-, but not α4D2-/- mice (Fig 5.5.E&G; significant 
drug by infusion by THIP dose interaction, F(1,28) = 13.98, p < 0.001, non-significant 
drug by infusion by THIP dose by genotype interaction, F(1,28) = 2.63, p = 0.11, NS, 
Fig.5.5.F&H; significant drug by infusion by THIP dose interaction, F(1,28) = 4.86, p < 
0.05, significant drug by infusion by THIP dose by genotype interaction, F(1,28) = 7.70, p 
< 0.01). 
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Figure 5.5. 
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Fig. 5.5. Conditioned reinforcement in wildtype and dopamine D1- or D2-expressing 
neuron specific GABAAR α4-subunit knockout mice with intra-accumbal THIP. (A) 
Histology of intra-accumbal infusions in α4D1 WT (n=8) and α4D1-/- (n=8) mice. (B) 
Histology of intra-accumbal infusions in α4D2 WT (n=8) and α4D2-/- (n=8) mice. (C&D) 
Pavlovian training over 10 consecutive days of 60 minute sessions; all genotypes learnt 
the association between a Pavlovian cue and a food reward to a similar degree. (E&G) 
Nose-poke responses for the CS+ during 60 minute sessions following local NAc 
infusion of saline/THIP (3µM/3mM) and an i.p injection of saline/cocaine (10mg/kg) in 
α4D1 WT and α4D1-/- mice. In a saline/saline control test, responding for the CS+ was 
equivalent in both genotypes. Similarly, a challenge injection of cocaine (10mg/kg) 
potentiated responding to a similar degree in both genotypes. CS+ responding and 
cocaine-potentiated CS+ responding were not effected by an intra-accumbal infusion of 
THIP (3µM or 3mM) in both genotypes. Intra-accumbal 3mM but not 3µM THIP 
blocked the ability of cocaine to potentiate responding both genotypes. (F&H) Nose-
poke responses for the CS+ during 60 minute sessions following local NAc infusion of 
saline/THIP (3µM/3mM) and an i.p injection of saline/cocaine (10mg/kg) in α4D2 WT 
and α4D2-/- mice. In a saline-saline control test, α4D2-/- mice showed increased 
conditioned responding for the CS+ compared to α4D2 WT mice. A challenge injection 
of cocaine- (10mg/kg) potentiated responding equally in both genotypes. CS+ 
responding and cocaine-potentiated CS+ responding were not effected by an intra-
accumbal infusion of THIP (3µM or 3mM) in α4D2 WT and α4D2-/- mice. Intra-accumbal 
3mM but not 3µM THIP blocked the ability of cocaine to potentiate responding in α4D2 
WT but not α4D2-/- mice. Error bars represent SEM. *p < 0.05, post hoc paired t test. 
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5.4. Discussion 
 
These data demonstrate that a global deletion of α4-GABAARs increases instrumental 
responding for a conditioned reinforcer, indicating that inhibition mediated by these 
receptors may serve as a protective mechanism against excessive responding for 
reward-conditioned cues. However, activation of NAc α4βδ GABAARs using THIP was 
not able to reduce baseline CRf responding at either low or high doses, indicating that 
the protective effect of α4-GABAAR-mediated inhibition cannot be induced to a greater 
degree than is provided by physiological levels of GABA activation. Interestingly, a 
3mM dose of THIP blocked cocaine-potentiated responding in wildtype but not α4-
subunit knockout mice when infused directly into the NAc. Thus, activation of NAc α4-
GABAARs is sufficient to block cocaine potentiation of CRf. Given that the same dose 
of THIP was also able to block cocaine-potentiation of CPP (see Chapter 4, Fig. 4.5.F), 
it is possible that α4βδ GABAARs may play a general role in modulating potentiation of 
behaviours by cocaine. The implications and limitations of this hypothesis will be 
discussed later (see Chapter 6).  
 
The specificity of these mechanisms to the NAc was confirmed after an intra-accumbal 
viral knockdown of α4-subunits produced an increased CRf response comparable to that 
of constitutive knockout mice. The location of the viral infusions was largely confined 
to the NAc core, suggesting that inhibition of NAc core MSNs through α4-GABAAR 
activity serves as a mechanism to limit levels of responding for conditioned reinforcers. 
This is not surprising given that previous evidence shows the NAc core rather than shell 
to be implicated in the expression of instrumental responses for conditioned stimuli 
(Kelley et al., 1997; Bassareo and Di Chiara, 1999; Parkinson et al., 1999; Ito et al., 
2000; Parkinson et al., 2000). However, as the effects of viral knockdown of α4-
subunits in the NAc shell are yet to be explored, their possible influence in mediating 
responding with CRf cannot be discounted. Administration of systemic THIP interfered 
with cocaine-potentiated CRf responding in both control and α4-subunit knockdown 
mice. It is possible that systemic THIP may have acted at α4-GABAARs within the NAc 
shell (which we presume to be unaffected in both virus groups) to block the potentiation 
of CRf responding by cocaine. Indeed evidence indicates that the NAc shell rather than 
core is involved with psychostimulant potentiation of CRf responding (Parkinson et al., 
1999). However, a decrease in baseline CRf responding also occurs in both control and 
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α4-subunit knockdown mice. This is interesting, as a decrease in cocaine-CPP is not 
observed following systemic THIP at the same dose (see Chapter 4, Fig. 4.4.B). It is 
possible that systemic THIP may inhibit the ability to perform more complex 
instrumental tasks such as the nose-poke responses in CRf, but not simpler motor 
behaviours such as Pavlovian approach in CPP. These systemic THIP effects are likely 
to be due to an action at δ-containing GABAARs outside of the NAc as a decrease in 
baseline CRf responding does not occur following intra-accumbal administration of 
THIP at a dose that blocks cocaine-potentiation of CRf in wildtype mice.  
 
Interestingly, the virus experiment indicates that α4-subunit expression within the NAc 
only needs to be reduced by a proportion (67%) to get a similar behavioural effect to 
that produced by a total deletion of α4-subunits in the constitutive knockout mice. This 
is further emphasized by evidence that heterozygote α4+/- mice, with 50% expression of 
α4-subunits, demonstrate a similar level of CRf responding as α4-/- mice rather than WT 
mice (data not shown). This suggests that α4-GABAARs are maximally active during 
CRf responding, as any reduction in α4-subunits has a behavioural impact, and intra-
accumbal THIP does not affect responding. Interestingly, previous evidence indicates 
that sustained inhibition of NAc MSNs, disinhibits target regions, permissively gating 
and maintaining appetitive behaviors (Taha and Fields, 2006). Tonically active 
extrasynaptic α4-GABAARs may provide the mechanism by which this sustained 
inhibition is achieved. 
 
Finally, the contribution of α4-GABAAR–mediated inhibition of distinct striatal 
pathways was explored using mice in which α4-subunits had been deleted from either 
dopamine D1 or D2-expressing neurons. The increased CRf responding seen in both the 
α4- constitutive knockout and α4-viral knockdown mice was replicated in D2-specific 
knockout mice only, as was the THIP blockade of cocaine-potentiated responding seen 
in constitutive knockouts. Mice with the α4 receptor ablated from D1-expressing 
neurons were indistinguishable in their behaviour from wildtypes. Constitutive and 
dopamine D1 and D2-specific α4-KO mice, as well as α4-subunit viral knockdown mice 
demonstrated a similar ability to learn the reward-predictive properties of a conditioned 
cue as the WT mice in all experiments. Thus, α4-GABAARs do not appear to be 
involved in Pavlovian associative learning processes, but rather mediate the expression 
of behavioural responses to conditioned stimuli.   
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Electrophysiological evidence indicates that activation of dopamine D2-receptors 
induces a reduction of α4βδ GABAAR-mediated tonic currents in NAc D2-MSNs, 
which presumably increases the excitability of these neurons (Maguire et al, submitted). 
Here it is demonstrated that release of D2-expressing neurons from α4-GABAAR-
mediated inhibition results in increased responding for a conditioned reinforcer, 
suggesting that activation of D2-MSNs (possibly through dopamine agonsim) 
potentiates CRf responding. Indeed, this is in agreement with previous evidence that 
D2-receptor agonists quinpirole and bromocriptine both facilitate CRf responding 
(Beninger et al., 1989; Beninger and Ranaldi, 1992). The current experiments also 
indicate that the NAc is likely the site of action of D2-neuron-mediated potentiation of 
CRf responding. Mice with a viral knockdown of α4-subunits within the NAc 
demonstrate a similar phenotype to constitutive and D2-specific α4-subunit knockout 
mice, with increased responding for a conditioned reinforcer. This is supported by 
previous evidence that intra-accumbal administration of quinpirole increases CRf 
responding (Wolterink et al., 1993). The potentiation of CRf responding by 
psychostimulants also appears to be mediated by D2-MSNs within the NAc. In the 
current experiments, intra-accumbal THIP at a high dose was able to block the cocaine-
potentiation of CRf responding in wildtype but not their counterpart constitutive or D2-
specific α4-subunit knockout mice. This role of D2-MSNs is further supported by 
evidence that intra-accumbal administration of D2-antagonist raclopride blocks 
amphetamine-induced potentiation of CRf responding (Wolterink et al., 1993). 
 
If an action of dopamine agonsim is to reduce tonic GABAergic currents in D2 cells, 
then THIP would be expected to oppose this as it would overrule decreased tonic 
inhibition. However, decreased tonic currents were only observed when NAc D2-MSNs 
were incubated in dopamine agonists, suggesting reduced inhibition is not a rapidly 
induced effect, and so may only come into play with sustained agonism of D2 dopamine 
receptors, as might be expected following cocaine administration. If under physiological 
conditions dopamine levels are not sufficient to switch off tonic currents then THIP has 
nothing to oppose, and so has no behavioural effect. Therefore, it could be predicted 
that in heterozygote mice THIP would produce a reduced attenuation of cocaine-
potentiation of CRf responding. This would likely need to be tested with intra-accumbal 
THIP, as in α4-subunit viral knockdown and control mice systemic THIP reduced 
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baseline and cocaine-potentiated CRf responding to minimal levels, indicating it 
interferes with the ability to produce nose-poke instrumental responses. 
 
The enhanced CRf responding observed following release of D2- but not D1-expressing 
neurons from α4-GABAAR-mediated inhibition is interesting, given that D1- but not 
D2-specific α4-subunit knockout mice show an increased cocaine-CPP effect compared 
with wildtype counterparts (see Chapter 4, Fig. 4.6.A). Deletion of α4-GABAARs from 
D1-expressing neurons did not increase CRf responding, and THIP-potentiated α4-
GABAAR-mediated inhibition of D1-expressing neurons was not able to block cocaine 
potentiation of CRf responding. Interestingly, previous evidence reveals that 
pharmacological activation of D1-receptors using full and partial agonists produces 
varying effects on CRf responding. Intra-accumbal infusion of the D1-receptor agonist 
SKF 38393 dose-dependently potentiates CRf responding (Wolterink et al., 1993). 
However, systemically, SKF 38393, and D1-receptor partial agonists SKF 81297, SKF 
77434 and CY 208-243 do not alter CRf responding at low-to-medium doses, but all 
impair responding for conditioned reinforcers at high doses (Beninger and Rolfe, 1995). 
It is difficult to extrapolate intracranial doses to those used systemically, however these 
data may provide evidence for a dose-dependent inverted U-shaped potentiation of CRf 
responding, as is seen following systemic psychostimulant administration (Beninger and 
Ranaldi, 1992). A mechanism to explain this curve may be provided by 
electrophysiological evidence that activation of D1-receptors increases α4-GABAAR-
mediated tonic currents in NAc D1-MSNs, thus acting as a homeostatic control to 
prevent excessive neuronal excitation by dopamine at these neurons (Maguire et al, 
submitted). Thus when α4-GABAAR-mediated inhibition is removed from D1-
expressing neurons it may produce an over-activation of D1-receptors by dopamine and 
block any potentiating effects of activation of D1-neurons. This may explain the current 
experiments where D1-specific α4-subunit knockout mice demonstrate a similar level of 
CRf responding as their wildtype counterparts. The potentiating effects of cocaine in 
these mice would therefore be a product of activation of D2-receptors on D2 MSNs, 
masking a detrimental effect of over-activation of D1-MSNs.  
 
Currently proposed models of striatal functioning hold that activation of MSNs within 
the direct and indirect pathways produce opposing effects, enhancing or inhibiting 
reward-seeking, respectively (Kravitz and Kreitzer, 2012; Kravitz et al., 2012). 
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However, it is unclear how D1- and D2-MSN control over behavioural responses to 
conditioned stimuli may fit into these models.  D2- rather than D1-expressing MSNs 
appear to be important in the mediation of CRf responding, as demonstrated by an 
increased response following their release from α4-GABAAR-mediated inhibition. The 
protective influence of α4-GABAARs on D2-neurons in CRf responding and its 
potentiation by cocaine occurs within the NAc, therefore it could be hypothesised that 
α4-GABAARs may be functioning to modulate the incentive salience of conditioned 
stimuli, and/or the motivation for instrumental responding. Indeed, D2-MSNs have 
previously been implicated in the computation of costs and benefits, as well as the 
mediation of motivation for effortful behaviour (Trifilieff et al., 2013). PET studies in 
rodents and humans indicate that D2-receptor availability in the striatum is positively 
correlated with optimal goal-directed behaviour and levels of positive incentive 
motivation (Dalley et al., 2007; Tomer et al., 2008). Similarly, overexpression of D2-
receptors in the NAc of mice using a viral vector is able to increase motivation to work 
for a food reward without altering the representation of the value of the reward 
(Trifilieff et al., 2013). The increased CRf responding following disinhibition of D2-
expressing neurons in the current experiments may be the result of a similar such 
increase in motivation to respond for a rewarding stimuli, in this case a conditioned 
reinforcer rather than a primary reward. As activation of α4-GABAARs on D2-
expressing neurons (by THIP) is able to block the potentiating effects of cocaine it is 
possible that cocaine potentiation of CRf responding is also a result of a D2-MSN-
mediated increase in motivation. It is yet unclear whether this may be occurring through 
the same potentiating effect of increased MSN (presumably D2-MSN) excitability 
within the NAc core, as demonstrated by the virus experiment. Alternatively, cocaine 
potentiation of CRf responding may be the result of dopamine activation of D2-MSNs 
within the NAc shell, as previous evidence suggests (Parkinson et al., 1999). 
 
These questions may be elucidated by further experiments employing the use of viral 
knockdown of α4-subunits specifically within the NAc shell. Additionally, optogenetic 
and chemicogenetic techniques, such as those used in CPP experiments (Hikida et al., 
2010; Lobo et al., 2010), would allow direct activation or inhibition of either D1- or D2-
MSNs of the direct and indirect striatal pathways, respectively. This would provide an 
efficacious method of testing the predictions made as a result of the current experiments 
regarding the role of D1- and D2-MSNs in mediating responding for CRf. 
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To conclude, these data suggest that α4-GABAAR inhibition of dopamine D2-
expressing NAc MSNs is a critical mechanism for controlling the expression of 
behavioural responses to conditioned stimuli. Furthermore, these experiments provide 
additional evidence that α4-GABAARs are critically involved in modulating the 
potentiating effects of cocaine in behaviours associated with addiction to drugs of 
abuse. 
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Chapter	  6	  	  
General	  Discussion	  	  	  The	   data	   presented	   within	   this	   thesis	   have	   helped	   to	   elucidate	   a	   role	   for	   α4-
GABAARs in mediating locomotor and reward-conditioned behaviours associated with 
addiction to drugs of abuse. α4βδ-GABAARs have been shown to be able to modulate 
baseline and acute cocaine-potentiated locomotor activity, as well as the ability of 
repeated cocaine to produce a sensitised increase in activity. Additionally, α4-
GABAARs produce pathway-specific effects in the initiation of reward-seeking 
behaviours by conditioned contextual or discrete cues, and the ability of cocaine to 
enhance these behaviours. A discussion of the physiological mechanisms thought to 
underlie these findings and their wider implications will be presented here.	  	  
6.1. α4-GABAARs in Locomotor Activity 	  The	   locomotor	   experiments	   in	   this	   thesis	   indicate	   that	   α4-GABAAR-mediated 
inhibition of NAc MSNs is able to attenuate the ability of cocaine-increased dopamine-
facilitation of glutamatergic NAc inputs to potentiate locomotor activity.  
 
Deletion of the Gabra4 gene encoding α4-subunits did not affect baseline locomotor 
activity or the ability of cocaine to enhance locomotor activity. However, 
pharmacological activation of α4βδ GABAARs using systemic THIP was able to reduce 
both baseline (when analysed using the first 5 minutes of activity) and cocaine-
potentiated locomotor activity in WT but not α4-/- mice. This is in agreement with 
previous reports of a dose-dependent reduction in baseline locomotor activity following 
systemic THIP (Agmo and Giordano, 1985; Herd et al., 2009; Vashchinkina et al., 
2012). Similarly, a 3µM dose of intra-accumbal THIP attenuated cocaine-potentiated 
locomotor activity, indicating that the NAc is likely to be the site of action for effects 
seen with systemic THIP.   
 
Functionally, the predominant effect of THIP in the NAc is probably a suppression of 
MSN excitability, due to activation of postsynaptic α4βδ receptors and the associated 
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decreased input resistance (Maguire et al, submitted). Thus, THIP activation of α4βδ 
GABAARs on NAc MSNs will increase tonic inhibitory currents and promote a 
downstate in these neurons. This will presumably limit the excitability of these neurons 
in response to glutamatergic inputs, and reduce the ability of dopamine to facilitate 
excitatory inputs. As release of NAc MSNs from α4βδ GABAAR-mediated tonic 
inhibition in α4-/- mice did not increase locomotor activity it appears that under normal 
physiological conditions, there exists little tonic inhibition.  
 
While a 3µM dose of intra-accumbal THIP is able to block cocaine-potentiation of 
locomotor activity, it does not alter cocaine-enhancement of cocaine-CPP or CRf 
responding. It is possible that during cocaine-CPP and CRf, NAc MSNs are put into an 
upstate by excitatory inputs in response to conditioned cues. Therefore, a greater dose of 
THIP would be needed to produce sufficient inhibition to block behaviour. Indeed, a 
3mM dose of intra-accumbal THIP is able to block cocaine-enhancement of cocaine-
CPP or CRf responding, but, interestingly, it has no affect on cocaine-potentiation of 
locomotor activity. When given in the absence of cocaine, this dose of 3mM intra-
accumbal THIP is able to greatly increase locomotor activity in WT and, to a lesser 
extent, α4-/- mice. A proportion (approximately half) of this increase appears to be 
mediated by receptors other than α4-GABAARs, although possibly containing δ-
subunits, as α4-/- mice also show an increase in activity. However, an explanation for the 
α4-dependent proportion of the increase in WT mice is still elusive. It is possible that 
the increase in locomotor activity seen at this 3mM intra-accumbal dose overrides the 
ability of THIP to inhibit NAc MSNs and attenuate cocaine potentiation of locomotor 
activity.  
 
These data indicate that α4-GABAARs within the NAc provide an efficacious target for 
control of locomotor activity and its potentiation by cocaine. Interestingly, systemic or 
intra-accumbal THIP-induced changes in baseline- and cocaine-potentiated locomotor 
activity do not appear to directly affect cocaine-CPP or CRf responding.  
 
6.2. α4-GABAARs in Behavioural Sensitisation to Cocaine 
Deletion of GABAAR α4-subunits did not alter the augmentation of locomotor activity 
observed following repeated, intermittent cocaine, indicating that unlike α2-GABAARs, 
α4-GABAARs are not involved in the development of behavioural sensitisation to 
	   165	  
cocaine. These data indicate that α2- and α4-GABAARs play dissociable functional 
roles in the NAc. It is hypothesised that α2-GABAARs may mediate a lateral inhibition 
of NAc MSNs required for behavioural sensitisation, while α4-GABAARs likely 
mediate a general tonic inhibition of NAc MSNs (Dixon et al., 2010). Indeed, as with 
locomotor activity following acute cocaine, systemic THIP was able to reduce the 
sensitised increase in locomotor activity. 
 
6.3. α4-GABAARs in Cocaine-CPP 
Investigation of the role of α4-GABAARs in cocaine-CPP revealed that deletion of α4-
subunits did not alter acquisition of cocaine-CPP. However, specific deletion from 
dopamine D1- but not D2-expressing neurons was able to increase the time spent in the 
cocaine-paired chamber, presumably due to an increase in D1-MSN excitability. This 
data is in agreement with previous evidence demonstrating optogenetic activation of 
D1-expressing NAc MSNs during cocaine-paired chamber conditioning to enhance 
acquisition of cocaine-CPP (Lobo et al., 2010).  
A major novel finding of this thesis was that a cocaine challenge given during the test 
session enhanced the cocaine-CPP effect in wildtype, constitutive and dopamine D1-, 
but not D2-expressing neuron specific GABAAR α4-subunit knockout mice. It is 
hypothesized that this may be explained by the interoceptive properties of cocaine 
increasing the salience of the CPP. 
Finally, pharmacological activation of α4βδ-GABAARs by THIP suppressed cocaine 
enhancement of the CPP effect in wildtype but not constitutive and dopamine D1-
expressing neuron specific GABAAR α4-subunit knockout mice. Thus α4βδ-GABAAR 
modulation of MSN excitability plays a role in regulating dopamine’s effects in the 
NAc.  
6.4. α4-GABAARs in CRf 
Following global deletion of GABAAR α4-subunits, Pavlovian conditioning of a 
discrete cue with a food reward was unaffected, but instrumental responding for this 
conditioned reinforcer was increased. Subsequent investigation revealed viral 
knockdown of α4-subunits specifically within the NAc resulted in a similar increase in 
CRf responding. Targeted deletion of α4-subunits from dopamine D2-, but not D1-
expressing neurons also demonstrated an increased CRf responding phenotype.  
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CRf responding was potentiated in all genotypes by cocaine challenge during the test 
session. Cocaine potentiation of CRf responding was blocked by a 3mM dose of intra-
accumbal THIP in wildtype and dopamine D1-expressing neuron specific, but not 
constitutive or D2-expressing neuron specific GABAAR α4-subunit knockout mice.  
 
These data indicate that α4-GABAAR-mediated inhibition of dopamine D2-expressing 
NAc MSNs is a critical mechanism for controlling the expression of behavioural 
responses to conditioned stimuli. In addition to the cocaine CPP experiments, these data 
provide evidence that α4-GABAARs are critically involved in modulating the 
potentiating effects of cocaine in behaviours associated with addiction to drugs of 
abuse. 
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Table 6.1. 
Behaviour Constitutive α4-/- α4D1-/- α4D2-/- 
Cocaine-potentiated  
locomotor activity 
Normal ? ? 
Behavioural sensitisation  
to cocaine 
+ THIP 
Normal 
 
Not Blocked 
? 
 
? 
? 
 
? 
Cocaine-CPP Normal Enhanced Normal 
Cocaine-enhanced Cocaine-CPP  
+ THIP 
Normal 
Not Blocked 
Normal 
Not Blocked 
Absent 
- 
CRf Enhanced Normal Enhanced 
Cocaine potentiated CRf 
+ THIP 
Normal 
Not Blocked 
Normal 
Blocked 
Normal 
Not Blocked 
Table 6.1. Summary of the behavioural consequences of constitutive or dopamine D1-
/D2-expressing neuron specific GABAAR α4-subunit knockout mice, and 
pharmacological activation of α4βδ-GABAARs by THIP. 
 
 
6.5. A Dissociation Between NAc MSNs Mediating Reward-Seeking in Response to 
Contextual or Discrete Cues?  
 
A main finding of this thesis is that deletion of α4-GABAARs from D1-expressing 
neurons increases cocaine-CPP, while deletion from D2-expressing neurons increases 
CRf responding. Thus, α4-GABAARs on NAc dopamine D1- or D2-MSNs appear to 
have dissociable roles in modulating various aspects of conditioned reward-seeking. 
Electrophysiological evidence indicates that α4-GABAARs have a similar physiological 
role on both D1- and D2-MSNs, mediating a tonic inhibition that controls the ability of 
excitatory inputs to generate an action potential in the MSN output projections of both 
the indirect and direct pathways (Maguire et al, submitted). Thus, the dissociation 
between the neurons mediating these two behaviours may be better explained by the 
difference in the glutamatergic inputs onto these two neuronal groups and the 
information that they provide.  
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NAc MSNs are known to receive multiple inputs from several afferent structures, 
including the amygdala, PFC, and hippocampus (French and Totterdell, 2003; Stuber et 
al., 2011; Stamatakis and Stuber, 2012). It could be hypothesised that while 
glutamatergic projections from cortical and subcortical regions project to both D1- and 
D2-MSNs, information about contextual cues needed for cocaine-CPP may be provided 
by inputs onto NAc D1-MSNs, while information about discrete cues important for CRf 
responding arrives onto D2-MSNs. Indeed, blockade of NMDA conductance 
specifically in D1-MSNs by selective expression of an NR1 subunit, which contains a 
mutation in the pore that reduces calcium flux, decreases acquisition of cocaine-CPP 
(Heusner and Palmiter, 2005). The origin of these glutamatergic inputs onto D1-MSNs 
is currently unknown. However it is thought that projections from the hippocampus to 
the NAc may provide information about contextual cues during acquisition and 
expression of CPP (Ferbinteanu and McDonald, 2001; Britt et al., 2012). This would 
suggest that the enhanced cocaine-CPP seen in α4D1-/- mice may be the result of an 
increased ability of glutamatergic inputs from the hippocampus to excite D1-MSNs 
within the NAc in the absence of α4-mediated inhibition. 
 
At present, little is known about glutamatergic projections onto NAc D2-MSNs. The 
increased CRf responding following removal of α4-GABAAR tonic inhibition from D2-
MSNs suggests that glutamatergic inputs onto D2-MSNs may be important for driving 
responding for conditioned reinforcers. Thus, activity in the indirect pathway might not 
necessarily be a reward-opposing, demotivating force, as some models propose (Kravitz 
et al., 2012), but it could simply encode a separate dimension of certain behaviors (Britt 
et al., 2012). Indeed, it might be that D2-MSNs are the site of input within the NAc for 
information about discrete cues arriving from areas including the PFC and BLA. This 
hypothesis is supported by evidence that the D2 receptor antagonists metoclopramide 
and haloperidol inhibit responding for a food-conditioned reinforcer and disrupt 
secondary cue-induced cocaine-seeking, respectively (Beninger et al., 1987; Gál and 
Gyertyán, 2006). Interestingly, deletion of mGlur5 receptors specifically from NAc D1-
MSNs also attenuates CRf responding, suggesting that glutamatergic signaling at D1-
MSNs may also play a role in CRf responding (Novak et al., 2010). However, in the 
current experiments removal of α4-GABAAR-mediated tonic inhibition from D1-MSNs 
did not increase CRf responding. It is still unclear how these data fit together into 
neurobiological model of CRf. 
	   169	  
 
Further support for a dissociation in the roles of direct and indirect pathways in 
mediating distinct reward-seeking behaviours may be provided by evidence that specific 
patterns of NAc dopamine release help to enhance or attenuate glutamatergic activation 
of either D1- or D2-MSNs. Under normal conditions, a tonic, basal level of DA release 
is thought to maintain the balance between limbic and cortical inputs in the NAc (Goto 
and Grace, 2005). Therefore, both increases and decreases in NAc dopamine release 
may exert a potent effect on the influence of information delivered to NAc MSNs via 
glutamatergic projections. D1 and D2 receptors show low and high affinities to 
dopamine, respectively (Creese et al., 1983). It is thought that D1 receptor activation 
requires phasic DA release, while D2 receptors are activated continuously by basal, 
tonic DA release (Grace, 1991). Within the NAc, phasic dopamine release activates D1 
receptors to selectively facilitate hippocampus inputs at D1-MSNs, indicated by an 
increased local field potential response (Goto and Grace, 2005). On the other hand, 
increased or decreased tonic DA release impacts D2 receptors, producing an attenuation 
or facilitation, respectively, of PFC, but not hippocampal inputs at D2-MSNs (Goto and 
Grace, 2005). Therefore, increased NAc phasic dopamine release may enhance the 
influence of contextual cue information from the hippocampus onto D1-MSNs needed 
for cocaine-CPP. Whereas, decreased tonic NAc dopamine release may enhance the 
influence of discrete cue information from the PFC onto D2-MSNs important for CRf 
responding. However, phasic dopamine is known to be released within the NAc in 
response to both contextual cues in cocaine-CPP (Schiffer et al., 2009), and discrete 
cues associated with rewards (Schultz, 1998; Weiss et al., 2000). Thus, a mechanism 
must exist by which PFC inputs onto D2-MSNs that can overrule phasic dopamine-
induced strengthening of hippocampal inputs onto D1-MSNs. Indeed, administration of 
the D2 antagonist eticlopride during phasic dopamine release is able to attenuate 
facilitation of hippocampus inputs (Goto and Grace, 2005). A decrease in tonic 
dopamine release, and the resulting facilitation of PFC inputs, would therefore attenuate 
hippocampus afferent drive. It is still unknown how amygdala projections onto NAc 
neurons may be modulated by dopamine; however given their proposed role in CRf 
responding (Everitt et al., 1999; 2000), it might be predicted they would also 
demonstrate enhanced excitement of D2-MSNs in response to decreased tonic 
dopamine. 
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The findings of this thesis reveal that activation of α4-GABAARs specifically on D1- or 
D2-expressing neurons may a provide mechanism by which reward-conditioned 
behaviours can be controlled. It will be discussed later how targeting these receptors can 
be predicted to be efficacious in the treatment of addiction-related behaviours (see 
6.7.1.). 
6.6. Does Activation of α4-GABAARs Attenuate Cocaine-Potentiation of 
Behaviours by Inhibition of MSNs Within the NAc Shell? 
 
Given that intra-accumbal THIP is able to block cocaine-enhancement of cocaine-CPP, 
CRf responding and locomotor activity (albeit at different doses), it appears that α4βδ 
GABAARs within the NAc play a critical role in the modulation of the behaviour-
enhancing properties of psychostimulants. In rats, the ability of psychostimulant to 
potentiate CRf responding is reported to be mediated by NAc shell region (Parkinson et 
al., 1999; Ito et al., 2000). However, delineation of regions involved in psychostimulant-
increased locomotor activity is more complex, with rat studies indicating the 
involvement of the NAc shell (Heidbreder and Feldon, 1998), core (Boye et al., 2001; 
Sellings and Clarke, 2003; 2006) or even both regions (Ikemoto, 2002). Here, for the 
first time, it is demonstrated that psychostimulants are also able to enhance cocaine-
induced CPP.  
 
The co-ordinates used for the intra-accumbal infusions in the current experiments are 
situated at what is described to be the dorsomedial NAc core/shell boundary (Paxinos 
and Franklin, 2001). Thus, it is likely that THIP would activate α4βδ GABAARs within 
the both the NAc core and shell. In this case, the THIP-induced blockade of the 
enhancing effects of cocaine on CRf responding, CPP and locomotor activity may be 
due to a α4βδ GABAAR-mediated tonic inhibition of MSNs within the NAc shell. 
Interestingly, activation of α4-GABAARs on D1-MSNs by THIP blocks cocaine 
enhancement of cocaine-CPP, while removal of these receptors from D1-MSNs 
increases cocaine-CPP. Conversely, activation of α4-GABAARs on D2-MSNs by THIP 
blocks cocaine potentiation of CRf responding, while removal of these receptors from 
D2-MSNs increases CRf responding. Thus, cocaine-enhancement of cocaine-CPP and 
CRf responding appears to be modulated by activation of α4βδ GABAARs on the same 
MSN type as those on which deletion of these receptors increases cocaine-CPP and CRf 
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responding respectively. It is possible that the increase in cocaine-CPP and CRf 
responding observed in α4D1-/- and α4D2-/- mice, respectively, in the absence of cocaine, 
may also be the result of a disinhibition of NAc shell neurons, allowing a greater 
response to ambient levels of dopamine. However, an increase in CRf responding was 
also observed following a viral knockdown of α4-subunits that was largely specific to 
the NAc core. This indicates that, at least for CRf responding, the NAc core plays an 
important role in mediating behavioural responses to conditioned stimuli.  
 
In conclusion, it is possible that there may be NAc core/shell dissociation in the 
mediation of the baseline effect and the enhancement by cocaine of cocaine-CPP and 
CRf responding. However, if this is the case, it is clear that the ability of cocaine to 
enhance these behaviours is complex and involves activation of the same MSN types 
that mediate the baseline effect. A more plausible explanation for the current data would 
be that the same MSN ensembles mediate the baseline effect and the enhancement by 
cocaine, although, at present, not enough data is available to ascertain the location 
within the NAc of these MSNs. Finally, it is also still unknown whether the attenuation 
of cocaine potentiated locomotor activity by intra-accumbal THIP is mediated by 
activation of α4βδ GABAARs on D1- MSNs, D2-MSNs or the combination of both.  
 
6.7. Implications for Drug Abuse 
 
6.7.1. Compounds acting at α4-GABAARs as a treatment for cocaine abuse? 
The experiments of this thesis reveal that α4-GABAARs are able to modulate 
behavioural responses to reward-conditioned cues, indicating that compounds acting at 
α4-GABAARs may have potential therapeutic value in the treatment of some behaviours 
associated with drug addiction. Unfortunately, systemic or intra-accumbal 
administration of THIP was not able to reduce cocaine-CPP and CRf responding under 
drug-free (baseline) test conditions. However, THIP was able to reduce cocaine-
enhancement of cocaine-CPP, CRf responding and locomotor activity, as well as 
behavioural sensitisation to cocaine. These data indicate that THIP is able to block the 
energising effects of cocaine. Although unclear what the effects may be in humans, it 
could be speculated that THIP may hold a potential therapeutic value in blocking the 
hyperlocomotor and drug-seeking potentiating effects of cocaine while the drug is still 
within the system. It could also be speculated that THIP may be able to block other 
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effects of cocaine, including the subjective euphoric effects in humans. However, when 
administered systemically, THIP also has sedative properties. Therefore until THIP 
activation of α4βδ GABAARs can be targeted specifically to the NAc, this compound 
may have limited therapeutic use in treating cocaine abuse. However, an additional 
problem is that deletion of GABAAR α4-subunits from the NAc has been revealed to 
reduce alcohol drinking in mice (Rewal et al., 2009; Lobo et al., 2010; Rewal et al., 
2011). Therefore although targeting these subunits pharmacologically with THIP or 
other compounds may be beneficial for reducing the effects of cocaine, it could be 
speculated that they may produce other adverse effects, i.e. increased alcohol drinking.  
 
6.7.2. Investigation of GABRA4 genes in humans 
Linkage and association analysis indicates that a region of chromosome 4p (the 16-cM 
region), containing a cluster of genes encoding a number of GABAAR subunits, 
including Gabra2 and Gabra4, is associated with an increased risk of drug dependence 
(Reich et al., 1998; Edenberg, 2002; Enoch, 2008; Enoch et al., 2013). Indeed, single 
nucleotide polymorphisms (SNPs) of the Gabra2 gene are associated with alcohol 
dependence and cocaine addiction in humans (Edenberg et al., 2004; Dixon et al., 
2010). Given that this thesis reveals deletion of the Gabra4 gene in mice to alter the 
behavioural response to reward-conditioned cues, it could be hypothesised that SNPs or 
altered expression of the Gabra4 gene in humans may also be associated with drug 
addiction. However, although post-mortem analysis of GABAergic gene expression has 
revealed the Gabra2 gene to be altered in hippocampus of alcohol and cocaine addicts, 
Gabra4 expression was unaltered (Enoch et al., 2012; 2013). Similarly, an association 
study revealed that six Gabra4 SNPs were not significantly correlated with risk for 
alcohol dependence (Edenberg et al., 2004). Future studies may benefit from 
investigation of other Gabra4 SNPs and changes in Gabra4 expression within the NAc 
of alcohol and cocaine addicts.  
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6.8. Considerations 
 
6.8.1. The use of THIP to target α4-GABAARs 
At present there are limited pharmacological tools for the specific activation of α4-
GABAARs. In this thesis the GABAAR agonist THIP was used due to its preferred 
action at δ-subunit containing GABAARs, which within the NAc are largely co-
assembled with α4-subunits in extrasynaptic locations (Pirker et al., 2000; Belelli et al., 
2005; Brickley and Mody, 2012). However, it has been reported that THIP	  doses	  over	  3µM may begin to act at γ2-containing synaptic GABAARs in addition to its action at δ-
containing extrasynaptic receptors (Ebert et al., 1994; Mortensen et al., 2004; 2010). In 
the locomotor activity experiments presented in this thesis there is some evidence that 
intra-accumbal 3mM THIP may have also acted at receptors other than α4-GABAARs. 
However, in the cocaine-CPP and CRf studies the behavioural effects of 3mM THIP 
were contingent upon the presence of α4-subunits within the NAc. Recent 
immunohistochemical analysis of NAc slices reveals that the expression pattern of the 
GABAAR α4-subunit is indistinguishable from that of GABAAR δ-subunits, and distinct 
from expression of neuroligin2 (NL2), a cell adhesion protein that is selectively 
expressed in inhibitory synapses (Maguire et al, submitted). Thus, there appears to be 
few or no synaptic α4-GABAARs within the NAc, indicating that the α4-GABAAR-
mediated effects of intra-accumbal 3mM THIP observed in the cocaine-CPP and CRf 
experiments are highly likely to be due to an action at extrasynaptic α4βδ receptors. 
 
The recent creation of delta-selective compound 2 (DS2), a novel positive allosteric 
modulator of δ-containing GABAARs may help to specifically target extrasynaptic α4βδ 
receptors. An in-vitro concentration-response curve indicates that DS2 produces a 
similar peak stimulated inhibitory current as THIP in α4βδ receptors, but, unlike THIP, 
does not produce any response in α4βγ2 or α1βγ2 receptors even at high doses 
(Mortensen et al., 2010; Jensen et al., 2013). Unfortunately, when tested in-vivo 
systemic administration DS2 demonstrates a poor brain/plasma ratio, suggesting DS2 
does not readily cross the blood-brain barrier (Jensen et al., 2013). Indeed, systemic 
doses of up to 100mg/kg fail to produce the effect in animal models of gross 
behavioural changes (locomotor activity, rotarod) seen with relevant doses of systemic 
THIP (Wafford and Ebert, 2006; Herd et al., 2009). Similarly, problems arise with 
intracranial administration of DS2, as unlike THIP it is not readily soluble in saline 
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solution. In electrophysiological studies DS2 was dissolved in OR2 buffer 
(composition, in mM: 90 NaCl, 2.5 KCl, 2.5 CaCl2, 1 MgCl2, 5 HEPES; pH adjusted to 
7.4) (Jensen et al., 2013). However, it is unknown whether this buffer may produce 
effects on its own when infused intracranially. 
Alternatively, it may soon be possible to target α4βδ receptors specifically with the use 
of designer receptors. DREADD (designer receptor exclusively activated by a designer 
drug) receptors are receptors that have been modified such that they no longer respond 
to their endogenous ligand but instead can be activated by the administration of 
synthetic ligands. At present this technology only exists to modify G-protein coupled 
receptors, but similar such techniques have been used to modify ligand-gated ion 
channels such as GABAARs, such that they are specifically activated by certain drugs.  
Zolpidem, a systemically active allosteric modulator that enhances the function of the 
GABAARs, requires a phenylalanine residue (Phe77) in the γ2-subunit. By changing 
this residue to isoleucine, then subsequently modifying γ2-subunits on specific neurons 
using Cre recombinase (exchanging Ile77 for Phe77), zolpidem sensitivity can be 
restored to chosen cell types (Wulff et al., 2007). Similar such techniques could one day 
be created for δ-subunit containing GABAARs and may be able to be used in 
combination with dopamine D1- or D2-cre-recombinase lines to allow these receptors to 
be activated specifically on D1- or D2-expressing neurons.  
 
6.8.2. The use of mouse behavioural paradigms to model addiction-associated 
behaviours 
It is also important to consider the limitations of the behavioural paradigms used within 
this thesis. Firstly, although neural and behavioural sensitisation has been widely 
documented in animals, it has been questioned whether such sensitisation also occurs in 
humans. Investigation of neuroadaptations in human cocaine addicts has produced 
conflicting results. While some studies report that repeated intermittent administration 
of amphetamine results in sensitisation of dopamine release (Boileau et al., 2006), 
others have found that detoxified cocaine addicts actually show a decrease in evoked 
dopamine release rather than a sensitised increase (Volkow et al., 1997; Martinez et al., 
2007). Behaviourally, there is some evidence for progressive drug effects in humans. 
Repeated amphetamine increased self-report of the subjective effects of the drug 
(Strakowski et al., 2001; Boileau et al., 2006), and clinician-rated levels of energy and 
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motor activity (Strakowski et al., 1996; Strakowski and Sax, 1998). However, other 
studies have failed to find evidence for a sensitisation of subjective drug effects 
following repeated amphetamine administration (Johanson and Uhlenhuth, 1981; Kelly 
et al., 1991). An explanation for these conflicting reports may be that in humans, as with 
in animals, the expression of sensitisation is powerfully modulated by the context of the 
drug administration (Robinson and Berridge, 2008). Thus, a drug challenge in the test 
environment may not result in the expression of behavioural sensitisation as it would in 
the context where the drugs were previously taken. Further investigation is needed to 
elucidate the complexity of behavioural sensitisation in humans. 
 
There are also a number of limitations with using CPP as a model of the drug-seeking 
behaviour. Firstly, it has been questioned whether pairing the drug with one context 
may block or impair the habituation to that environment, rendering it more novel when 
compared with the saline-paired chamber (Bardo and Bevins, 2000). Animals are 
known to prefer novel contexts over familiar contexts (Hughes, 1968; Parker, 1992). A 
method to overcome this problem would be to include a third chamber to the apparatus 
to create three distinct contexts, one that is drug-paired, one that is saline-paired, and 
one that is novel. Secondly, it could be questioned whether CPP is directly comparable 
with drug-seeking in humans as in the CPP paradigm animals passively receive drugs 
rather than self-administering them. Indeed, animal studies comparing CPP to drug self-
administration reveal that the increase in dopaminergic activity observed with self-
administration of stimulant drugs is attenuated in yoked control animals that receive the 
drug passively (Di Ciano et al., 1996; Hemby et al., 1997; Stefanski et al., 1999). A 
solution to this may be to modify the CPP design so that the animal is able to self-
administer the drug or saline while confined in the drug- or saline-paired chamber. 
6.8.3. Genetic limitations 
A limitation of the use of mutant mouse lines is that genetic alteration of gene 
expression often results in compensatory changes in other gene products. Indeed, in this 
thesis, qRT-PCR analysis of NAc tissue samples revealed that mRNA expression levels 
of two GABAAR subunits were altered following global or dopamine D1-/D2-
expressing neuron specific deletion of GABAAR α4-subunits. Firstly, a decrease in δ-
subunits was detected. This is likely due to a lack or decrease in α4-subunits subunits 
for δ-subunits to associate with resulting in a downregulation. Secondly, increased 
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mRNA expression levels of the GABAAR α2-subunit were detected. As the Gabra4 and 
Gabra2 genes are located adjacently on chromosome 4 it is possible that deletion of 
Gabra4 may have interfered with expression of Gabra2. However, electrophysiological 
evidence indicates that deletion of α4-subunit has no impact on the kinetics of the phase 
currents mediated by synaptic receptors within the NAc (Maguire et al, submitted). 
Thus it appears that the increase in α2-subunits mRNA in the NAc is not translated into 
α2-subunit proteins in functional receptors. This could be further confirmed by 
investigating α2-subunit protein levels in GABAAR α4-subunit knockout mice. 
 
6.9. Future Work 
 
6.9.1. Further investigation of the role of α4-GABAARs in locomotor activity and 
behavioural sensitisation to cocaine. 
 
The findings from Chapters 4 and 5 indicate that α4-GABAARs on dopamine D1- or 
D2-expressing neurons are able to modulate both baseline and cocaine-enhanced 
cocaine-CPP and CRf behaviours. However, although ability of α4-GABAARs to 
modulate locomotor activity and its sensitisation by repeated, intermittent cocaine have 
been established, it is still unclear how α4-GABAARs expressed on neurons within 
distinct striatal pathways may control these behaviours.  
 
The investigation of the role of α4-GABAARs in controlling locomotor activity and its 
potentiation by cocaine could be extended by repeating the experiments presented in 
Chapter 2 using D1- or D2-expressing neuron specific GABAARs α4-subunit knockout 
mice. Current evidence indicates that activation of D1-expressing neurons of the direct 
striatal pathway facilitate locomotor activity, while activation of D2-expressing neurons 
of the indirect striatal pathway oppose locomotor activity (Kravitz and Kreitzer, 2012). 
Thus, it could be predicted that deletion of α4-GABAARs from D1-expressing neurons 
may disinhibit the direct pathway and increase locomotor activity, while deletion from 
α4-GABAARs from D2-expressing neurons would release the indirect pathway from 
inhibition and thus attenuate locomotor activity. If this is found to be correct, it might 
indicate that the lack of a change in baseline or cocaine-potentiated locomotor activity 
observed following constitutive deletion of α4-subunits is due to the effects of 
disinhibiting both direct and indirect pathways cancelling each other out, as was 
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observed with cocaine-CPP. In the cocaine-CPP and CRf experiments cocaine-
enhancement of these behaviours was modulated by activation of α4βδ GABAARs on 
the same MSN type as those on which deletion of these receptors increased the baseline 
effect. Based upon these evidence, it is hypothesised that cocaine-potentiation of 
locomotor activity would also be attenuated by THIP-induced activation of α4βδ 
GABAARs on D1-expressing neurons, while activation of the same receptors on D2-
expressing neurons would have no effect or possibly even increase cocaine-potentiated 
locomotor activity. 
 
In this thesis it was revealed that deletion of α4-GABAARs did not alter induction of 
behavioural sensitisation to cocaine. Nevertheless, it is possible that deletion of α4-
GABAARs from D1- or D2-expressing neurons may be able to influence this 
phenomenon. Indeed, transient disruption of D1-expressing direct striatal pathway 
neurons using a synthetic inhibitory Gαi- coupled DREADD (designer receptor 
exclusively activated by a designer drug) receptor was able to impair behavioural 
sensitisation to amphetamine, while the reverse was reported following disruption of 
D2-expressing indirect striatal pathway neurons. (Ferguson et al., 2011). Thus, as with 
the hypothesis for locomotor activity, it is predicted that deletion of α4-GABAARs from 
D1-expressing neurons would increase behavioural sensitisation to cocaine, while 
deletion of α4-GABAARs from D2-expressing neurons would attenuate sensitisation. 
This could also be investigated by co-administering THIP with cocaine in during the 
induction of cocaine behavioural sensitisation in D1- or D2-expressing neuron specific 
GABAAR α4-subunit knockout mice. 
 
6.9.2. Further investigation of the role of α4-GABAARs on D1- or D2-expressing 
neurons in controlling reward-conditioned behaviours. 
 
Earlier it was hypothesised that there may be dissociation between the NAc MSN types 
that mediate behavioural responses to contextual cues and discrete cues. If this is indeed 
correct, then it would be predicted that mice in which GABAAR α4-subunits are 
removed from D2-expressing neurons would also show a facilitation of other 
behaviours influenced by discrete cues, including Pavlovian-instrumental transfer (PIT). 
In this paradigm, discrete cues previously paired with food can markedly elevate the 
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rate of food-reinforced instrumental responding (Estes, 1943; Lovibond, 1983; Colwill 
and Rescorla, 1988). Indeed, there is some evidence to suggest that D2 receptors may 
play an important role in mediating PIT. Instrumental responding during the 
presentation of a Pavlovian cue was reduced by microinjection of the D2 receptor 
antagonist raclopride into the NAc shell (Lex and Hauber, 2008).  
 
The role of α4-GABAARs on D1- or D2-expressing neurons in controlling reward-
conditioned behaviours could also be further investigated using a procedure developed 
by Ito et al (2006), which involves the animal making behavioural responses to both 
conditioned spatial and discrete cues within the same test. Under this paradigm, animals 
are initially trained to associate a discrete cue with delivery of a sucrose reward in a Y-
maze apparatus with three topographically identical chambers. The same animals then 
undergo ‘place/contextual conditioning’ during which the conditioned discrete cue is 
presented in one, but not the other two chambers. The behavioural response to discrete 
or contextual cues could then be measured using head entries into the food magazine 
following CS presentation and time spent in the reward-paired chamber, respectively. 
Using this paradigm, Ito (2006) found lesions of the hippocampus disrupt the CPP 
effect but not magazine approaches following the discrete cue, with the reverse seen 
following BLA lesions. Based upon the findings from the cocaine-CPP and CRf 
experiments of this thesis, it is predicted that mice in which α4-GABAARs are deleted 
from D1-expressing neurons would show an unaltered behavioural response to discrete 
cues but an increased CPP effect. Whereas, mice in which α4-GABAARs are deleted 
from D2-expressing neurons are predicted to demonstrate an increased behavioural 
response to discrete cues but unaltered CPP. If these predictions are correct, these data 
would add credence to the hypothesis that information about contextual cues from the 
hippocampus is received onto NAc D1-MSNs, while information about discrete cues 
from the amygdala and PFC are received onto D2-MSNs.  
Finally, it is important to note that in the CPP and CRf expreriments described within 
this thesis, the reward received by the mouse was different between these paradigms. A 
cocaine reward was used for conditioning in the CPP paradigm, whereas, mice received 
a sucrose reward in the CRf paradigm. In future, recreating the CPP experiments of this 
thesis using a food-CPP paradigm would allow for a more direct comparison of CPP 
and CRf responding. Alternatively, the Ito (2006) procedure described above, in which 
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sucrose is conditioned to contextual and discrete cues, would also allow for a more 
direct comparison of behavioural responses to contextual and discrete cues. 
 
6.9.3. Further investigation of the role of α4-GABAARs in the NAc core or shell 
The data presented in this thesis indicate that the NAc is the site of action for α4-
GABAAR modulation of CRf responding and the ability of cocaine to enhance CRf 
responding and cocaine-CPP. However, as described above, it is still not clear whether 
α4-GABAARs may have different functional roles within the NAc core and shell.  
 
In chapter 5 (see 5.3.4.) an adenovirus was used to knockdown expression of GABAAR 
α4-subunits. Post-infusion immunohistochemical analysis of coronal brain slices 
revealed that the GFP-tagged virus was largely limited to the NAc core (see chapter 5; 
Fig. 5.3.A.). The specificity of these infusions means that future experiments could 
continue to use this protocol to explore the role of NAc core α4-GABAARs in mediating 
cocaine-CPP, locomotor activity and behavioural sensitisation to cocaine. Furthermore, 
adjustment of the infusion location could allow for specific knockdown of α4-subunits 
within the NAc shell, thus allowing a comparison between NAc core and shell α4-
GABAARs in the behaviours described. Indeed, there is already evidence that in rats α4-
GABAARs within specific locations of the NAc contribute to the reinforcing effects of 
alcohol. Viral knockdown of α4-subunits within the medial NAc shell, but not ventral or 
lateral shell, or core, reduced ethanol intake in a two-bottle choice test and instrumental 
responding for ethanol (Rewal et al., 2009; 2011).  
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6.9. Conclusions 
 
In conclusion, α4-GABAARs are potent modulators of the excitability of NAc MSNs, 
and therefore play an important role in controlling both locomotor and conditioned 
behaviours. Deletion of α4-GABAARs specifically from D1- or D2-expressing neurons 
is able to increase cocaine-CPP and CRf responding, respectively, likely through a 
disinhibition of the separate striatal output pathways within which these neurons are 
contained. Furthermore, activation of α4-GABAARs within the NAc by intra-accumbal 
THIP at specific doses, is able to attenuate the enhancement of locomotor activity, 
cocaine-CPP and CRf responding by cocaine. These data indicate α4-GABAARs within 
the NAc play an important role in controlling reward-seeking behaviours and that their 
selective agonism provides a method by which to reduce the energising effects of 
cocaine. 
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